ADVANCES IN
Applied Micro biology VOLUME 77
CONTRIBUTORS TO THIS VOLUME
I. Campbell William A. Clark
P. S. S. Daws...
40 downloads
2958 Views
20MB Size
Report
This content was uploaded by our users and we assume good faith they have the permission to share this book. If you own the copyright to this book and it is wrongfully on our website, we offer a simple DMCA procedure to remove your content from our site. Start by pressing the button below!
Report copyright / DMCA form
ADVANCES IN
Applied Micro biology VOLUME 77
CONTRIBUTORS TO THIS VOLUME
I. Campbell William A. Clark
P. S. S. Dawson Dorothy H. Geary William E. Gledhill J. M. T. Hamilton-Miller
K. L. Phillips David L. Pruess James P. Scannell Norman Shaw G. G. Stewart Wayne W. Umbreit
E. J. Vandamme J. P. Voets B. J. B. Wood
F. M. Yong
ADVANCES IN
Applied Microbiology Edited by D. PERLMAN School of Pharmacy The University of Wisconsin Madison. Wisconsin
VOLUME 17
@
1974
ACADEMIC PRESS, New York and London A Subsidiary of Harcourt Brace Jovanovich, Publishers
COPYRIGHT 0 1974, BY ACADEMIC PRESS,INC. ALL RIGHTS RESERVED. NO PART OF THIS PUBLICATION MAY BE REPRODUCED OR TRANSMITTED IN ANY FORM OR BY ANY MEANS, ELECTRONIC OR MECHANICAL, INCLUDING PHOTOCOPY, RECORDING, OR ANY INFORMATION STORAGE AND RETRIEVAL SYSTEM, WITHOUT PERMISSION IN WRITING FROM THE PUBLISHER.
ACADEMIC PRESS, INC.
111 Fifth Avenue, New York. New York 10003
United Kingdom Edition published by ACADEMIC PRESS, INC. (LONDON) LTD. 24/28 Oval Road. London NWl
LIBRARY OF
CONGRESS CATALOG CARD NUMBER:
ISBN 0-12-002617-
1
PRINTED IN THE UNlTED STATES OF AMERICA
59-13823
CONTENTS LIST
OF
CONTRIBUTORS ..............................................
ix
Education and Training in Applied Microbiology
WAYNEW . UMBREIT I. I1. I11. IV.
Introduction .................................................. Education and Training in the United States ...................... Training in Applied Microbiology in the Developing Countries . . . . . . Summary ....................................................
1 1 11 17
Antimetabolites from Microorganisms
DAVIDL. PRUESSAND I. I1. I11. IV . V. VI . VII.
JAMES
P. SCANNELL
Introduction .................................................. Definition of an Antimetabolite .................................. Detection Methods ............................................ Mechanisms of Action and Reversal .............................. Antimetabolites Isolated from Microorganisms ..................... Incidence of Antimetabolite Production ........................... Chemotherapeutic Applications .................................. Note Added in Proof .......................................... References ...................................................
19 19 21 22 24 50 51 53 54
lipid Composition as a Guide to the Classification of Bacteria
NORMANSHAW I. I1. I11. IV . V. VI.
Introduction .................................................. 63 The Major Types of Lipids Found in Bacteria ...................... 64 Analysis of Bacterial Lipids .................................... 71 Distribution of Lipids in Bacteria ............................... 74 Correlation of Lipid Composition with Taxonomic Classification ...... 98 Conclusions .................................................. 103 References ................................................... 104 V
vi
CONTENTS
Fungal Sterols and rhe Mode of Action of the Polyene Antibiotics
J . M . T . HAMILTON-MILLER I. I1. I11. IV. V. VI . VII . VIII .
Introduction .................................................. Sterols in the Microbial Kingdom ................................ Factors Affecting the Sterol Content of Fungal Cells . . . . . . . . . . . . . . . Physiological Role of Sterols .................................... Sterols and the Mode of Action of Polyenes ........................ Resistance to the Polyene Antibiotics ............................ The Role of Sterols in Resistance to the Polyenes . . . . . . . . . . . . . . . . . . Conclusions .................................................. References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
109 110 112 114 115 126 128 130 131
Methods of Numerical Taxonomy for Various Genera of Yeasts
I. CAMPBELL I. I1. I11. IV .
Theory of Classification of Yeasts ................................ Numerical Taxonomy Applied to Yeasts ........................... Comparison of Numerical and Classical Taxonomy . . . . . . . . . . . . . . . . . Application of Computer Techniques to Identification . . . . . . . . . . . . . . . References ...................................................
135 137 146 150 154
Microbiology and Biochemistry of Soy S.auce Fermentation
.
F. M . YONG AND B . J . B WOOD I. Introduction .................................................. I1. Fermented Soy Products ....................................... 111. History of Soy Sauce Production ................................ IV . Chemical Composition of Soy Sauce .............................. V . Raw Materials ................................................ VI . Treatment of Raw Materials .................................... VII . Koji ......................................................... VIII. Culturing the Koji ............................................. IX . Mash (Moromi) .............................................. X . Pressing ..................................................... XI. Pasteurization ................................................. XI1. “Chemical” Soy Sauce ........................................ XI11. Semichemical Soy Sauce, or Shinshiki Shoyu ...................... XIV . Future Developments in the Soy Sauce Industry .................... xv. Conclusions ................................................... References ...................................................
157 159 161 163 165 169 171 173 175 182 182 183 184 185
188 188
CONTENTS
vii
Contemporary Thoughts on Aspects of Applied Microbiology
P. S . S . DAWSONAND K . L . PHILLIPS I. I1. I11. IV . V.
Introduction .................................................. Biological Considerations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Nonbiological Considerations .................................... Mathematical Considerations .................................... General Considerations ........................................ References ...................................................
195 196 213 224 227 230
Some Thoughts on the Microbiological Aspects of Brewing and Other Industries Utilizing Yeast
.
G G . STEWART
. .
I I1 I11. IV . V. VI . VII . VIII IX. X. XI . XI1. XI11. XIV.
.
Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Historical Survey of the Industrial Uses of Yeast . . . . . . . . . . . . . . . . . . . Present-Day Industrial Uses of Yeasts . Outline of Traditional Brewing Processes ......................... New Developments in Batch Processes for Brewing . . . . . . . . . . . . . . . . . Continuous Fermentation in Brewing ............................ Comparison of the Available Modern Fermenting Systems in Brewing . . Selection. Behavior. and Efficiency of Yeasts . . . . . . Baker’s Yeast ................................. The Fed-Batch Process ......................................... Continuous Processes ............................ Distiller’s Yeast . . . . . ................... ............. Food and Fodder Yeas .................................... Biochemicals froin Yeast . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . References ....................... .........................
233 235 238 239 241 244 247 248 250 252 253 254 256 260 262
linear Alkylbenzene Sulfonate: Biodegradation and Aquatic Interactions
WILLIAME . GLEDHILL I. I1. I11. IV .
Introduction .................................................. LAS Biodegradation Studies .................................... LAS and the Aquatic Environment .............................. Summary and Conclusions ...................................... References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
265 266 281 286 289
The Story of the American Type Culture CollectionIts History and Development ( 1 899-1973)
WILLIAMA . CLARKAND DOROTHY H . GEARY I. Founding and Early Years ...................................... I1. Expansion ....................................................
295 299
viii
CONTENTS
I11. Permanent Facilities ........................................... References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
303 309
Microbial Penicillin Acylases
E . J . VANDAMME AND J . P . VOETS I. I1. I11. IV . V. VI . VII . VIII . IX. X. XI . XI1.
Introduction .................................................. History ...................................................... Biotransformation of Penicillins into 6-APA ........................ Screening Procedures .......................................... Penicillin Acylases ............................................. Physiological Role of the Penicillin Acylases ....................... Coexistence of Acylase and 8-Lactamase .......................... Penicillin Acylase and Cephalosporins ........................... Nonmicrobial Penicillin Acylases ................................. Aspecific Amidases ............................................. Chemical Transformation of Penicillins into 6-APA .................. Concluding Remarks ........................................... References ....................................................
SUBJECTINDEX...................................................... CONTENTSOF PREVIOUS VOLUMES.....................................
311 312 316 323 325 347 352 354 356 356 358 359 361
371 377
LIST
OF CONTRIBUTORS
Numbers in parentheses indicate the pages on which the authors' contributions begin.
I. CAMPBELL,Department of Brewing and Biological Sciences, Heriot-Watt University, Edinburgh, Scotland ( 135) WILLIAMA. CLARK,American Type Culture Collection, Rockville, Maryland (295) P. S. S. DAWSON, National Research Council of Canada, Prairie Regional Laboratory, Saskatoon, Saskatchewan, Canada ( 195)
DOROTHY H . ~GEARY, American Type Culture Collection, Rockville, Maryland (295) WILLIAME. GLEDHILL, Monsanto Company, S t . Louis, Missouri (265) J . M . T. HAMILTON-MILLER, Department of Medical Microbiology, University of London, Royal Free Hospital, London, Great Britain (109)
K . L. PHILLIPS,National Research Council of Canada, Prairie Regional Laboratory, Saskatoon, Saskatchewan, Canada ( 195) DAVIDL. PRUESS,Chemical Research Department, Hoffmann-La Roche Inc., NutZey, New Jersey (19) P. SCANNELL, Chemical Research Department, Hoffmann-La Roche Inc., Nutley, New Jersey (19)
JAMES
NORMANSHAW, Microbiological Chemistry Research Laboratory, School of Chemistry, University of Newcastle upon Tyne, Newcastle upon Tyne, England ( 63 ) G. G. STEWART,Beverage Science Department, Labatt Breweries of Canada Ltd., London, Ontario, Canada (233) WAYNEW. UMBREIT,Department of Microbiology, Rutgers University, New Brunswick, New Jersey ( 1 ) E. J . VANDAMME,Laboratory of General and Industrial Microbiology, University of Gent, Gent, Belgium (311) J. P. VOETS, Laboratory of General and Industrial Microbiology, University of Gent, Gent, BeEgium (311)
B. J . B. WOOD,Department of Applied Microbiology, University of Strathclyde, Glasgow, Scotland (157)
F. M . YONG,*Department
of Applied Microbiology, University of Strathclyde, Glasgow, Scotland ( 157)
* Present address: Singapore Institute of Standards and Industrial Research, Republic of Singapore. ix
This Page Intentionally Left Blank
ADVANCES IN
Applied Microbiology VOLUME 77
This Page Intentionally Left Blank
Education and Training in Applied Microbiology
WAYNEW. UMBREIT Department of Microbiology, Rutgers University, New B r u m i c k , New Jersey I. Introduction ...................................... 11. Education and Training in the United States ......... 111. Training in Applied Microbiology in the Developing Countries ........................................ IV. Summary ........................................
1 1 11 17
I. Introduction The education and training of microbiologists is a complex problem with many facets. This informal essay is a personal opinion, not documented with surveys and statistics, but based upon experience with applied microbiology on both sides of the fence. It is divided into two sections. One is concerned with the needs and problems in the United States. These considerations might apply to other developed countries, but I do not myself have the necessary experience to handle this subject. The other is the problem of training in the developing countries. It is clearly unlikely that people training or employing applied microbiologists in developing countries will ever see this essay, so that it is primarily designed to explain to microbiologists in developed countries some of the problems faced by their colleagues elsewhere. 11.
Education and Training in the United States
A discussion of the training could well begin with a discussion of the question: “What do we expect an applied microbiologist to do?” Clearly, it will be rather difficult to design and conduct a training program without knowing its ultimate objective. However, microbiology is applied in many fields: in public health, in water purification, in soils, in foods, in industrial fermentations, in evaluation of clinically useful drugs, in the “fine” chemical industry, in the pharmaceutical industry, in the cosmetic industry, in waste disposal mechanisms, in eutrophication studies, in the oil refinery, and even in mining and metallurgy. These are clearly not all alike and results in different kinds of work that require markedly different skills. A training program for applied microbiologists ought to leave room for a variety of talents since its practitioners undertake a wide variety of tasks. That is, there are different kinds of applied microbiologists and these may well require different types of training. 1
2
WAYNE W. UMBREIT
There is a rarely appreciated aspect to the training of applied microbiologists, namely, that it is relatively rare for the beginning college student to decide upon a career in applied microbiology at the start of the program. Rather, as knowledge develops, an interest in microbiology may develop, and finally, conditioned by ability, interest, and opportunity, a career in applied microbiology develops. While there has been much discussion about “choosing a career,” it is my own opinion that most people, myself included, “fall into” a career rather than deliberately “choose” it by making use of the opportunities that arise in the course of growing older and more experienced. But this means, in fact, that a career in applied microbiology, as a professional microbiologist, is rarely “chosen” even in college, and that, therefore, a program labeled “applied microbiology,” even at the undergraduate college level, will probably not attract many students. The time available to the undergraduate is usually somewhat limited and, depending upon the students’ objectives, may be very limited indeed. Because so many different kinds of skills are required in the many fields of applied microbiology and because young people do not, as a rule, deliberately choose applied microbiology as a career, one cannot set up (in a practical sense) a training program for applied microbiologists as such. One may design programs with more limited objectives, and one can devise intensive programs for food microbiologists, or water microbiologists, or others. But it is clearly difficult to provide a training program at the undergraduate level, and even at the graduate level, in the general field. Indeed, who is to tell in which subject a position may open when the student has completed the work and needs such a position? Two other aspects of applied microbiology should be emphasized. First, an applied microbiologist always works under, and is normally acutely aware of, economic restraints. No one expects a molecular biologist to pay his way-i.e., that the product of his work should be economically more valuable than its cost. Yet this is continually required of the applied microbiologist. Even in such subsidized situations as water purification or sewage disposal, his work is expected to be of direct application and direct economic benefit to the overall operation. Clearly, of course, there are sometimes indirect applications, such as meeting the requirements of regulatory agencies, but these too have an economic vector. It is this constant awareness of economic constraints that seems to be most difficult for the present generation of students to assimilate. Possibly, having been brought up in an affluent society, in which essentially all the activities, especially in the schools, have been heavily subsidized, they have had minimal contact with the economic facts of life. Possibly an era of scarcity will change this viewpoint, but as it presently
EDUCATION AND TRAINING IN APPLIED MICROBIOLOGY
3
exists, a student expects to be supported and subsidized in work in the future, as in the past, and to “get a grant” to do the research. It rarely, if ever, occurs to him that he might develop a problem to the stage of economic value, and from this provide support. A second constraint of the applied microbiologist is that one must take the situation as one finds it, that one cannot choose the ideal circumstances. One cannot, for example, make citric acid from pure cane sugar (it is not economic, one does not have it, the apparatus is missing, etc.), but rather one must make it from molasses or even corn stalks, because that constitutes the raw material that is available and economically feasible. Furthermore, one must make it with as little modification of available equipment as possible. Microbiologists are trained at three levels. First, there are technicians who do valuable, but probably mostly routine, work. They should, understand what they are doing, but one ought not to expect very much beyond the “cook book approach. There is a tendency to downgrade the importance of the technician in the sciences, even to the extent that no training at all is acceptable or, rather, that “on the job training” is all that is required. For many technician jobs this might be true, provided that the organization has other people who can interpret the results, who can carry out the innovative functions, and who know how to move into a new routine and how to train individuals for the new operation when it is required. Our educational system does not provide adequate numbers of beginning level microbiological technicians. What seems to happen, in the majority of cases, is that the positions are filled by persons with college degrees in fields other than microbiology or by people without any extensive college training. They are trained on the job. Most of the results are not very satisfactory. True, a few technicians become quite good, but the majority stay mediocre, protected usually by their union, and show little interest in further accomplishment, or indeed, further training. Because usually their training has been limited to the job at hand, they are quite unaware of other applications of microbiology and tend to stick closely to a routine. With advancement via seniority, with the accumulation of dependents and mortgages, it is difficult for them to move to any higher intellectual level, and few make the attempt. This is not to say that they may not do valuable work, but normally they have had no training in microbiology per se except what they were given in a busy laboratory or plant. But if they wanted further training in microbiology, where would they get it? Unfortunately, there are few places for such training. In the high schools there is none. In the normal course of events, the first place they can acquire microbiology is the junior year in college and they must have chosen a science background to do that; i.e., they must
4
WAYNE
W. UMBREm
have had general chemistry, organic chemistry, calculus, and general biology. Many applied oriented individuals never go to college or go to majors other than science. Now, I do not think that training for a microbiology technician need be all that difficult, and I am sure that it can be done without years of chemistry or advanced mathematics, but there is no place known to me where such training is, in fact, available. The requirements of the community colleges and of technical or vocational institutes are every bit as complex as those of the colleges. Furthermore, the total number of technicians in microbiology (aside from the hospital-related or diagnostic laboratories) is not great enough so that special schools can be set up for them. But what, in fact, do these people need? I think there are two needs. One is a regular course in general microbiology, possibly without detailed intermediary metabolism, with laboratory training so that they will know some microbiology in addition to that which they see in their own laboratories. I would suggest that the industries of a given area cooperate with a local college or university, to provide such a course when necessary, preferably in a laboratory away from the place of employment, and- that they hire a suitable member of the teaching staff to provide this “special” course, which is not to be restricted by university entrance requirements, etc. The other need is some counseling or contact with the teaching staff of the local institutions so that opportunities available for their further training can be brought to their attention. I would suppose that their union might have an interest in such opportunities for its members, although, possibly I have been away from such contacts too long. The second level of training is the B.A., B.Sc. (or M.A., M.Sc.) level. In theory, at least, it is the function of individuals at the higher level to see that things are properly done and to adjust, modify, and improve operations as required. Here at least, the training is in microbiology and, in my opinion, is generally pretty good. A typical program, to the bachelor’s level, involves two years of chemistry (through organic chemistry), mathematics through calculus, about two years of general biology and genetics, with additional microbiology represented by a course in general and pathogenic microbiology plus one or more advanced courses. These are frequently listed as food microbiology, dairy microbiology, soil microbiology, water microbiology, etc., or they may be combined into one course, called “applied microbiology.” All these courses are generally accompanied by laboratory sessions which rarely have more than 20-25 students per laboratory instructor ( a graduate student). Furthermore, the standards are actually more than adequate, and a bachelor’s degree from most schools in the United States represents a reasonably standardized training of rather good quality. One hears two complaints. One is that individuals do not have ade-
EDUCATION AND TRAINING IN APPLIED MICROBIOLOGY
5
quate laboratory experience, i.e., that they “can’t do a plate count,” “can’t do a chemical determination,” “must be trained in our laboratory,” etc. There is some substance to this type of complaint. It is not that an individual does not know how to do a plate count, but rather that he or she has not had much experience with such counts, maybe has done no more than two or three. Further, these counts were done in an undergraduate teaching laboratory, where facilities and expertise were quite different from those in the industrial laboratory, so he or she does not know how to do it as the employer wants it done. This the employer will have to teach and to allow time to acquire the experience in the hands which the more experienced technician has already acquired. After all, how did the student know who was to be his employer? And how was he supposed to know that the employer wanted plate counts done in a particular way with particular equipment? Most laboratory or microbiological or chemical determinations involve operations which, while essentially the same in principle, differ in the details of the operations; thus one must always be prepared for a “break in” period for each new individual added to a group. The second kind of complaint is that the college product is inadequately trained in the communication skills: “he can’t write a report,” “he can’t give a clear discussion,” “he can’t approach the problem realistically,” etc. It is, of course, true that the present generation seems to communicate mostly by way of monotones at a high decible and it is a mystery to me why we need such high fidelity stereo, 8-channel reproduction of this nonsense. And it is quite true that verbal communication and written work are poorly handled, although folksongs seem to substitute. I am afraid that there is little that microbiologists can do about it, and the protests should be directed to our colleagues in the liberal arts. While I think that the product at the bachelor’s level in the developed countries of the world is quite adequate (given a lack of experience), I do see a serious difficulty in the training of applied microbiologists in our colleges and universities. These so regularly advocate “fundamental” work, research, and “pure” science that the notion that application of science might also be a reasonable alternative to “men good and true,” seems to be mentioned but rarely, if at all. Application is almost submerged in the exciting “new” discoveries of fundamental research. If fundamental science is “pure,” then there must be an “impure” science, presumably applied. Thus it is rather difficult to attract students to “applied microbiology” when they can take “molecular biology” or “fundamentals of the gene.” Further, in most universities the majority of the faculty and a vast majority of the graduate students regard as secondary any application of their work. “If it can be applied, let some-
6
WAYNE W. UMBREIT
one else apply it. After all, it’s not in my research grant and besides I’m not interested.” There seems to be little one can do about this attitude. It is clearly predominant in the graduate schools, and since these by and large provide the personnel for the undergraduate schools, the same attitude prevails. I believe that this attitude is the principal difficulty encountered in the training of microbiologists for the applied fields. It is somehow regarded as beneath the “important” work of fundamental science. As a secondary issue, I believe that we are teaching too much biochemistry in our beginning microbiology, and most popular texts reflect this error. I think that intermediary metabolism should be relegated to advanced courses, and only an absolute minimum be placed in the general beginning microbiology. The time thus released should be devoted to more discussion of applied microbiology, and if there are any modifications we need to make, over and above attempting to change the attitude toward application, it is to increase the applied areas in microbiology at the expense of metabolic studies. I can hear the cry-that one cannot understand how a cell works unless one understands its intermediary metabolism-but I could submit that many students (and instructors) have a fairly good notion of how a cell grows and how it controls the enzymes within it, without having a very good understanding of intermediary metabolism. I would ( and do ) place intermediary metabolism much later in the sequence of subjects. But such sequences do not really matter too much. I think that we might improve the product a little, but I doubt that we shall make any great change. With respect to persons with the bachelor’s degree, there still remain two problems. The first is that the individual who takes a job in the applied fields at the bachelor’s degree level normally does so because he is not doing too well intellectually and he has given up the idea of medical school or graduate school because his record is not adequate. We tell such individuals that there is indeed a place for them in microbiology, but that if they wish to go farther they must take either of two routes. One is to obtain more education and training to the Ph.D. level if at all possible. Since this is not, in fact, what they do well, we try to point out that they should consider adding to their background other types of activity-sales, or business management, or whatever they might be good in, so that they can develop a career in which their science is a valuable background but not their sole asset and in perhaps a decade they may leave the bench entirely. Still we do have the “late bloomer,” the person who went into application directly for financial or other reasons, and at the bachelor’s level we certainly do have individuals who may have ceased their formal training without reaching their intellectual maximum. Many of these do indeed become bored with
EDUCATION AND TRAINING
IN APPJJED
MICROBIOLDGY
7
their activities and yearn to go to graduate school and obtain advanced degrees. This route is, in fact, a long hard road, but for some few it is desirable. The second problem has to do with the training of persons to the bachelor’s degree. It is our opinion that work at the bench is the “bread and butter” of applied microbiology. We therefore think that such courses should have laboratory instruction and that a considerable effort should be made to make the laboratory the prime vehicle of the learning experience. In this opinion we are opposed by both administration and students. This is an expensive way to teach, not that it requires more materials, but it does require more personnel and more back up facilities, and the number of students taught per dollar expended is considerably lower. We have been forced to cut laboratory instruction partly because the extra personnel required was simply eliminated on the grounds that other departments, not doing at least as much laboratory teaching, were doing a good job without these individuals and therefore we could do it too, “if we only put our mind to it.” It turns out that this is true-if we only lecture (“put our mind to it”) we certainly can teach more cheaply. It is putting our “hands” to it that costs money. Next the students do not like the idea; it takes too long, it’s too confining, indeed it is work. It is only near the end of their training period, when many realize that some credentials must be presented that will lead to a means of employment, that they begin to regard the laboratories in a more favorable light. Frankly, I think most university departments need insistence and assistance (and assistants) on the laboratory type of teaching and that, if more personnel is required, it should somehow be provided. Such training is not exactly the same as producing a product (although we are doing that); one should not try to produce an acceptable product as cheaply as one can, but one should try to produce the best product one can. By the time graduate work is undertaken, the student is committed to a career in microbiology. In certain individuals, this career is directed toward applied microbiology. More frequently, however, the entering graduate student does not know enough about the subject nor about opportunities, to make a reasonable judgment, so that he tends to work in the areas either where there is support or where there is activity that appeals to him, either because of the subject, the personality of the professor, or the ambiance of the laboratory. For the past two decades the support picture has been somewhat unfavorable for applied microbiology in that much of the federal money going into departments of microbiology has been channeled into fundamental rather than applied training. I think it proper to point out that such funding was not due to the mere “glamour” of the rising science of molecular biology, which
8
WAYNE W. UMBREIT
drew so heavily upon microbiology for its materials. In one sense, one could say that the past quarter century was dominated by Escherichia coli just as it is likely that the next decade ( a quarter century is too long to predict) will doubtless be dominated by HeLa. In both cases, I think the reason is the development of simple methods for obtaining quantities of cells. The situation fifteen years ago was that the federal government, through the National Institutes of Health, set about to build a research establishment second to none for a variety of reasons, most of which were quite valid, The NIH used both an internal research laboratory development and a system of external research grants and by the early 1960s had built a research organization in this country that was without question the very best in the world; and they did it economically, with an enormous amount of freedom for the individual investigator, and with due and appropriate concern for the young men and women just beginning their careers. Of the National Institutes of Health, some provided training grants for graduate education which offered, in contrast to the research grants, the freedom of choice for the individual to study what he liked. From about 1965 on, however, the research establishment in microbiology possibly reached the point of diminishing returns; too many people were involved, too large a bureaucracy was required to “run” it, too many restrictions on the freedom of the investigator, too many projects of marginal value, too many reports, too much documentation, etc. There was a breakdown in communication and, in addition to increased cost and a small, well publicized wastage, there was the accumulation within the system of people whose objective seemed to be to destroy it. The system did not, in fact, shrink, but it did not continue to expand. The impact of all of this development upon applied microbiology is that, until about 1965, money was easily available for the support of graduate students and for research, but “fundamental” research was the main beneficiary. Applied areas remained at a low level, and industrial money, which might have been a source of support, was not easily forthcoming, partly on the ground that there was SO much government money. At least such support failed to make any major impact. As of today, the educational facilities are staffed mostly by people brought up during the easy money period (it actually was called “soft” money and encouraged the expansion of many departments far beyond the resources of their university to maintain them), and these people are not, from their training or experience, oriented to application. During this same period, however, the opportunities in applied microbiology outside of the training institution did not markedly expand. The fermentation industry faced serious problems from petrochemicals.
EDUCATION AND TRAINING IN APPLIED MICROBIOLOGY
9
Further, many functions traditionally those of microbiologists were taken over by engineers, biochemists, etc. whose training in microbiology, if any, was minimal. I think that we have now reached the end of this period of doldrums in the applied field and that we will see a marked expansion of applied microbiology. In this essay I have earlier argued that one does not “choose” a career and that applied microbiology is not normally “chosen” in the early stages of work. The same applies to graduate students. The period of graduate work develops research ability, develops a knowledge in depth of one very narrow area of the field, and provides an overall view of the state of microbiological science as contemporary as possible. But an individual develops his (the “or her” is understood) talents and becomes aware of his strengths, and inclinations, in addition to acquiring a vast repository of knowledge. He is a very different individual after the four or more years of graduate work then he was at the start. It is rare that we, his instructors, can tell at the very start of the program whether or not his talents lie in applied microbiology; before long, however, the courses he selects, the kinds of things that interest him, what he studies on his own without being required to do so, begin to shape his acquired knowledge, and these may well orient him toward application in spite of the pressures of graduate schools to other directions. It is at this point, somewhere well along into the graduate program, that an option for applied work should be available. But this should not be a rigid training program. One must seriously consider the nature of the product desired at the end of the training period. In a program designed to train applied microbiologists, one may end up with an individual well aware of today’s technology and problems, but what one really wants is a person capable of developing new approaches and able to face future problems. It happens too frequently to be sheer chance; a man trained in one field makes really significant contributions to another. In a sense he does not know that it can’t be done, so he does it. of course the gap between the two fields must be small; it is rare for a major in English literature to contribute anything to microbiology. But perhaps we are dealing with what Pasteur pointed out as “chance favors the prepared mind.” Pasteur was a good example of this transfer of knowledge. The knowledge of the “diseases” of silk worm, or wine, resulted from the application of principles learned in highly theoretical chemistry. Therefore, a good graduate program should not concentrate on too narrow a range of scientific awareness. Indeed, it is a period of exploration, of filling the store of knowledge that an individual carries, of developing the habit of life-long learning, and of developing that unpleasant but necessary critical facility that questions all statements of fact or all generally ac-
10
WAYNE W. UMBRElT
cepted concepts until experience proves them valid. A good graduate program should have a minimum of time, perhaps one thorough thoughtprovoking course, devoted to all aspects of applied microbiology (from industrial production of antibiotics to lignin decomposition in soils, for example) and a specialty course as, for example, food microbiology, for the training in specific specialties in which the department is engaged, but the rest of the training shouId not be so oriented but should provide more than a smattering of the fundamentals so that the student develops sufficient knowledge to be flexible in his future work. A second factor, in addition to inclination and ability, which determines entry into the applied area is opportunity. A young man who has invested at least four years of his life, who is financially not very well off, will, in a market where jobs are scarce, take whatever offers present themselves, and this is conditioned by the market place. It is certainly unreasonable to train an individual to run a butyl fermentation plant when there are no opportunities to run such a plant. Certainly this was the case four to five years ago when the present crop of Ph.D.’s began their training. The current shortage of petroleum makes butyl fermentation a more economically attractive possibility, and, while there may be few men specifically trained in this area, there are enough good men who know enough of related matters to learn what they need to know rapidly when and if opportunity opens and there is a demand for their services. Two years ago one would not have thought of these possibilities. As such, in the United States, it is my contention that our graduate programs are for the most part doing the right thing by concentrating on fundamentals, but as with the undergraduate programs, the attitude that only fundamentals are important should be changed. And there should be at least one course on applied microbiology taught by a man with experience in one or more of the applied fields. The program should emphasize fundamentals, while developing the relevant aspects of the applied areas. But for the rest I would not tinker with the system; it has produced good men. There is no serious demand for change. We have gone through a period of “innovative” teaching promoted largely by people who were bored with what they were doing. To the best of our knowledge it has not improved the product appreciably, and in some ways it has lowered its quality. Nor is it reasonable to set up specific training programs, partly because an individual’s talents are not clearly evident at the start, and he thus chooses a field when he lacks the very knowledge necessary to make such a choice, and partly because the demand of the market place is continually changing and with a four-year lag in the training program it is impossible to know where the opportunities will be when an individual completes his train-
EDUCATION AND TRAINING I N APPLIED MICROBIOLOGY
11
ing. Since in many cases the inclinations to applied microbiology are not evident until late in the graduate program and since a broad applied training is normally not possible, one solution may be postdoctoral training for a specific applied field. That is, once a career in applied microbiology is in the cards, one knows which part of applied microbiology one is then engaged in, and one could obtain specific “mission-oriented training or indeed experience in the specific applied field (large-scale fermentation, for example, or waste water treatment). A further possibility is to provide to the B.Sc. cheinical engineer, who is almost certainly oriented to the applied field, microbiological training useful in his profession. Surely this training would not need to be nearly as broad based because the outlines of the career and the orientation of the individual are already somewhat delineated. It is my feeling that the training institutions need to be much more flexible in their approach to inultidiscipline or cross-discipline offerings, and rules and regulations of admission to colleges, graduate schools, and specific programs need to be more imaginative and accommodating. Ill.
Training in Applied Microbiology in t h e Developing Countries
The problems of training in applied microbiology in the developing countries are at least different, if not more complex, than those of the developed countries. Further, things are not always what they seem, and the Western eye may read into situations and progranis something quite different from reality. Nevertheless, in devcloping countries, “ppIied microbiology is an iniportniit field and their rather limited resources can frequently be improved by microbial methods. The following observations are based on some practical experience i n teaching in some of the developing countries, of rather close observation of their educational systems and of the environment in which the individual must work. It is aIso derived from the open and very frank discussions of education in niicrobiology in the developing countries at the Congresses of the Global Impacts of Applied Microbiology held at Addis Abnba (1967), Bombay (1969), Sao Paulo, Brazil (1973) as well as the similar discussion held at the Tenth International Congress of Microbiology, Mexico City (1970). I am further indebted to a wide variety of microbiologists who took time from their busy schedules to write to me about their views and who further spent much time and patience with me explaining the situation in their own countries. The distillate of the problems and the solutions I have prepared represents an average opinion, not a consensus--colored, of course, by my own background and experience. Clearly, not all developing countries are alike, and for a Westerner
12
WAYNE W. WMBREIT
to understand any one requires a reasonably long period of living in the country and attempting to work within the system. But there are some problems, which seem to be common to most if not all developing countries, that should be pointed out. The workers in the countries are quite aware of them; indeed, they must live with them. But the rest of the world is not so aware of them; so that in calling attention to the problems we mean no criticism of the developing world, but would hope to assist them. The first problem evident in most countries is lack of maintenance. Excellent buildings of which one can be really proud are, after a year or two, almost nonfunctional. The window is never washed, the faucet leak is never repaired, there is no gas in the supply line, the centrifuge has rusted, and the electricity is unreliable. For the research laboratories this is not insurmountable; the inhabitants of the laboratory can do it themselves or improvise. Whether they do or not depends on the leader and upon the customs of the country. But teaching laboratories, which are frequently shared by several departments, have no such regular inhabitants, and usually no one takes the slightest responsibility. Very similar things happen in the laboratories of the developed countries as well. It is very difficult to teach skills and precision under these circumstances. One solution is to channel more money into maintenance, and in most developing countries maintenance personnel are available; indeed there is usually an excess of untrained personnel-“bearers,’’ “porters,” “assistants,’’ etc. Unfortunately, these individuals often do little more than make tea or coffee (not always of drinkable quality) and, indeed, frequently hamper the work of the department, but they cannot be replaced for a variety of understandable reasons. This means that the department head must set the tone, and I have seen places run under these very conditions that are models of upkeep. The department head must see to it that the laboratory is maintained, that a budget is provided for paint and plumbing, for soap and scrub brushes, and that the men available to do the work, do it right; and at times, the head must actually do the maintenance himself. The credentials of the department head in microbiology may be excellent, but unless he is also a good plumber and spends a great deal of his time seeing that the housekeeping details are adequately taken care of, chaos soon results. A second serious difficulty is the lack of technical infrastructure. This means not only the lack of technicians but of the whole concept of a technical competence, of skill, persistence, adaptability, and responsibility-indeed, of pride in work of scientific and technical nature. People with these skills are poorly paid, are not treated with the respect they deserve, are regarded as merely a pair of hands, replaceable, without
EDUCATION AND TRAINING IN APPLIED MICROBIOLOGY
13
a status above, that of the “bearer.” Yet they are considerably above the “bearer” status in terms of education, skills, and background. There are, it is true, all too few of them, and they ought, therefore, to be regarded with more respect and attention. It is futile to set up schools for training technicians when technicians are so poorly treated after such training. There are both surface and subsurface reasons for this situation. Sometimes the cause arises from deep-seated attitudes of the culture, but clearly it constitutes a difficulty. A third difficulty in most developing countries is the actual size of the undergraduate classes. A general microbiology course, for example, may be required for all majors in premedicine, agriculture, biological sciences, pharmacy, and a variety of others. A class may consist of 1000 students and may be arbitrarily increased to 2000 due to some regulation in the “ministry” of education without any change in personnel. The course must have a laboratory (usually specified in the regulations) and must occupy X number of hours. Compared to Western standards this is not desirable. It is clearly impossible to teach laboratory skills under these circumstances. Hence, much is done by demonstration. It is remarkable indeed that the students learn anything at all, and transfer to a graduate school in a developed country must be a terrifying experience. The more advanced courses are usually also overcrowded or, at times, completely neglected. In many countries the course content is also controlled by a syllabus-prepared in many cases by the ministry of education. Unfortunately, there seems to be Iittle input by microbiologists (and especially little application). It has been suggested frequently that a worldwide textbook on microbiology backed by some international organization might be useful in changing the course content. While the results of such efforts may be dubious, the difficulties in writing such a text are real. A fourth difficulty is that opportunities for effective positions are limited, and we see countries struggle to train hundreds of people even though they have an excess of people already trained but unemployed or working at alternative positions. The microbiologist working as a cab driver is not at all uncommon, and salaries of even well established individuals are barely enough to live on, so moonlighting is also common. These four difficulties-lack of maintenance, lack of technical infrastructure, excessive size of classes, and lack of opportunity once training is complete-seem to be characteristic of the majority of the developing world although clearly there are exceptions. Let us, however, make it clear that it is not the fault of the microbiologists involved, and they are quite aware of these difficulties. In most cases to overcome one of the difficulties is only to exaggerate another, and usually the cause of the problem lies in some unapproachable ministry or administrative
14
WAYNE W. UMBREIT
unit. At times it is sheer inertia and the custom of centuries that one must reform, and frequently this is not only difficult but also dangerous. Since it is unlikely that many in the developing world will read this essay (one limitation being that most do not have funds to buy publications of this sort), I am clearly not speaking to them, but I am pointing out that these are the conditions under which they must work and solutions or programs of the developed world are not directly transferable unless these factors are taken into account. Applied microbiology in the developing countries has three primary functions. One is the improvement of existing applications of microbiological science-legume inoculation or composting, for example. A second is to develop new resources: antibiotics from the sisal plant, for example, or citric acid from the local sage brush. And the third is the transfer of such portions of world technology as are applicable to their situation-for example, the production of butyl from local molasses or the control of powdery mildew. Within the limits of the system and such reforms as are locally possible, there seems to be a reasonable approach to applied microbiological training based upon two basic principles. The first is the “need to know”; i.e., it is not necessary for every microbiologist to know everything. Especially at the technician level, one may train individuals for certain tasks (public health laboratories, for example) without a complete background in mathematics or organic chemistry. Where there are specific objectives in mind, the training program can be concentrated upon the requirements of those objectives rather than broadly scattered. The second principle is that while the introductory material may be widely disseminated, only a small percentage with talent and imagination need to be trained further. At the college level, a class of perhaps 1000 students in the beginning course can be taught by way of lecture or lecture-demonstration only and those who wish to go on into microbiology obtain their first laboratory in the second course. These two principles, together with some sincere emphasis on maintenance, would go a long way to improve the technical and undergraduate programs of most developing countries. It seems unreasonable to expect that undergraduate training can be accomplished outside of the country for any but a small number. With respect to graduate education, there is a sharp division of opinion as to whether it should be accomplished within the country or outside it. Many of those who have obtained their Ph.D.’s externally (and some of those with internal Ph.D.’s) are strongly of the opinion that a local Ph.D. is of low merit. But there are numerous difficulties found by the student in obtaining his Ph.D. externally in addition to the sometimes insurmountable one of financing its cost. First, his laboratory training is generally most inadequate in preparing him to compete with the
EDUCATION AND TRAINING IN APPLIED MICROBIOLOGY
15
average graduate student of the Western world. Next, he must do his work in a language not his own, and this is normally given very little consideration. He also becomes involved in a research project (since a Ph.D. is a research degree) usually chosen by his professor; he does well at it, it becomes his absorbing interest; he returns to find that he really cannot work on this project or anything comparable and that there are other limitations he had forgotten while abroad. Thus, a significant percentage of the returned Ph.D.’s, who certainly represent an important potential for the country, are bitterly unhappy and frustrated. Frequently, also, upon return, they are arbitrarily assigned to positions that in many cases bear little relation to their training. In the external country itself, the chance of a student getting to the right place, i.e., where he can get the training useful to his country, is relatively small and depends to a large extent upon those his undergraduate professors happened to know when they were out of the country twenty years ago. Further, on moving to the external country such students undergo “cultural shock and upon return have become alienated from their own country. To avoid this difficulty it has been proposed that institutes for the training of applied microbiologists should be established in locations not too far removed from the countries requiring them, to minimize the culture shock and the cost while yet retaining the advantages of foreign experience. For example, an institute in Beirut (where it could make use of university facilities) teaching in both English and French might be suitable for the countries of Africa. A similar applied institute in Hong Kong or Singapore would be suitable for the far east, and one in Puerto Rico or Mexico for the Central and South American countries. Many countries in these geographical areas have adequate facilities, but for those who do not, and for those who hold that experience in the “outer world is important, such institutes could provide both the basic training necessary and a transition phase before further study elsewhere. Such proposals are favorites of the international congresses, but success in organizing and financing them seems rather remote. A student from the developing countries entering the graduate schools of microbiology in the United States will be given extensive training in biochemistry, physiology, molecular biology, and genetics but rather less, if any at all, in applied microbiology. Yet in many developing countries the feeling is that these subjects are expensive and useless toys and that the need for such knowledge has not yet reached the point of relevancy. Many countries select and send the very best of their young people (although the selection i s rarely for dedication to applied aspects), and then the students given such training are “useless” (or worse) upon their return. “All of this wonderful training is wasted
16
WAYNE W. UMJ3ElElT
is the complaint from the individuals themselves. There is something to be said for this position. However, the programs of any country are designed for its own students, and they are not specifically oriented toward a country a thousand miles away with a different culture and requirements, Such training rarely pretends to provide any solution to the problems of the developing nations. The bright young men sent to the prestige universities become fascinated by the subjects offered, and these are what they study, Some, it is true, on return cannot readapt to a clearly different situation in which they are now placed. And while it is senseless to suggest that developing countries ought to concentrate only on applied matters, it is probably equally senseless to suggest that the training obtained should be essentially applied. Applied training is only rarely available, is likely to concentrate on advanced technology perhaps not feasible for the country of origin, and is likely not to produce men of vision, who are the ones most needed. It is thought by many that foreign travel and training is a necessary part of the Ph.D. training. An internal degree program with perhaps a six months sojourn in a developed country, or perhaps a mission-oriented program, if such were developed, might be a solution to the problem. But surely some of the best men should be Westernized, should “think Western” to provide the necessary push to modify the system and gradually overcome its present difficulties. Some of the negative aspects of training in the developed countries could be overcome if the student were assisted in getting to the right place, where the useful training for his country and his talents was available. On the other hand, there are those who feel that an internal degree is more useful since it is more attuned to facilities and needs of the country. Certainly a great deal of money (both internal and external) has been put into the higher education and facilities of many countries, and some of them are excellent. Further, excellent men have been (and thus can be) produced by these internal facilities when circumstances are right, granting that a certain percentage are not very satisfactory. A reasonable solution to the dilemma of culture shock for those countries having the facilities would again be to concentrate upon the internal degree, and then, a year or two later, when the man has settled into a position, send him abroad on a mission-oriented visit to one or more institutions for a relatively short period, perhaps 3 months at a given location. As a general compromise one could suggest the following: 1. A B.Sc. at home 2. An MSc. with emphasis on the applied aspects at an institute for applied microbiology ( Beirut, Puerto Rico, or Singapore) 3. Two years of work in applied microbiology in the home country
EDUCATION AND TRAINING IN APPLIED MICROBIOLOGY
17
4. Either: ( a ) a Ph.D. abroad at an institution providing the applied training ( b ) a local Ph.D. with a postdoctoral (of perhaps 6 months) in a developed country in a field related to the work he is expected to do. This kind of “mission-oriented work could be most useful. The advantages of foreign training could be provided by step 2, and the transfer of developed nation technology could be assisted by step 4, especially step 4b. IV.
Summary
For the United States, there is a lack of facilities and opportunities for the training of technicians. There is at the college level neglect of training in applications; at the graduate level, there is the general lack of broad training in applied microbiology although specialty training is adequate, Each training level has certain problems, but the general assessment is that there is reasonably adequate response to the demand. Training in the developing nations is a somewhat different problem and may require somewhat different solutions. Some of the problems have been outlined and some solutions have been proposed. ACKNOWLEDGMENTS
I wish to especially thank Dr. B. W. Koft and Dr. R. W. Thoma for very pertinent suggestions. While I am indebted to many foreign colleagues, I should like to mention especially the following: (Argentina) M. D.’Aquino, G. W. Marengo, T. S. Molina, S. Soriano; (Brazil) W. Borzani, L. P. De C Lima, J. S. Furtado, A. Neghme, W. Schmidell Netto; (Costa Rica) F. Montero-Gei; (Egypt) Badr El-Din, A. S. El Nawawy, M. A. Foda, M. A. Samie, S. Taha; (Ethiopia) R. M. Baxter; (Ghana) G. Tewari; (India) J. V. Bhat, F. Femandes, K. G. Gopal Krishanan, S. Gorhe, C . Rangaswami, M. S. S. Rao, T. N. R. Rao, D. V. Rege, S. R. Saksina, G. D’Souza, S. R. Vyas; (Kenya) M. G. Rogoff; (Mexico) C. CasasCampillo, M. Servin-Massieu; (Pakistan) A. Anwar; (Thailand) S. Sirisinha; (Uganda) J. Mukiibi; (Venezuela) A. Divo, J. Gomez-Ruiz, J. J. Gutierrez-Alfaro.
This Page Intentionally Left Blank
Antimetabolites from Microorganisms
DAVDL. PRUESSAND
JAMES
P. SCANNELL
Chemical Research Department, Hofmann-La Roche Znc., Nutley, New Jersey
I. Introduction
.....................................
11. Definition of an Antimetabolite ..................... 111. Detection Methods ................................
IV. Mechanisms of Action and Reversal . . . . . . . . . . . . . . . . . V. Antimetabolites Isolated from Microorganisms ......... A. Amino Acids and Related Compounds ............ B. Nucleosides and Related Compounds ............. C. Vitamin Antimetabolites ....................... D. Miscellaneous Antimetabolites . . . . . . . . . . . . . . . . . . VI. Incidence of Antimetabolite Production .............. VII. Chemotherapeutic Applications ..................... Note Added in Proof .............................. References ......................................
I.
19 19 21 22 24 25 38
44 48 50 51 53 54
Introduction
Although almost 2000 antibiotics had been described by the rnid-l960’s, only about 10 of these were commonly regarded as antimetabolites. Since then, several microbiological screens have been developed specifically designed to detect antimetabolites, and the number of antimetabolite antibiotics has increased to about 70 compounds. The purpose of this review is to describe the screening methods, to catalog the antimetabolites, and to summarize what is known about the biochemistry of these compounds. We hope, thereby, to stimulate an interest in the biosynthesis, mechanism of action, and basis of selective activity of this group of compounds. II.
Definition of an Antimetabolite
Woolley (1963) defined an antimetabolite as ‘a structural analog of an essential metabolite, vitamin, hormone, or amino acid, etc., which is able to cause signs of deficiency of the essential metabolite in some living thing or in some biological reaction.” This definition was based on the theory that antimetabolites act as isosteric enzyme inhibitors ( Woolley, 1952). Accordingly, reversible inhibition would be relieved by the addition to the test system of either the product or an excess of substrate. In the case of irreversible inhibition, only addition of product would be effective. Thus, experimental reversibility has become commonly accepted as evidence for antimetabolite activity, although this is not explicitly required by the original definition. The association of 19
20
DAVID L. PRUESS AND JAMES P. SCANNELL
experimental reversibility with the original definition of an antimetabolite has led to two major difficulties: (1) Antibiotics, such as penicillin and puromycin, can be considered as structural analogs of essential metabolites which cause signs of deficiency of the metabolites. However, since the metabolites are often complex macromolecules ( cell wall components, proteins, nucleic acids), they cannot be effectively supplied to an intact cell, hence reversibility cannot be demonstrated. (2) Often there is no apparent structural analogy between reversant and antimetabolite. This can sometimes be explained by the complexity of metabolic pathways and control mechanisms. It is possible to devise screens to detect reversible activities but structural analogy can be made only after isolation and structure determination. Thus, a definition based on reversal of activity rather than structural analogy is more useful in the search for naturally occurring antimetabolites. In this review an antimetabolite is defined operationally as an organic compound which at a low concentration has a deleterious effect on the growth or viability of an organism, the effect of which can be prevented by concurrent administration of one or more common biochemicals. It should be noted that an in vivo effect is required by this definition; thus, compounds that have only been shown to be in vitro enzyme inhibitors are not included. However, a successful program has been developed ( Umezawa, 1973 ) for screening fermentation broths for inhibitors of specific enzymes. This approach is more narrowly focused than the antimetabolite screen since feedback inhibitors and repressors cannot be detected. However, it has the advantage that inhibitors of nonmicrobial enzymes can be directly discovered. The screening of fermentation samples for antibiotic activity is usually based on observing growth inhibition of one or more test organisms. The reason antimetabolites are seldom discovered by this method is that the media used for the growth of the test organisms usually contain substances such as yeast extract and meat peptones. These media provide all the common biochemicals and therefore would be expected to reverse the activities of any antimetabolites present in the tested samples. Many microorganisms possess all the enzymes necessary to synthesize the common amino acids and vitamins from simple nutrients and therefore can grow well on a glucose-salts medium with ammonium ion as the sole source of nitrogen. Growth of a microorganism in such a medium can be prevented by the presence of an antimetabolite since there are no external sources of metabolites which can reverse the activity of the antimetabolite. The technique of growing test organisms on a defined minimal medium has been extensively applied to investigations of the properties of synthetic antimetabolites ( Richmond, 1962; Kaiser, 1960), but until five years ago the method was infrequently applied to the
ANTIMETABOLlTES FROM MICROORGANISMS
21
detection of antimetabolites in fermentation broths. Not only are antimetabolites detected by this method, but they are also differentiated from antibiotics since the activity of the latter is not reversed by the addition of nutrients to the assay medium. Moreover, the metabolic pathway affected can be determined by the selective addition of individual nutrients to the assay medium. For example, the antimetabolite activity of L-3(2,5-dihydrophenyl) alanine (XX ) is reversed by addition of L-phenylalanine or L-tyrosine to the assay medium, but not by the addition of other amino acids ( Fickenscher and Zahner, 1971). Ill.
Detection Methods
Techniques to demonstrate antimetabolite reversibility have been known for some time and have been reviewed by Woolley (1952) and Kaiser ( 1960). The techniques stem primarily from studies on synthetic antimetabolites. Of special interest is the first description of the counterdiffusion agar-well test developed by Cuthbertson et al. (1956) in their studies of vitamin B,, antimetabolites, and which was later modified by Smith (1965) and Simon (1969) to measure indexes of inhibition. Outgrowth of Neurospma CTUSSU from an agar well into minimal medium has been used to measure the effect of many synthetic antimetabolites ( Fuerst and Skellenger, 1958; Fuerst, 1964). Techniques of screening microbial products for antimetabolite activity have been developed independently in several laboratories. A very sensitive spread-plate method developed by Foster and Pittillo (1953a,b) to detect reversal of antibiotics by metabolites has been used to select synergistic pairs of antimetabolites ( Pittillo and Foster, 1954). However, this technique does not appear to have been used widely by others. Schabel and Pittillo (1961) described a method to detect antimetabolite activity in those antitumor compounds which inhibit the growth of one or more microorganisms in minimal agar medium. The antitumor compound is incorporated into seeded agar at a concentration sufficient to inhibit completely the growth of the test microorganism. Filter paper disks impregnated with various metabolites are placed on the agar surface. After suitable incubation, growth around one or more of the metabolite-containing disks denotes antimetabolite activity. A counterdiffusion disk assay has been used by Stapley et al. (1968) to screen for antimetabolites in fermentation broths. In their method, paper disks containing metabolites are first applied to seeded agar and then disks containing fermentation broth are placed near the metabolite disks. If a zone of inhibition caused by the fermentation broth is distorted or eliminated by one or more of the metabolites, antimetabolite activity is indicated.
22
DAVW
L. PRUESS AND JAMES P. SCANNELL
The “Kreutztest” used in the laboratory of Professor Zahner (Zahner et al., 1960; Keller-Schierlein et al., 1969) also employs the counterdiffusion principle. Two paper strips, one containing sample and the other containing metabolite, are placed crosswise on seeded minimal agar. From the shape of the zone of inhibition along the sample strip, a reversal can be demonstrated to be competitive or noncompetitive in nature. A method which probably evolved from work on the microbiological assay ( Hanka and Burch, 1960) and mechanism of action (Hanka, 1960) of psicofuranine has been described by Hanka (1968). Broth samples are placed separately on nutrient-agar and minimal-agar plates which have been inoculated with the same test microorganism. Antimetabolite activity is recognized as a zone of inhibition occurring on only the minimal-agar plate. Leads are then evaluated in a second stage where broth samples are tested on four inoculated minimal-agar plates, containing low concentrations of one of the following: common purines and pyrimidines, amino acids, vitamins, or Krebs cycle intermediates. Samples which give no inhibition on one or more of these plates are chosen for the third and final stage of testing where individual members of the metabolite groups are used to supplement the agar. By means of this three-stage procedure, it is possible to detect antimetabolites and to differentiate them on the basis of the metabolites which cause reversal. IV.
Mechanisms of Action and Reversal
The counterdiffusion method may be used to differentiate two types of reversal mechanisms. A competitive reversal is shown in Fig. 1A.
A
B
FIG. 1. Counterdiffusion antimetabolite assay. ( A ) Competitive reversal. ( B ) Noncompetitive reversal.
A"I'lMETAB0LITES FROM MICROORGANISMS
23
The boundary between the area of inhibition and the area of reversal is a straight line. At all points on this line the ratio of inhibitor to reversant is constant. In contrast, a noncompetitive reversal is shown in Fig. 1B. In this case, all points on the boundary are equidistant from the center of the disk from which the reversant diffused. At that distance the concentration of reversant is sufficient to supply the minimum requirement for growth, and the concentration of antimetabolite which varies along the boundary is not a factor. A noncompetitive reversal does not imply that an enzyme is inhibited in a non- or uncompetitive manner. In a whole-cell system, an exogenous supply of the product of an inhibited enzyme or metabolic pathway is often the most efficient reversant. Such product reversals are noncompetitive. The type of reversal may be related to the mechanism of action of the antimetabolite. An isosteric enzyme inhibitor is reversed noncompetitively in vivo by the product of the inhibited reaction and often by subsequent compounds in the metabolic pathway. Sometimes these compounds are not structurally related to the enzyme inhibitor, as, for example, certain glutamine analogs which are reversed by purines. The substrate and possibly its metabolic precursors, which also may be structurally dissimilar, will reverse competitively. However, in cases where the inhibitor is very tightly bound, substrate reversal may not be demonstrable. Many metabolic pathways are regulated by the end product of the pathway by two mechanisms. The first enzyme in the metabolic sequence may be inhibited allosterically; i.e., the end product of the pathway inactivates the first enzyme in the pathway by binding at a site other than the active site of the enzyme. This is commonly referred to as feedback inhibition. When an end product analog causes inhibition, synthesis of the end product and its precursors is stopped, and an antimetabolite effect is observed which can be reversed noncompetitively by the end product and many of its precursors. Alternatively, an end product or end product analog may repress the synthesis of many or all of the enzymes in a metabolic sequence. If such is the case, only the end product of the metabolic sequence will reverse, and the reversal will be noncompetitive. When intersecting metabolic pathways are controlled by such mechanisms, unusual reversal effects can be observed. For example, uracil inhibits the growth of an Escherichia coli mutant, and this growth inhibition is relieved by addition of L-arginine or L-citrulline to the medium (Novick and Maas, 1961). The mechanism underlying this effect is well understood. Uracil is converted to uridylic acid, which represses the biosynthesis (Anderson and Meister, 1966; Pierard et al., 1965) and inhibits the activity (Pierard et al., 1965) of carbamyl phosphate synthetase. These feedback mechanisms not only prevent the un-
24
DAVID L. PRUESS AND JAMES P. SCANNELL
necessary biosynthesis of pyrimidine nucleotides by shutting off the sup-
ply of carbamyl phosphate, but also prevent the carbamylation of ornithine to citrulline, the immediate precursor of the essential amino acid arginine. This example of the complexity of metabolic controls provides a partial explanation for two apparent anomalies sometimes observed with antimetabolites: (1) lack of structural analogy to reversant; ( 2 ) antagonism between common essential metabolites. In addition, this example illustrates lethal synthesis whereby the inhibited organism biosynthesizes the active antimetabolite ( uridylic acid) from the administered precursor (uracil). Another mechanism of antimetabolite action which has been postulated (Mathews, 1958) is the incorporation of the antimetabolite into macromolecules which then have altered activities. One would expect a competitive reversal for this effect. Transport may be involved in antimetabolite reversals. Thus, normal metabolites may interfere with the uptake of a toxic substance thereby preventing growth inhibition. Such reversals can generally be recognized when two structurally related but metabolically unrelated compounds ( e.g., arginine and lysine ) relieve inhibition competitively. It should be noted that even though reversal occurs by a transport mechanism this does not necessarily mean that the mechanism of action of the toxic substance is at the transport level. Reversal patterns are not always clear cut and may vary markedly with different test organisms. At best, they can be taken only as a guide to the enzyme studies needed to define a mechanism. Detailed reviews have appeared on the mechanisms of action of amino acid (Fowden et al., 1967; Nass et al., 1971; Woods, 1964), water-soluble vitamin ( Woolley, 1963), and nucleoside ( Suhadolnik, 1970; Wagner, 1971) antimetabolites.
V.
Antimetabolites Isolated from Microorganisms
Seventy antimetabolites are described in detail in this section, Of these, 8 are vitamin structural' analogs, 14 are nucleosides or related compounds, 25 are amino acids, 8 are di- or tripeptides and 15 are of undetermined or miscellaneous structure. Excluded are antibiotics which react chemically with broth constituents to give apparent reversal of activity. Among these are naphthomycin, which is inactivated by thiols (Balerna et al., 1969); aranciamycin, by amino acids (Keller-Schierlein et al., 1970); and penicillic acid, by amines ( Oxford, 1942). Cell membrane active antibiotics, which are reversed by a variety of sterols, lipids, and phospholipids (Halder and Bose, 1971), are also excluded. It should be noted that a somewhat
ANTIMETABOLITES FROM MICROORGANISMS
25
bewildering array of reversants, including certain amino acids, have been reported for the actinomycins (Modest et al., 1963). Several other antibiotics are reported to be reversed by various substances. Gottlieb and Shaw (1967) have discussed such reversals for sarkomycin, mitomycin, puromycin, cycloheximide, tetracycline, and patulin. In addition a reversal of iodinin by naphthoquinones and anthraquinones ( McIlwain, 1943) and a reversal of daunomycin by xanthine (Pittillo and Hunt, 1968) have been reported. Other reversals in the older literature could well have been overlooked. The sideromycins, iron-binding peptide hydroxamate antibiotics, are reversed by the structurally related sideramines. These have been reviewed elsewhere (Emery, 1971; Maehr, 1971). Also excluded are the many antagonisms (Meister, 1965) between the common naturally occurring amino acids such as that reported b e tween glycine and alanine (Snell and Guirard, 1943). The following antimetabolites are arranged somewhat arbitrarily by chemical structure. Any structural uncertainties, synthetic procedures or resolutions have been noted. If not otherwise indicated, proof of structure is contained in the publication listed under “Source.” The comments under “Mechanism” usually refer to in vitro observations, but in only a few cases has a definitive in vivo mechanism been established. In general, the biosynthesis and mode of action of many of these compounds remain to be investigated. Only the nucleoside antibiotics have been intensively studied in this respect, and these compounds have been thoroughly reviewed elsewhere ( Suhadolnik, 1970 ) . Four compounds (XXII, XXVII, XXVIII, and duazomycin C ) closely related to known antimetabolites have been included although reversal studies have not been reported. It should be noted that about half of the compounds in this list, particularly the nucleoside antimetabolites, were first detected in antibiotic or antitumor screens and only later shown to be antimetabolites. A. AMINO ACIDSAND RELATEDCOMPOUNDS
1. Aliphatic Amino Acids
~-2-Amino-4,4,-dichlorobutanoic acid c‘\
NH2 0 I II CH-C HZ - C H - C - 0 H
/
CI’
Reversant: Source:
(I)
L-Leucine in Proteus mirabilis, Eschenichia coli, P. vulgaris, P. rettgeri ( Argoudelis et al., 1967) Streptomyces armentosus ( Argoudelis et al., 1967)
26
DAVID L. PRUESS AND JAMES P. SCANNELL
L- ( threo ) -2-Amino-3,4-dihydroxybutanoic acid NHZ 0 I II HO- C H z - C H - C H - C - O H I OH (III
Reversant: Source: Synthesis:
L-Serine, L-threonine in Escherichia coli ( Westley et al., 1971) Streptomyces species ( Westley et al., 1971) ( Hamel and Painter, 1953)
L-2-Amino-3-dimethylaminopropionic acid ( L-4-azaleucine) CH
NH2 0 \"N-CH2-CH-C-OH I II
/
CH3
(rn)
L-Leucine in Proteus mildenbergii, P. rettgeri, and Sarcina lutea (Argoudelis et al., 1967), L-leucine ( competitive) in Escherichia coli and Leuconostoc dextranicum (Smith et al., 1963), L-leucine in Salmonelkz typhimurium (Stieglitz and Calvo, 1971) Source: Streptomyces neocaliberis ( Argoudelis et al., 1967) Mechanism: Inhibition of cY-isopropylmalate synthetase, the first enzyme unique to leucine biosynthesis; and incorporation into protein (Stieglitz and Calvo, 1971) Synthesis: Racemate (Smith et at., 1963) Reversant:
~-2-Amino-4-methoxy-trans-3-butenoic acid NH2 0 I II C-OH
H I
CH3 - 0 - C = C - C H I
H
cm, Reversant:
Source:
D-Alanine, L-alanine, D-ghtamic acid, D-aspartic acid, D-2-aminobutanoic acid, L-2-aminobutanoic acid in Bacillus sp. 1283B (Scannell et al., 1972a). Methionine, homocysteine, cystathionine in Escherichia coli (Sahm et al., 1973). Pseudomonas aeruginosa (Scannell et al., 1972a; Sahm et al., 1973).
ANTIMETABOLITES FROM MICROORGANISMS
27
Mechanism: The unusual reversal pattern (Scannell et al., 1972a) may indicate the compound affects enzymes involved in cell wall biosynthesis. In E . coli pseudo feedback effects on homoserine O-succinyltransferase are probably involved ( Sahm et al., 1973).
~-2-Amino-4-methyl-5-hexenoicacid Y 3 NH2 I O II HzC=CH- CH-CHZ-CH-C-OH
IP I
Leucine in Staphylococcus aureus, Bacillus subtilis, Sarcinu lutea (to a lesser extent by valine and isoleucine) (Kelly et al., 1969) Streptomyces species ( Kelly et al., 1969), Boletus Source: ixocomus nudi (New Guinea fungus) (Rudzats et al., 1972) Stereochemistry: Unknown at C-4 (Kelly et al., 1969; Rudzats et al., 1972) Reversant:
L-2-Amino-4-pentynoicacid ( propargylglycine ) NH2 0 I I1 H-CEC-CH2-CH-C-OH lpIi
L-Methionine, L-leucine in Bacillus subtilis ( Scannell et al., 1970a); L-valine in Saccharomqces cerevisiae (Shapira and Dittmer, 1961) Streptomyces species (Scannell et al., 1971a) Source: Synthesis: Racemate (Gershon et al., 1949, 1954; Schlijgl, 1958; Shapira and Dittmer, 1961) Synthesis and resolution: (Scannell et al., 1971a) Reversant:
L-S-Ethyl homocysteine ( L-ethionine )
Reversant:
L-Methionine in Escherichia coli (Harris and Kohn, 1941) and the rat (Dyer, 1938); adenine and ATP in the rat ( Villa-Trevino et al., 1963)
28
DAVID L. PRUESS AND JAMES P. SCANNELL
Source:
Synthesis: Mechanism:
Escherichia coli, Bacillus megaterium, Pseudomonas aeruginosa and Aerobacter aerogenes ( Fisher and Mallette, 1961) (Dyer, 1938) Detailed review (Fowden et al., 1967)
L-Selenomethionine CH3
- Se -CH2-CH2
Y 2:
-CH-C-OH
[rn) Reversant: Source: Synthesis: Review:
L-Methionine in Chlorellu vulgaris ( Schrift, 1954, 1961) Escherichia coli (Tuve and Williams, 1961) (Painter, 1947) (Fowden et al., 1967)
2. Basic Amino Acids L-2-Amino-3-( 2-aminoethoxy ) propionic acid ( L-4-oxaly sine ) NH2 0 I II H2N-CH2-CH2 - 0 - C H 2 - C H - C - 0 H
(Ix)
Reversant:
L-Lysine, diaminopimelic acid and L-lysylglycine in Escherichia coli (Stapley et al., 1968); L-lysine in several species of Lactobacillus and Streptococcus (McCord et al., 1957); L-lysine (competitively) in Leuconostoc destranicum ( McCord et al., 1957) Source: Streptomyces chartreusis and Streptomyces erythrochromogenes (Stapley et al., 1968) Synthesis : Racemate (McCord et al., 1957; Tesser and Nefkens, 1959) Resolution : (Tesser et al., 1962) L-2-Amino-4-( 2-aminoethoxy ) -trans-Sbutenoic acid NH2
H
I
I
H2N-CH2-CH2 - 0 - C = C -
0 II
CH-C-OH I
H
(XI
Reversant:
Source:
L-Cysteine ( noncompetitive), L-arginine, and L-lysine (competitive) in Streptomyces cellulosae (Pruess et al., 1974) Streptomyces species (Pruess et al., 1974)
ANTIMETABOLITES FROM MICROORGANISMS
29
2-Amino-4-( 2-amino-3-hy droxypropoxy ) -tram-3-butenoic acid ( rhizobitoxine) H NH2 0 NH2 I I I 11 HC-CH2-O-C=C-~~-C-O~ I I CH2-OH n
(XI)
Homocysteine, L-methionine in Salmonella typhimurium (Owens et al., 1968); L-methionine partially reverses inhibition of ethylene biosynthesis in apple and sorghum (Owens et al., 1971). Rhizobium japonicum (Owens and Wright, 1965) Source: (Owens et al., 1972) Structure: Mechanism: Inhibition of p-cystathionase ( Giovanelli et al., 1971) Reversant:
L-N~( l-iminoethyl ) ornithine NH2 0 y 3 I II HN=C - NH - C H ~C H ~ C - H -~C H - C - OH
-
Reversant: Source: Synthesis:
L-Arginine, L-citrulline, L-ornithine, and L-NZ-acetylornithine in Escherichia coli (Scannell et al., 1972b) Streptomyces species (Scannell et al., 1972b) (Scannell et al., 1972b)
3. Acidic Amino Acids ~-2-Amino-3( N-nitroso) hydroxaminopropionic acid ( alanosine ) N=O NH2 0 I I I1 HO-N-CH2-CHC-OH
(Xm)
Reversant: Source: Mechanism:
L-Aspartic acid and adenine in Candida albicans (Gale et al., 1968) S,treptomyces alanosiruicus ATCC 15710 (Murthy et al., 1966; Coronelli et al., 1966) Postulated inhibition of aspartate transcarbamylase and adenylosuccinate synthetase (Gale et al., 1968). Inhibition of glutamic acid carboxy-lyase has been demonstrated (Gale and Atkins, 1968)
30 (
DAVID L. PRUESS AND JAMES P. SCANNELL
+) -2,SDiaminosuccinic acid 0 NH2 NH2 0
I l l I II HO-C-CH-CH-C-OH
mr
Reversant: Source: Synthesis:
L-Aspartic acid in Escherichia coli (meso form). The optically active form has apparently not been tested (Shive and Macow, 1946) Streptomyces rimosw ( Hochstein, 1959) Review of dl and meso forms (McKennis and Yard, 1958)
N-Formyl-N-hydroxyglycine ( hadacidin ) 0 II
0
CH
II HO-N-CH2-C-OH I
(XPI
L-Aspartic acid and adenine in KB cells (Neuman and Tytell, 1963), Escherichia coli (Shigeura, 1963), and chloroplasts from Euglena (Mego, 1964) Source: A wide variety of Penicillia including the following species: P. frequentans (Gittennan et al., 1962), P. purpurescens (Gray et al., 1964), P . aurantio-uiolaceum, P . caseicolum, P . cr&osum, P. implicatum, P. janthinellum, P . liuidum, P . spinulowm, P . trzebinskii, and P . turbatum (Dulaney and Gray, 1962) Synthesis: (Kaczka et al., 1962) Mechanism: Inhibition of adenylosuccinate synthetase ( Shigeura and Gordon, 1962) Review: (Shigeura, 1967) Reversant:
4. Cyclic Amino Acids L-%Amino-( cis-2,5-dihydro-5-methyl)furan-2-acetic acid ( furanomycin; threomycin ) 0
II H2N - C H - C - O H
I
^. ,..H HC’IIL\o HCiC’
/ .... CH3
ANTlMETABOLITES FROM MICROORGANISMS
31
L-Isoleucine ( competitive), L-valine (noncompetitive) in Escherichia coli (Katagiri et al., 1967) Source: Streptomyces (Katagiri et al., 1967) Mechanism: Inhibition of isoleucyl tRNA synthetase at high antimetabolite concentration (Tanaka et al., 1969) Reversant:
l-Amino-2-.nitrocyclopentanecarboxylic acid
(Xm)
Reversant: Source: Synthesis: Stereochemistry:
Leucine in pea root (Brian et a,?.,1965) Aspergillus wentii (Burrows and Turner, 1966) (Burrows and Turner, 1966) Unknown
2- ( l-Cyclohexen-3( R ) -yl ) -S-glycine and l-cyclohexen-3( R ) -yl glyoxylic acid NH2 0
CH-cHz
//
\
I
l
l
CH -CH-C-OH HC / ‘cH~-cH~
(Xm)
Competitively by L-homoserine, L-threonine, a-ketobutyrate, a-keto-p-methylvalerate, a-ketoisovalerate, L-valine, a-ketoisocapronate, and L-leucine, and noncompetitively by L-isoleucine in Bacillus subtilis ( Keller-Schierlein et al., 1969) Source: Streptomyces antibioticus ( Celmer, 1964) Synthesis: (Edelson et al., 1958) Mechanism: Competitive inhibition of threonine deaminase after lethal synthesis of the amino acid from the keto acid ( Keller-Schierlein et al., 1969; Zahner and Poralla, 1970; Kruepe and Poralla, 1972) Review: (Nass et al., 1971)
Reversant:
32
DAVID L. PRUESS AND J A M E S P. SCANNELL
~ - 32,s-Dihydrophenyl ( ) alanine
(xx) Reversant:
L-Phenylalanine, L-tyrosine in Eschericlaia coli ( Shoulders et al., 1968; Scannell et al., 1970; Fickenscher et al., 1971),Leuconostoc dextranicum (Snow et al., 1968;Yamashita et al., 1970),Bacillus subtilis ( Scannell et al., 1970),Pseudomonas aeruginosa (Yamashita et al., 1970), Lactobacillus plantarum ( Shoulders et al., 1968) and Sacchuromyces cerevisiae ( Genghof,
1970) Streptomyces, several strains ( Yamashita et al., 1970; Scannell et al., 1970;Fickenscher et al., 1971) Synthesis: ( Snow et al., 1968;Shoulders et al., 1968;Ressler, 1972) Mechanism: Feedback inhibition of 3-deoxy-~-arabinoheptulosonSource:
Review:
ate-7-phosphate synthetase and prephenate dehydratase (Fickenscher et al., 1971; Fickenscher and Zahner, 1971) (Nass et al., 1971)
~-2,3-Epoxy-4-oxohexahydrophenylalanine ( anticapsin ) 0 I1 H2N- C H - C - O H I
1XXI1
Reversant:
Glutamine, glucosamine, and N-acetylglucosamine in hyaluronic acid capsule of Streptococcus p yogenes ( Whitney and Funderburk, 1970) Source: Streptomyces griseoplanus (Shah et al., 1970) Structure: (Neuss et al., 1970) Mechanism: Inhibition of ~-glutamine-~-fructose-6-phosphate amidotransferase ( Whitney and Funderburk, 1970)
ANTIMETABOLITES FROM MICROORGANISMS
33
~-Alanyl-~-2,3-epoxy-4-oxohexahydrophenylalanine ( bacilysin, tetanine) 0 0 I1 I1 H2N-CH-C-NH-CH-C-OH I I CH3 y 2
Reversant: Source: Structure: Mechanism: Bacillin Reversant: Source: Structure:
Not demonstrated; presumed to be the same as for anticapsin; active toward Staphylococcus aureus Bacillus subtilis (Rogers et al., 1965; Florey et al., 1949); B . pumilus (Kamiliski and Sokolowska, 1973) (Walker and Abrahams, 1970) Inhibition of bacterial cell wall biosynthesis ( Chmara and Borowski, 1973) N-Acetylglucosamine in gram-positive organisms (Walton and Rickes, 1962) Bacillus szibtilis ( Foster and Woodruff, 1946) Unknown; may be related to or identical with bacilysin
5. D-Amino Acids ~-4-Amino-3-isoxazolidinone( cycloserine ) H2N
\CH-C
//”
c m 1
Reversant:
Source:
Synthesis: Review:
and L-Alanine in Bacillus species (Harned et al., 1955; Harris et al., 1955; Shull and Sardinas, 1955; Kurosawa, 1952) Several specics of Streptomyces ( Harned et al., 1955; Harris et al., 1955;Shull and Sardinas, 1955;Kurosawa, 1952) (Stammer et al., 1955) (Neuhaus, 1967;Stammer, 1971) D-
DAVID L. PRUESS AND JAMES P. SCANNELL
34
0-Carbamyl-D-serine 0
NH2 0
II I I1 H2N-C-0-CH2-CH-C-OH
(xxm) Reversant: Source: Synthesis: Review:
D-Alanine and L-alanine in Bacillus species and Streptococcus faecalis (Hagemann et al., 1955) Streptomyces polychromogenes ( Hagemann et al., 1955) (Skinner et al., 1955) (Neuhaus, 1967)
6. Diazo Amino Acids
0-Diazoacetyl-L-serine ( azaserine )
(xxp)
Reversant:.
L-Glutamine, adenine, aromatic and basic amino acids (Pittillo and Hunt, 1967) Streptomyces fragilis (Stock et al., 1954; Anderson Source: et al., 1956) Synthesis: (Moore et al., 1954) Review: (Pittillo and Hunt, 1967) Mechanism: Inhibition of de nooo purine biosynthesis (Pittillo and Hunt, 1967)
6-Diazo-5-oxo-~-norleucine ( DON ) 0 NH2 0 @ I1 I II N = N =C H - C - C H 2 -.C H 2 - C H - C -OH
Q
L-Glutamine, purine bases and nucleosides, various amino acids in several organisms (reviewed by Pittillo and Hunt, 1967) Streptomyces species (Ehrlich et al., 1956) Source: ( DeWald and Moore, 1958) Synthesis: Mechanism : Inhibition of de nooo purine biosynthesis ( reviewed by Pittillo and Hunt, 1967) Review: (Pittillo and Hunt, 1967)
Reversant:
L-Alanyl- ( 6-diazo-5-0x0) -L-norleucyl-( 6-diazo-5-0x0) +norleucine
( alazopeptin )
ANTIMETABOLITES FROM MICROORGANISMS
0
0 I1 H2 N -CH -C-NH
I
0 II
II
- CH - C - N H
-CH- C-OH I
I
CH2 I CH2 I
CH3
35
CH2 I CH2
I
c=o
c=o
I CH II
I CH II @N II 8 N
BN II
BN
(rn) Reversant: Source: Structure:
Presumed to be same as for DON Streptomyces griseoplanus ( DeVoe et al., 1957) (Patterson et al., 1966)
N *-Acetyl-( 6-diazo-5-0x0) +norleucine ( N-acetyl-DON, duazomycin A ) 0 I1
H N - C -CH3
1 :
8
@ 0 II N=N=CH-C-CH2-CH2-CH-C-OH
(m) Reversant: Source: Structure:
Presumed to be same as for DON Streptomyces ambofaciens (Rao et al., 1960) (Rao, 1962)
5-~-Glutamyl( 6-diazo-5-0x0) -L-norleucyl-( 6-diazo-5-0x0) -L-norleucine ( duazomycin B) 0
0 0 II II II H2N-CH-CH~-CH2-C-NH-CH-C-NH-CH-C-OH I I I C-OH CH2 CH2 I1 I I 0
CH2
1
c=o I
CH I1
@N II ON
CH2 I
c=o
I CH II N@ II
NQ
36
DAVID L. PRUESS AND JAMES P. SCANNELL
Reversant: Source: Structure:
L-Glutamine in lymphocytes (Hersh and Brown, 1971); presumed to be same as for DON Streptomyces ambofaciens (Rao et al., 1960) (Rao, 1963)
Duazomycin C Reversant: Source: Structure:
Presumed to be same as for DON Streptomyces ambofaciens (Rao et al., 1960) Unknown
7. Di- and Tripeptides 2-Amino-4-( 3-hydroxy-2-0~0-3-azetidinyl) butanoyl-L-threonine (wild fire toxin, tabtoxin) 0 II
0 II
HZN-CH-C-NH-CH -C-OH I I CH-OH CHZ I I CHZ CH3 I +o HO-C-C I I HzC-NH
(xxx) Reversant:
L-Glutamine in tobacco leaves (Sinden and Durbin, 1968),L-methionine in Chlorella vulgaris (Braun, 1950) Source: Pseudomonus tabaci (Johnson and Murwin, 1925; Woolley et al., 1965);Pseudomom sp. (Taylor et al., 1972) Structure: Revised (Stewart, 1971) Mechanism: Glutamine synthetase inhibition ( Sinden and Durbin, 1968)
2-Amino-4-methylphosphinobutanoyl-~-alanyl-~-alanine ( phosphinothricyl-alanyl-alanine )
CH2 I $.HZ
no-
P=O I CH3
(XXXI)
Reversant:
L-Glutamine in Escherichia coli, Bacillus subtilis, Botrytis cinerea, Pseudornonas saccharophilia ( Bayer et al., 1972)
ANTIMETABOLITES FROM MICROORGANISMS
37
Streptomyces viridochromogenes ( Bayer et al., 1972) Source: Mechanism: Inhibition of glutamine synthetase after enzymatic degradation to phosphinothricin (Bayer et aZ., 1972) Fumarylcarboxamido-~-2,3diaminopropionyl-~-alanine O
O H I l l
H2N - C
- C=C-
I H
I1
C -NH-CHz
NH2 0 I I1
CH3 0 I II
- C H - C - N H -CH-C-OH
(XXXLII
Reversant: Source:
D-Ghcosamine and N-acetylglucosamine in gram-negative microorganisms (Molloy et aZ., 1972) Streptomyces collinus, Lindenbein ( MoIloy et al., 1972)
( S,S ) -N-Methylisoleucyl-~-2-amino-4( 4-amino-2,5-cyclohexadien1-yl ) butanoic acid (stravidin, MSD 235 S,)
Reversant: Source: Structure:
Biotin in Escherichia coli and other gram-negative microorganisms (Stapley et al., 1964) Streptomyces avidinii, S. Lavendulae (Stapley et al., 1964) (Baggaley et al., 1969)
L-( N5-Phosphono) methionine-( S ) -sulfoximinyl-L-alanyl-L-alanine ) 0
0
0
I1 I1 11 H2N-CH-C-NH-CH-C-NH-CH-C-OH I I I CH3 CH3
CH3
OH
DAVID L. PRUESS AND JAMES P. SCANNELL
38 Reversant: Source: Structure:
L-Glutamine in Serratia sp. and Bacillus subtilis (Pruess et al., 1973) Streptomyces sp. (Pruess et al., 1973) (Scannell et al., 1972c)
B. NUCLEOSIDES AND RELATED COMPOUNDS 1. Pyrimidine Type SAzacytidine
d
HOCH2
on
OH
Cytidine, uridine in Escherichia colt (Cihik and Sorm, 1965; Hanka et al., 1967) Streptooerticillium kzahkanus ( Bergy and Herr, 1967) Source: Synthesis: (Piskala and Sorm, 1964) Mechanism: ( Reviewed by Suhadolnik, 1970) (Suhadolnik, 1970) Review :
Reversant:
Emimycin ( 1,2-dihydro-2-oxopyrazine-4-oxide)
Reversant: Source: Structure: Synthesis:
Uracil in Escherichia coli ( DeZeeuw and Tynan, 1969) Streptomyces sp. (Terao et at., 1960) (Terao, 1963); confirmation by X-ray analysis of 2-bromo derivative (Tamura, 1963) Improved method (Bobek and Block, 1972)
ANTIMETABOLITES FROM MICROORGANISMS
39
Oxazinomycin ( minimycin )
HoH2w OH
Reversant: Source: Structure:
OH
Deoxycytidine in Staphylococcus aureus ( Haneishi et al., 1970) Streptomyces tunesashinensis ( Haneishi et al., 1971); Streptomyces hygroscopicus ( Kusakabe et al., 1972) (Haneishi et al., 1971; Sasaki et al., 1972)
Polyoxins
II C-HN-CH I H 2 N-CH I HC- R
I OH OH 0 I II CHz-O-C-NHz
H0 - C H
Peptides in Pellicularia sasakii ( Mitani and Inoue, 1968) Source: Streptomyces cacaoi var. asoenis (Suzuki et al., 1965) Structure: (Isono et al., 1969) Mechanism: Inhibitor of chitin synthetase; it is competitive with UDP-N-acetylglucosamine ( Endo et al., 1970) Review: ( Suhadolnik, 1970) Reversant:
40
DAVID L. PRUESS AND J A M E S P. SCANNELL
Pyrazomycin 0
HoH2H OH OH
Uridine and uridylic acid in vaccinia virus (Streightoff et al., 1969) Streptomyces candidus ( Streightoff et at., 1969) Source: Structure: (Gerzon et al., 1969) Mechanism: 5’-Phosphate ester is inhibitor of orotidylic decarboxylase (Gerzon et al., 1971) Review : (Gerzon et al., 1971) Reversant:
Showdomycin
OH OH
Ribo- and deoxyribonucleosides and sulfhydryl compounds (Nishimura and Komatsu, 1968) Streptomyces showdoensis ( Nishimura et al., 1964) Source: (Nakagawa et al., 1967; Darnall et al., 1967) Structure: Mechanism: Reversal by nucleosides shown to be due to use of same transport system ( Roy-Burman and Visser, 1972); inhibits formation of deoxyribonucleotides from
Reversant:
ANTIMETABOLITES FROM MICROORGANISMS
Review:
41
corresponding ribonucleotides ( Komatsu and Tanaka, 1971) (Suhadolnik, 1970; Gerzon et al., 1971)
2. Purine Type Aristeromycin
Reversant:
Source: Structure: Synthesis: Review:
Adenosine, and to a lesser extent by adenine, deoxyadenosine and inosine in Xanthomonus oryxae (Kusaka, 1971) Streptomyces citrocolor (Kusaka et al., 1968) Absolute configuration determined by X-ray analysis (Kishi et al., 1972) (Shealy and Clayton, 1966,1969) ( Suhadolnik, 1970)
Decoyinine ( angustmycin A )
OH OH
[mu) Reversant:
Guanosine, guanine in Bacillus subtilis and Mycobacterium sp. (Tanaka et al., 1960) and Streptococcus faecalis (Bloch and Nichol, 1964)
42
DAVID L. PRUESS A N D JAMES P. SCANNELL
Source: Structure: Review:
Streptomyces hygroscopicus var. angustmyceticus (Yuntsen et al., 1956) and Streptomyces hygroscopicus var. decoyicus (Hoeksema et al., 1964) (Hoeksema et al., 1964) (Suhadolnik, 1970)
Cordycepin ( 3'-deoxyadenosine)
Reversant: Source: Structure: Review:
Guanosine, adenosine in Bacillus subtilis ( Rottman and Guarino, 1964) Cordyceps militans (Cunningham et al., 1951); Aspergillus nidulans (Kaczka et al., 1964) (Kaczka et al., 1964) ( Suhadolnik, 1970)
Fonnycin B OH
ANTIMETABOLITES FROM MICROORGANISMS
Reversant: Source: Structure:
P3 Adenosine, inosine, thymidine, and uridine in Xanthomonm oryzae (Hori et al., 1968) Nocardia interforma ( Koyama and Umezawa, 1965) (Koyama et al., 1966)
Psicofuranine ( angustmycin C)
OH OH
(XLTI
Reversant:
Source:
Structure: Review:
Guanine and guanosine in Staphylococcus aureus (Hanka, 1960); Escherichia coli (Slechta, 1960); Bacillus subtilis (Tanaka et al., 1960) Streptomyces hygroscopicus var. angustmyceticus (Yuntsen et al., 1956); Streptomyces hygroscopicus var. decoyicus (Eble et al., 1959) ( Yuntsen, 1958; Schroeder and Hocksema, 1959) ( Suhadolnik, 1970)
Thioguanine SH
Reversant: Source: Synthesis : Review:
Adenine or guanine in Escherichia coli (Scannell et al., 1971b) Pseudomoms sp. GH (Scannell et al., 1971b) ( Elion and Hitchings, 1955) (Hitchings and Elion, 1963)
44
DAVID L. PRUESS AND JAMES P. SCANNELL
Toyocamycin
OH OH
Reversant: Adenosine and inosine ( D. L. Pruess, unpublished observation ) Streptomyces toyocaensis ( Nishimura et al., 1956) Source: Structure: (Ohkuma, 1961) Review: (Suhadolnik, 1970) Tubercidin
Reversant: Source: Structure: Review:
Adenosine, 2’-deoxyadenosine, uridine, cysteine, pyruvate, ribose-5’-phosphate in Streptococcus faecalis (Bloch et al., 1967) Streptomyces tubercidicus ( Anzai et al., 1957) (Suzuki and Marumo, 1961) ( Suhadolnik, 1970) C. VITAMINANTIMETABOLITES
1. Biotin Reversed Actithiazic acid
ANTIMETABOLITES FROM MICROORGANISMS
45
0
LNH (XLIX)
Reversant:
Source:
Structure : Synthesis: Review:
Biotin in Mycobacteria (Grundy et al., 1952; Umezawa et al., 1953; Kawashima et al., 1953; Pittillo and Foster, 1954); Aerobacter aerogenes (PittilIo and Foster, 1954); Bacillus subtilis (Stim et al., 1959) Streptomyces virginiae (Grundy et al., 1952); S. acidomyceticus ( Miyake et al., 1953); S. lavendulae (Tejera et al., 1952); S . cinnamonensis (Maeda et al., 1952) (McLamore et al., 1953; Schenck and DeRose, 1952; Miyake et al., 1953) (Clark and Schenck, 1952; McLamore et al., 1953) (Caltrider, 1967)
a-Dehydrobiotin
Reversant: Source: Synthesis:
Biotin in Escherichia coli (Hanka et al., 1966) Streptomyces lydicus (Hanka et al., 1966) (Field et al., 1970)
,-Methylbiotin U
(LI)
Reversant: Source: Synthesis:
Biotin in Mycobacteria and presumably Escherichia coli and Bacillus subtilis (Hanka et al., 1972) Streptomyces lydicus (Martin et al., 1971) (Martin et al., 1971)
46
DAVID L. FRUESS AND JAMES P. GCANNELL
a-Methyldethiobiotin
Reversant: Source:
Biotin in Mycobacteria and presumably Escherichia coli and Bacillus subtilis (Hanka et al., 1972) Streptomyces lydicus (Martin et al., 1971)
2. Ergocalciferol Reversed Cerulenin H
H
Ergocalciferol in Candida stellaloidea and Saccharomyces cerevisiae (Nomura et al., 1972b) Source: Cephalosporium caerulens ( Sano et al., 1967) Structure: (Omura et al., 1967) Mechanism: Inhibits p-ketoacyl-acyl carrier protein synthetase thus blocking fatty acid synthesis (Nomura et al., 1972a; DAgnolo et al., 1973)
Reversant:
3. Nicotinic Acid or Nicotinamide Reversed Albocycline
ANTIMETABOLITES FROM MICROORGANISMS
Reversant: Source:
Structure:
47
Nicotinic acid, nicotinamide, and quinolinic acid in Bacillus subtilis (Reusser, 1969) Streptornyces bruneogriseus ( Nagahama et al., 1967); S . roseocinereus and S . roseochromogenes (Furumai et al., 1968); S . maizeus (Reusser, 1969) (Nagahama et al., 1971)
Melinacidins Reversant: Source: Structure:
Nicotinic acid and nicotinamide in Bacillus subtilis ( Reusser, 1968) Acrostalagmus cinnabarinus var. melinucidinus ( Argoudelis and Reusser, 1971) Family of 3,6-epidithiadiketopiperazines, exact structure unknown ( Argoudelis, 1972)
Streptozotocin HOH2C
H O & - - -H O$ NH
I c=o I
N- NO
I CH3 (LP)
Nicotinamide reverses diabetogenic action in mouse and rat (Schein et al., 1967; Schein and Loftus, 1968) Source: Streptomyces achromogenes (Vavra et al., 1960; Herr et al., 1960 Structure: (Herr et al., 1967) Synthesis: (Herr et al., 1967; Hessler and Jahnke, 1970) Mechanism: Presumed to block NAD biosynthesis in pancreas (Schein and Loftus, 1968) Review: (Rudas, 1972) Reversant:
4. Thiamine Reversed Bacimethrin
48
DAVID L. PRUESS AND JAMES P. SCANNELL
Reversant: Source: Structure:
Thiamine and pyridoxine in Bacillus subtilis, Escherichia coli, and several yeasts ( Tanaka et al., 1961, 1962a) Bacillus mgatherium ( Tanaka et al., 1961,1962a) ( Tanaka et al., 1962b)
5. Vitamin B I 2 Reversed Descoboltocorrinoids Reversant:
Source:
Structure:
Vitamin B,, in vitamin B1,-requiring strains of Escherichia coli, Euglena gracilis, and Arthrobacter duodecadis (Perlman and Toohey, 1968) Chromatiurn, Rhodospirillum rubrum, and R. palustris (Toohey, 1965, 1966); Streptomyces olivaceus ( Sato et al., 1970) Exact structures not known. However, from Chromatiurn phenylhydrogenobamide and hydrogenobyric acid were isolated (Koppenhagen and Pfiffner, 1970), and from Chromatiurn grown in medium containing 5,6-dimethylbenzimidazole a-( 5,6-dimethylbenzimidazolyl) hydrogenobamide was isolated ( Koppenhagen and Pfiffner, 1971)
D. MISCELLANEOUS ANTIMETABOLITES Borrelidin CH3 I /CH-CH2
CH3 I -CH-CH2-
C H j OH I I
- -
CH CH CH CH2 C ‘ H ‘CH CH3 I OH
/
-
0 II
- c\
P
0
/CH-CH-CH-C-OH I I C = CH - CH=CH-CH2 CH2 CH2 I C I N CH2
II
\I
(LVlIl
L-Threonine, L-homoserine in Bacillus subtilis ( Hutter et al., 1966) Streptomyces rochei (Berger et al., 1949) Source: Structure: ( Keller-Schierlein, 1967) Mechanism: Inhibition of threonyl-tRNA synthetase ( Nass et al., 1969) Review: (Nass et al., 1971)
Reversant:
ANTIMETABOLITES FROM MlCROORGANISMS
49
Griseofulvin
CH30 CH3
(LYD)
Reversant:
Adenylic acid, guanylic acid in Microsporum canis ( McNall, 1960) Penicillium griseofuluum and other species ( Oxford et al., 1939) Structure and synthesis (Grove, 1963); mechanism of action (Huber, 1967)
Source: Review: Lycomarasmin
0
0 II HO-C-CHZ -CH-NH-CH~-CH-NH-CHZ-C-NH~ I I II
c =o
c=o I OH
I
OH
(LEI
Reversant:
Source: Structure:
Serylglycylglutamic acid and other peptide growth factors in tomato plant and Lactobacillus casei ( Woolley, 1946) Fusarium oxysporum, F. lycopusici ( Plattner and Clauson-Kaas, 1945) Revised (Hardegger et al., 1963)
Mycophenolic acid
Reversant: Source: Structure:
Guanosine, guanylic acid, deoxyguanylic acid in viral tissue culture test (Cline et al., 1969) Penicu’llium brevi-compactum ( Clutterbuck et al., 1932); P. stoloniferum (Williams et al., 1968) (Logan and Newbold, 1957)
DAVID L. PRUESS AND JAMES P. SCANNELL
50
Mechanism: Inhibition of guanylic synthetase ( Estermann and Sweeney, 1970) and inosine dehydrogenase ( Franklin and Cook, 1969) Pentalenolactone ( PA-132) y 3
(LXI)
Reversant: Adenine (Takeshima et al., 1969) Source: Streptomyces species (Koe et al., 1957; English et al., 1957) Structure: (Martin et al., 1970; Takeuchi et al., 1969) Tunicamy cin Reversant: Source: Structure:
N-Acetylglucosamine and related compounds ( Takatsuki and Tamura, 1971) Streptomyces lysosuperificus (Takatsuki et al., 1971) Unknown
Histidomycin Reversant: Source: Structure:
VI.
Mixture of amino acids in Escherichia coli (Stapley et al., 1967) Nocardia histidam (Stapley et al., 1967) Unknown, a complex of antimetabolites; one component, C25H3BNeOloC1, contains histidine ( Kaczka et al., 1967) Incidence of Antimetabolite Production
Hanka (1938) observed that 23% of the fermentation broths tested showed antimetabolite activity against E. coli and B . subtilis. Korobkova et al. (1970) reported that of 756 actinomycetes which showed no zones of inhibition on complex media, 25 produced antimetabolite activity in a minimal medium which was reversed by leucine. Gause et al. (1972) tested 2160 actinomycete cultures by an agar block method against two yeasts and a mutant derived from each yeast. The mutants, which had impaired respiration and enhanced glycolysis were found to be much more sensitive to antimetabolites than their parents; detection of antimetabolites was increased from 0.04%to 1.64: for Candida utilis and 0.0% to 5.00%
ANTIMETABOLITES FROM MICROORGANISMS
51
for Torulopsis globosa. In our experience, 5% of the actinomycetes screened produced detectable antimetabolite activity against at least one of five test organisms. As is the case for antibiotics, actinomycetes give a higher incidence of antimetabolite production compared to other orders of microorganisms. Antimetabolites which are reversed by aliphatic amino acids, diamino acids, or glutamine appear to be much more prevalent than those reversed by heterocyclic amino acids. Antimetabolites for proline and tryptophan have not as yet been reported as microbial products. A wide variety of nucleoside antimetabolites is now known with structural variations in either the sugar or the base moieties. With the exception of the biotin analogs, few antimetabolites structurally related to vitamins have been discovered. It is clear that the search for antimetabolites from natural sources has yielded compounds which had not been previously synthesized in spite of the intensive efforts of organic chemists in this field. Of the compounds listed in Section V, only 13 had been previously synthesized. Some of the novel compounds could well have been synthesized, but in other cases problems of stability or the multiplicity of optical or geometrical isomers would have presented rather difficult synthetic problems. The most interesting cases, however, are those in which the structural analogy between antimetabolite and reversant is so remote that the compounds would never have been the prior object of a deliberate synthetic effort, as for example, borrelidin (LVII) and mycophenolic acid ( LX) which are reversed by threonine and guanosine, respectively. Of particular interest to peptide chemists is the finding that the two phosphorus-containing tripeptide antimetabolites ( XXXI and XXXIV) are much more potent microbial growth inhibitors than are the constituent unusual amino acids (Bayer et al., 1972; Pruess et al., 1973), even though the amino acids are better enzyme inhibitors (Bayer et al., 1972; A. Meister, personal communication), A similar effect has been demonstrated ( Smith and Dunn, 1970) with the synthetic phenylalanine analog, P-2-thienylalanine. This probably indicates that the peptide is more readily taken into the cell and there enzymatically hydrolyzed to the active enzyme inhibitor. VII.
Chemotherapeutic Applications
The chemotherapeutic uses of antimetabolites have been the subject of a vast review literature. Advocates of a “rational approach to chemotherapy” are particularly interested in antimetabolites, since the comparative biochemistry of metabolic pathways is, in general, well understood and an elaborate theory of enzyme kinetics and inhibition has been
52
DAVID L. PRUESS AND JAMES P . SCANNELL
developed. Since essential amino acids and vitamins are produced by microorganisms, not by mammals, a favorable selective activity would be expected if biosynthesis were blocked by an antimetabolite. Accordingly, one might expect that antimetabolites for amino acids and vitamins would be an especially promising group of compounds for chemotherapeutic application. Nevertheless, only a few vitamin or amino acid antimetabolites are useful drugs, perhaps the most notable examples being D-cycloserine and the sulfonamides. An analysis of the consequences of antimetabolite action in terms of the mechanisms discussed in Section IV partially explains this lack of success. If the mechanism of action of an antimetabolite is simple isosteric competitive inhibition of an enzyme reaction, the substrate concentration might be expected to increase until it relieved the block. It has been suggested ( Baker, 1967) that noncompetitive irreversible inhibitors would not be subject to this drawback. A more serious problem, however, is reversal by the product of the inhibited reaction or metabolic pathway. Except for certain topical infections, one would expect the product to be exogenously supplied to the infecting organism; consequently, regardless of how effectively biosynthesis was shut off, the viability of the organism would be unaffected. If the mechanism of antimetabolite inhibition is at the level of control, either by repression of enzyme synthesis or by allosteric pseudo-feedback inhibition of enzyme action, the outlook is even less promising. Not only will an exogenous supply of the end product of the blocked metabolic sequence relieve growth inhibition, but the end product itself will also shut off its own biosynthesis, thus making the action of the antimetabolite redundant. Transport inhibition is only likely to be effective against organisms lacking the relevant biosynthetic pathway and thus dependent on an exogenous supply of an essential metabolite. In organisms where exogenous and endogenous supplies of an essential metabolite are available, the antimetabolite would either have to serve double duty in inhibiting both uptake and biosynthesis, or two antimetabolites would have to be administered simultaneously in order to cut off both sources of supply. This would present an additional problem since the uptake inhibitor would very likely also inhibit the transport of the biosynthesis inhibitor. Perhaps this difficulty could be obviated in the case of amino acid antimetabolites by incorporation of the biosynthesis inhibitor into a di- or tripeptide. There are cases in which inhibition of biosynthesis is effective by itself since an exogenous supply of the essential metabolite is either not available to the parasite because it is not produced by the host organism, or not taken up by the parasite because a transport capability
ANTIMETABOLlTES FROM MICROORGANISMS
53
is lacking. In many of the cases where antimetabolites have proved to be therapeutically useful, lack of access to an exogenous supply of product reversant appears to be important. For instance, the effectiveness of D-cycloserine and the sulfonamides may be ascribed to the unavailability of an exogenous supply of the products of the inhibited reactions, D-alanine and D-alanyl-walanine in the case of D-cycloserine ( Neuhaus, 1967) and folic acid, which apparently does not enter the bacterial cells effectively (Woods et aE., 196l), in the case of the sulfonamides. Thus, in the search for new therapeutically useful antimetabolites, special attention should be directed to agents that block the biosynthesis of metabolites which are not exogenously available to the parasite.
NOTEADDEDIN
PROOF
The following antimetabolites have appeared in the literature during
1973: ~-N~-Hydroxyarginine NH OH 11 I HzN-C-N-CH2-CHz
Reversant:
Source:
NH2 0 I II -CHz-CH-C-OH
L-Arginine (noncompetitive), L-citrulline ( competitive) in Escherichia coli (Fischer et al., 1973; Maehr et al., 1973) Bacillus species XB-13248 (Maehr et al., 1973); Mannizzia gypsea (Fischer et al., 1973)
0-[ 1-Norvalyld]-’isourea NH2 0 I II -CH2 -CH2 -CH-C-OH
NH II HzN-C-O-CHz
Reversant: L-Arginine, L-ornithine, and L-citrulline in Escherichia coli and Bacillus subtilis (Konig et al., 1973a) Unidentified gram-negative bacterium, TU 222 ( Konig Source: et al., 1973a)
~S,5S-~-Amino-3-chloro-2-isoxazoline-5-acetic acid ’N II
CI -C-CH2
Reversant: Source: Structure:
NH2 0 I I1 ‘CH-CH-C-OH
0
I
Histidine in Bacillus subtilis and Escherichia coli (Hanka and Dietz, 1973; Hanka et al., 1973) Streptomyces wiceus (Hanka and Dietz, 1973) (Martin et al., 1973)
54
DAVID L. PRUESS A N D J A M E S
P. SCANNELL
L-Arginyl-D-do-threonyl-L-phenylalanine y 3
0 HO-CH
II H2N-CH-C -NH I y 2
CH2 I CH2 1 NH I C=NH
I
0
0 I1
II
- CH-C-NH - CH - C-OH I
FH2
ACH
CH
I
CH
II
I
Reversant: L-Histidine, L-threonine in Paecilomyces varioti ( Konig et al., 1973b) Source: Keratinophyton terrum (Konig et al., 1973b) Synthesis: L-Arginyl-D,L-albthreonyl-L-phenylalanine ( Konig et al., 1973b)
A9145 Reversant: Source: Structure:
Undefined components of Sabouraud’s medium in Candida albicans (Gordee and Butler, 1973) Streptomyces griseo2us (Boeck et al., 1973) Unknown; the compound is weakly basic, has a molecular weight of 510, and contains adenine (Hamill and Hoehn, 1973) ACKNOWLEDGMENTS
We wish to acknowledge the helpful discussion and critical review provided by Drs. T. C. Demny and P. A. Miller. REFERENCES Anderson, L. E., Ehrlich, J., Sun, S. H., and Burkholder, P. R. (1956). Antibiot. Chemother. (Washington, D.C.)6, 100. Anderson, P. M., and Meister, A. (1966). Biochemistry 5, 3164. Anzai, K., Nakamura, G., and Suzuki, S. (1957). J. Antibiot. 10, 201. Argoudelis, A. D. (1972). J. Antibiot. 25, 171. ArgoudeIis, A. D., and Reusser, F. (1971). J. Antibiot. 24, 383. Argoudelis, A. D., Herr, R. R., Mason, D. J., Pyke, T. R., and Zierserl, F. J. ( 1967). Biochemistry 6, 165. Baggaley, K. H., Blessington, B., Falshaw, C . P., OW, W. D., Chaiet, L., and Wolf,F. J. (1969). Chem. Cmmun. p. 101. Baker, B. R. ( 1967). “Design of Active-Site-Directed Irreversible Enzyme Inhibitors.” Wiley, New York. Balema, M., KelIer-Schierlein, W., Martius, c., Wolf, H., and Zahner, H. (1969). Arch. Mikrobiol. 65, 303.
ANTIMETABOLITES FROM MICROORGANISMS
55
Bayer, E., Gugel, K. H., Hagele, K., Hagenmaier, H., Jessipow, S., Konig, W. A., and Ziihner, H. ( 1972). Helv. Chim. Acta 55, 224. Berger, J., Jampolsky, L. M., and Goldberg, M. W. (1949). Arch. Biochem. 22, 476. Berg, M. E., and Herr, R. R. (,1967).Antimicrob. Ag. Chemother. p. 625. Bloch, A., and Nichol, C. A. (1964). Fed. Proc., Fed. Amer. SOC. Exp. B i d . 23, 324. Bloch, A., Leonard, R. J., and Nichol, C. A. (1967). Biochim. Biophys. Acta 138, 10. Bobek, M., and Bloch, A. (1972). J . Med. Chem. 15, 164. Boeck, L. D., Clem, G. M., Wilson, M. M., and Westhead, J. E. (1973). Antimicrob. Ag. & Chemother. 3, 49. Braun, A. C. (1950). Proc. Nat. Acud. Sci. U.S. 36, 423. Brian, P. W., Elson, G. W., Hemming, H. G., and Radley, M. E. (1965). Nature (London) 207, 998. Burrows, B. F., and Turner, W. B. (1966). J. Chem. Soc., C . p. 255. Caltrider, P. G. (1967). In “Antibiotics” (D. Gottlieb and P. D. Shaw, eds.), Vol. 1, p. 666. Springer-Verlag, Berlin and New York. Celmer, W. D. ( 1964). Belgian Patent 644,682; Chern. Abstr. 63,9836a ( 1965). Chmara, H., a?d Borowski, E. (1973). Biochem. Biophys. Res. Commun. 52, 1381. CihBk, A., and Sorm, F. (1965). Collect. Czech. Chem. Commun. 30, 2091. Clark, R. K., Jr., and Schenck, J. R. ( 1952). Arch. Biochem. Biophys. 40, 270. Cline, J. C., Nelson, J. D., Gerzon, K., William, R. H., and DeLong, D. C. (1969). Appl. Microbiol. 18, 14. Clutterbuck, P. W., Oxford, A. E., Raistrick, H., and Smith, G. (1932). Biochem. J. 26, 1441. Coronelli, C., Pasqualucci, G. R., Tamoni, G., and Gallo, G. G. ( 1966). Famaco, Ed. Sci. 21, 269. Cunningham, K. G., Hutchinson, S. A., Manson, W., and Spring, F. S. (1951). J . Chem. Soc., London p. 2299. Cuthbertson, W. F. S., Gregory, J., OSullivan, P., and Pegler, H. F. (1956). Biochem. 1. 62, 15p. D’Agnolo, G., Rosenfeld, I. S., Awaya, J., Omura, S., and Vagelos, P. R. (1973). Biochim. Biophys. A d a 326, 155. Darnall, K., Townsend, L., and Robins, R. (1967). Proc. Nut. Acad. Sci. US. 57, 548. DeVoe, S. E., Rigler, W. E., Shay, A. J., Martin, J. H., Boyd, T. C., Backus, E. J., Mowat, J. H., and Bohonos, N. (1957). Antibiot. Annu. p. 730. DeWald, H. A,, and Moore, A. M. (1958). J. Amer. Chem. SOC. 80, 3941. DeZeeuw, J. R., and Tynan, E. (1969). J . Antibiot. 22, 386. Dulaney, E. L., and Gray, R. A. (1962). Mycologia 54, 476. Dyer, H. M. (1938). J. Biol. Chem. 124, 519. Eble, T. E., Hoeksema, H., Boyack, G., and Savage, G. M. ( 1959). Antibiot. Chemother. (Washington, D.C.) 9, 419. Edelson, J., Fissekis, J. D., Skinner, C. G., and Shive, W. (1958). 1. Amer. Chem. SOC. 80, 2698. Elulich, J., Coffey, G. L., Fisher, M. W., Hillegass, A. B., Kohberger, D. L., Machamer, H. E., Rightsel, W. A., and Roegner, T. R. (1956). Antibiot. Chemother. (Washington, D.C.) 8, 487. Elion, G. B., and Hitchings, G. H. (1955). J . Amer. Chem. SOC. 77, 1676. Emery, T. (1971). Aduan. Enzymol. 35, 135. Endo, A., Kakiki, K., and Misato, T. (1970). J . BacterioZ. 104, 189. English, A. R., McBride, T. J., and Lynch, J. E. (1957). Antibiot. Annu. p. 676. Esterman, M. A., and Sweeney, M. J. (1970). Proc. Amer, Ass. Cancer Res. 11, 91.
56
DAVID L. PRUESS AND JAMES P. SCANNELL
Fickenscher, U., and Zahner, H. (1971).Arch. Mikrobiol. 76, 28. Fickenscher, U., Keller-Schierlein, W., and Zahner, H. ( 1971). Arch. Mikrobiol. 75, 346. Field, G . F., Zally, W. J., and Sternbach, L. H. (1970).J. Amer. Chem. SOC. 92, 3520. Fischer, B., Keller-Schierlein, W., Kneifel, H., Konig, W. A,, Loeffler, W., Miiller, A., Muntwyler, R.,and Zahner, H. (1973).Arch. Mikrobiol. 91, 203. Fisher, J. F., and Mallette, M. F. (1961).J. Gen. Physiol. 45, 1. Florey, H. W., Chain, E., Heatly, N. G., Jennings, M. A., Sanders, A. G., Abraham, E. P., and Florey, M. E. (1949).“Antibiotics,” Vol. I, p. 457. Oxford Univ. Press, London and New York. Foster, J. W., and Pittillo, R. F. (1953a).J. Bacteriol. 65, 361. Foster, J. W., and Pittillo, R. F. (195313).J. Bacteriot. 66, 478. Foster, J. W., and Woodruff, H. B. (1946).J. Bacteriol. 51, 363. Fowden, L., Lewis, D., and Tristram, H. (1967).Aduan. Enzymol. 29, 89. Franklin, T.J., and Cook, J. M. (1969).Biochem. J. 113, 515. Fuerst, R. (1964). Proc. Int. Congr. Chemother., 3rd, 1963 Vol. I, p. 983. Fuerst, R., and Skellenger, W. M. (1958).Antibiot. Chemother. (Washington, D.C.) 8, 76. Furumai, T., Nagahama, N., and Okuda, T. (1968).J. Antibiot. 21, 85. Gale, G. R., and Atkins, L. M. ( 1968). Proc. SOC. Exp. Biol. Med. 129, 842. Gale, G. R., Ostrander, W. E., and Atkin, L. M. (1968).Biochem. Pharmacol. 17, 1823. Gause, G. F., Laiko, A. V., Kusovkova, L. I., and Selesneva, T.I. ( 1972).Experientia 28, 608. Genghof, D. S. (1970).Can. J . Microbiol. 16,545. Gershon, H., Meek, J. S., and Dittmer, K. (1949).1. Amer. Chem. SOC. 71, 3573. Gershon, H., Shapira, J., Meek, J. S., and Dittmer, K. (1954). J. Amer. Chem. SOC. 76,3484. Gerzon, K., Williams, R. H., Hoehn, M., Gorman, M., and DeLong, D. C. (1969). Proc. Int. Congr. HeterocycE. Chern., 2 4 , 1969 Abstract 30-C. Gerzon, K.,DeLong, D. C., and Cline, J. C. (1971).Pure Appl. Chem. 28, 489. Giovanelli, J., Owens, L. D., and Mudd, S. H. (1971). Biochim. Biophys. Acta 227, 671. Gitterman, C. O., Dulaney, E. L., Kaczka, E. A., Hendlin, D., and Woodruff, H. B. (1962).Proc. SOC. E x p . Biol. Med. 109, 852. Gordee, R. S., and Butler, T.F. (1973).J. Antibiot. 26, 466. Gottlieb, D., and Shaw, P. D., eds. ( 1967). “Antibiotics-Mechanism of Action,” Vol. 1, Springer-Verlag, Berlin and New York. Gray, R. A., Gauger, G. W., Dulaney, E. L., Kaczka, E. A., and Woodruff, H. B. (1964).Plant Physiol. 39, 204. Grove, J. (1963).Quart. Rev., Chem. SOC. 17, 1. Grundy, W. E., Whitman, A. L., Rdzok, E. G., Rdzok, E. J., Hanes, M. E., and Sylvester, J. C. ( 1962). Antibwt. Chemother. (Washington, D.C.)2, 399. Hagemann, G., Penasse, L., and Teillon, J. (1955). Biochim. Biophys. Acta 17, 240. Halder, A., and Bose, S. K. ( 1971).J . Antibiot. 24, 779. Hamel, E. E., and Painter, E. P. (1953). J . Amer. Chem. SOC. 75, 1362. Hamill, R. L., and Hoehn, M. M. (1973).J. Antibiot. 26, 463. Haneishi, T.,Nomura, M., Okazaki, T., Naito, A., Seki, D., Arai, M., Hata, R., and Tamura, C. (1970).174th Meet. Jap. Antibiot. Res. Ass.
ANTIMETABOLITES FROM MICROORGANISMS
57
Haneishi, T., Okazaki, T., Hata, T., Tamura, C., Nomura, M., Naito, A., Seki, I., and Arai, M. ( 1971). J. Antibiot. 24, 797. Hanka, L. J. (1960). 3. Bacteriol. 80, 30. Hanka, L. J. (1968). PTOC.Int. Congr. Chemother., Sth, 1967 Vol. HI, p. 351. Hanka, L. J., and Burch, M. B. (1960). Antibiot. Chemother. (Washington, D.C.) 10, 484. Hanka, L. J., and Dietz, A. (1973). Antimicrob. Ag. 6.Chemother. 3, 425. Hanka, L. J., Bergy, M. E., and Kelly, R. B. (1966). Science 154, 1667. Hanka, L. J., Evans, J. S., Mason, D. J., and Dietz, A. (1967). Antimicrob. Ag. Chemother. p. 619. Hanka, L. J., Martin, D. G., and Reinke, L. M. (1972). Antimicrob. Ag. (?1 Chemother. 1, 135. Hanka, L. J., Martin, D. G., and Neil, G. L. (1973). Cancer Chemother. Rep. 57, 141.
Hardegger, C., Liechti, P., Jackman, L. M., Butler, A., and Plattner, P. A. (1963). Helu. Chim. Acta 46, 60. Harned, R. L., Hidy, P. H., and LaBow, E. K. (1955). Antibiot. Chemother. (Washington, D.C.) 5, 204. Harris, D. A., Ruger, M., Reagon, M. A., Wolf, T. J., Peck, R. L., Wallick, H., and Woodruff, H. B. (1955). Antibiot. Chemother. (Washington, D.C.) 5, 183. Harris, J. S., and Kohn, H. I. ( 1941). J . P ~ U T ~ Q CExp. O ~ . Ther. 73, 383. Herr, R. R., Eble, T. E., Bergy, M. E., and Jahnke, H. K. (1960). Antibiot. Annu. p. 236. Herr, R. R., Jahnke, H. K., and Argoudelis (1967). J . Amer. Chem. SOC. 89, 4808. Hersh, E. M., and Brown, B. W. (1971). Cancer Res. 31, 834. Hoeksema, H., Slomp, G., and van Tamelen, E. E. (1964). Tetrahedron Lett. p. 1787. Hessler, E. J., and Jahnke, H. K. (1970). J. Org. Chem. 35,245. Hitchings, G. H., and Elion, G. M. (1963). In “Metabolic Inhibitors” (R. M. Hochster and J. H. Quastel, eds.) Vol. 1, p. 215. Academic Press, New York. Hochstein, F. A. (1959). I. Org. Chem. 24, 679. Hori, M., Wakashiro, T., Ito, E., Sawa, T., Takeuchi, T., and Umezawa, H. (1968). 1. Antibiot. 21, 264. Huber, F. M. (1967). In “Antibiotics” (D. Gottlieb and P. Shaw, eds.) Vol. 1, p. 181. Springer-Verlag, Berlin and New York. Hiitter, R., Poralla, K., Zachau, H. G., and Zahner, H. (1966). Biochm. Z. 344, 190. Isono, K., Asahi, K., and Suzuki, S. (1969). J . Amer. Chern. SOC. 91, 7490. Johnson, J., and Munvin, H. F. (1925). Wis., Agr. Exp. Sta., Res. Bull. 62, 1. Kaczka, E. A,, Gitterman, C. O., Dulaney, E. L., and Folkers, K. (1962). Biochemistry 1, 340. Kamka, E. A., Dulaney, E. L., Gitterman, C. O., Woodruff, H. B., and Folkers, K. (1964). Biochem. Biophys. Res. Commun. 14, 452. Kaczka, E., Miller, T., Tausig, F., and Wolf, F. (1967). Antimicrob. Ag. Chemother. p. 603. Kaiser, C. ( 1960). In “Medicinal Chemistry” (A. Burger, ed.), 2nd ed., pp. 89-132. Wiley (Interscience), New York. Kamihski, K., and Sokolowska, T. (1973). J . Antibiot. 26, 186. Katagiri, K., Ton, K., Kimura, Y., Yoshida, T., Nagasaki, T., and Minato, H. (1967). J . Med. Chem. 10, 1149.
58
DAVID L. PRUESS AND J A M E S P. BCANNELL
Kawashima, M., Hamada, Y., and Fujii, S. (1953). Phamt. BUZZ. I, 94. Keller-Schierlein, W. (1967). Helo. Chim. Acta 50, 731. Keller-Schierlein, W., Poralla, K., and Ziihner, H. (1969). Arch. Mikrobiol. 87, 339. Keller-Schierlein, W., Sauerbier, J., Vogler, U., and Zahner, H. (1970). Helo. Chim. Acta 53, 779. Kelly, R. B., Martin, D. G., and Hanka, L. J. (1969). Can. J . Chem. 47,2504. Kishi, T., Muroi, M., Kusaka, T., Nishikawa, M., Kamiya, K., and Mizuno, K. ( 1972). Chem. Phamz. Bull. 20, 940. Koe, B. K., Sobin, B. A., and Celmer, N. D. (1957). Antibiot. Annu. p. 672. Komatsu, Y., and Tanaka, K. ( 1971). Agr. Biol. Chem. 35, 526. Konig, W. A., Kneifel, H., Bayer, E., Miiller, G., and Zahner, H. (1973a). J. Antibiot. 20, 44. Konig, W. A,, Loeffler, W., Meyer, W. H., and Uhmann, R. (1973b). Chem. Ber. 108, 816. Koppenhagen, V. B., and Pfiffner, J. J. (1970). J. Bid. Chem. 245, 5865. Koppenhagen, V. B., and Pfiffner, J. J. (1971). J. Biol. Chem. 246, 3075. Korobkova, T. P., Terekhova, L. P., and Maksimova, T. S. (1970). Antibiotiki (Moscow) 15, 936. Koyama, G., and Umezawa, H. (1965). 1. Antibiot. 18, 175. Koyama, G., Maeda, K., Umezawa, H., and Sitaka, Y. (1966). Tetrahedron Lett. No. 6, p. 597. Kruepe, H., and Poralla, K. (1972). Arch. Mimobiol. 85, 253. Kurosawa, H. (1952). J. Antibiot. 5, 682. Kusaka, T. (1971). J . Antibiot. 24, 756. Kusaka, T., Yamamoto, H., Shibata, M., Muroi, M., Kishi, T., and Mizuno, K. (1968). J . Antibiot. 21, 255. Kusakabe, Y., Nagatsu, J., Shibuya, M., Kawaguchi, O., Hirose, C., and Shirato, S. (1972). 1. Antibiot. 25, 44. Logan, W. R., and Newbold, G. T. (1957). J. Chem. SOC., London p. 1946. McCord, T. J., Ravel, J. M., Skinner, C. G., and Shive, W. (1957). J. Amer. Chem. SOC. 79, 5693. McIlwain, H. ( 1943). Biochem. J . 37, 265. McKennis, H., and Yard, A. S. ( 1958). J . Org. Chem. 23, 980. McLamore, W. M., Celmer, W. D., Bogert, V. V., Pennington, F. C., Sobin, B. A,, and Solomons, I. A. (1953). J. Amer. Chem. SOC. 75, 105. McNall, E. G. (1960). AMA Arch. Dermutol. 81, 657. Maeda, K., Okami, Y., Kosaka, H., Taya, O., and Umezawa, H. (1952). J . Antibiot. 5. 572. Maehr, H. (1971). Pure Appl. Chem. %8, 603. Maehr, H., Blount, J. F., Pruess, D. L., Yarmchuk, L., Kellett, M. (1973). J. Antibiot. 28, 284. Martin, D. G., Slomp, G., Miysak, S., Duchamp, D. J., and Chidester, C. G. (1970). Tetrahedron Lett.No. 56, p. 4901. Martin, D. G., Hanka, L. J,, and Reineke, L. M. (1971). Tetrahedron Lett. No. 41, p. 3791. Martin, D. G., Duchamp, D. J., and Chidester, C. G. (1973). Tetrahedron Lett. No. 27, p. 2549. Mathews, R. E. F. (1958). PharniacoZ. Rev. 10, 359. Mego, J. L., (1964). Biochim. Biophys. Acta 79, 221. Meister, A. (1965). “Biochemistry of the Amino Acids,” 2nd ed., Vol. 1, p. 239. Academic Press, New York.
ANTIMETABOLITES FROM MICROORGANISMS
59
Mitani, M., and Inoue, Y. (1968). J. Antibiot. 21, 492. Miyake, A., Mormato, A., and Kinoshita, T. (1953). Phurm. Bull. 1, 84. Modest, E. J., Foley, G. E., and Farber, S. (1963). I n “Metabolic Inhibitors” (R. M. Hochster and J. H. Quastel, eds.), Vol. 1, pp. 75-129. Academic Press, New York. MolIoy, B. B., Lively, D. H., Gale, R. M., Gorman, M., Boeck, L. D.,Higgens, C. E., Kastner, R. E., Huchstep, L. L., and Neuss, N. (1972). J. Antibiot. 25, 137. Moore, J.. A., Dice, J. R., Nicolaides, E. D., Westland, R. D., and Wittle, C. L. (1954). J. Amer. Chem. SOC.76, 2884. Murthy, Y. K. S., Thiemann, J. E., Coronelli, C., and Sensi, P. (1966). Nature (London) 211, 1198. Nagahama, N., Suzuki, M., Awataguchi, S., and Okuda, T. (1967). J. Antibiot. 20, 261. Nagahama, N., Takamori, I., and Suzuki, M. (1971). Chem. Phurm. BuU. 19, 660. Nakagawa, Y., Kano, H., Tusukuda, Y., and Koyama, H. (1967). Tetrahedron Lett. No. 42, p. 4105. Nass, G., Poralla, K., and Zahner, H. ( 1969). Bioohem. Biophys. Res. Commun. 34, 89. Nass, G., Poralla, K., and Zahner, H. (1971). Naturwissenschaften 58, 603. Neuhaus, F. C. (1967). In “Antibiotics” ( D . Gottlieb and P. D. Shaw, eds.), Vol. 1, p. 40. Springer-Verlag, Berlin and New York. Neuman, R. E., and Tytell, A. A. (1983). Proc. Soc. Exp. BWZ. Med. 112, 57. Neuss, N., Molloy, B. B., Shak, R., and DeLaHiguera, N. (1970). Biochem. J. 118, 571. Nishimura, H., and Komatsu, Y. (1968). J. Antibiot. 21, 250. Nishimura, H., Kahgiri, K., Sato, K., Mayama, M., and Shimaoka, N. (1956). J . Antibiot. 9, 60. Nishimura, H., Mayama, M., Komatsu, Y., Kato, H., Shimaoka, N., and Tanaka, Y. 3 (1964). J . Antibiot. 17, 148. Nomura, S.,Horiuchi, T., Hata, T., and Omura, S. (1972a). I. Antibiot. 25, 365. Nomura, S., Horiuchi, T., Omura, S., and Hata, T. ( 1972b). J. Biodhem. (Tokyo) 71, 783. Novick, R. P., and Maas, W. K. (1961). J. BacterwZ. 81, 236. Ohkuma, K. ( 1961). J . Antibiot. 14, 343. Omura, S., Katagiri, M., Nakagawa, A,, Sano, Y., Nomura, S., and Hata, T. (1967). 1. Antibiot. 20, 349. Owens, L. D., and Wright, D. A. (1965). Plant Physiol. 40, 927. Owens, L. D., Guggenheim, S., and Hilton, J. (1968). Biochim. Biophys. Acta 158, 219. Owens, L. D., Lieberman, M., and Kunishi, A. (1971). Plant Physiol. 48, 1. Owens, L. D., Thompson, J. F., Pitcher, R. G., and Williams, T. (1972). Chem. Commun. p. 714. Oxford, A. E. (1942). Biochem. J. 36, 438. Oxford, A. E., Raistrick, H., and Simonart, P. (1939). Biochem. J . 33, 240. Painter, E. P. (1947). J . Amer. Chem. SOC.69, 232. Patterson, E. L., Johnson, B. L., DeVoe, S. E., and Bohonos, N. (1966). Antimicrob. Ag. Chemother. p. 115. Perlman, D., and Toohey, J. I. (1968). Arch. Biochem. Biophys. 124, 462. Pierard, A., Glansdorff, N., Mergeay, M., and Wiame, J. M. (1965). J. Mol. Biol. 14, 23. Ciskala, A., and Sorm, F. (1964). Collect. Czech. Chem. Commun. 29,2060.
60
DAVID L. PRUESS AND JAMES P. SCANNELL
Pittillo, R. F., and Foster, J. W. ( 1964). J . Baderiol. 67, 53. Pittillo, R. F., and Hunt, D. E. (1967). In “Antibiotics” (D. Gottlieb and P. D. Shaw, eds.), Vol. 1, p. 481. Springer-Verlag, Berlin and New York. Pittillo, R. F., and Hunt, D. E. (1968). Cancer Chemother. Rep. 52, 707. Plattner, P. A., and Clauson-Kaas, M. (1945). Helu. Chim. Acta 28, 188. Pruess, D. L., Scannell, J. P., Ax, H. A., Kellett, M., Weiss, F., Demny, T. C., and Stempel, A. (1973). 1. Antibiot. 26, 261. Pruess, D. L., Scannell, J. P., Kellett, M., Ax, H. A., Janecek, J., Williams, T. H., Stempel, A., and Berger, J. (1974). J. Antibiot. (in press). Rao, K. V. (1962). Antimicrob. Ag. Chemothu. p. 178. Rao, K. V. (1963). Antimicrob. Ag. Chemother p. 179. Rao, K. V., Brooks, S. C., Kugelman, M., and Romano, A. A. (1960). Antibiot. Annu. p. 943. Ressler, C. ( 1972). J. Org. Chem. 37, 2933. Reusser, F. (1968). J . Bacteriol. 96, 1285. Reusser, F. (1969). J. Bacteriol. 100, 11. Richmond, M. H. (1962). Bacteriol. Reo. 26, 398. Rogers, H. J., Newton, G. G. F., and Abraham, E. P. (1965). Biochem. 1. 97, 573. Rottman, F., and Guarino, A. J. (1964). Biochim. Biophys. Acta 80, 632. Roy-Burman, S., and Visser, D. W. (1972). Biochim. Biophys. Acta 282, 383. Rudas, B. ( 1972). Arzneim.-Forsah, 22, 830. Rudzats, R., Gellert, E., and Halpern, B. (1972). Biochem. Siophys. Res. Commun. 47, 290. Sahm, U., Knobloch, G., and Wagner, F. (1973) J . Antibiot. 26, 389. Sano, Y., Nomura, S., Kamio, Y., Omura, S., and Hata, T. (1967). J. Antibiot. 20, 344. Sasaki, K., Kusakabe, Y.,and Esumi, S. (1972). J. Antibiot. 25, 151. Sato, K., Shimizu, S., and Fukui, S. (1970). Biochem. Biophys. Res. Commun. 39, 170. Scannell, J. P., Pruess, D. L., Demny, T. C., Williams, T., and Stempel, A. (1970). J. Antibiot. 23, 619. Scannell, J. P., Pruess, D. L., Demny, T. C., Weiss, F., Williams, T., and Stempel, A. (1971a). J . Antibiot. 24, 239. Scannell, J. P., Pruess, D. L., Kellett, M., Demny, T. C.. and Stempel, A. (1971b). 1. Antibiot. 24, 328. Scannell, J. P., Pruess, D. L., Demny, T. C., Sello, L. H., Williams, T., and Stempel, A. (1972a). J. Antibiot. 25, 122. Scannell, J. P., Ax, H. A,, Pruess, D. L., Williams, T., Demny, T. C., and Stempel, A. (1972b). J. Antibiot. 25, 179. Scannell, J. P., Pruess, D. L., Demny, T. C., Ax, H. A,, Weiss, F., Williams, T., and Stempel, A. ( 1 9 7 2 ~ )In . “Chemistry and Biology of Peptides” (J. Meinhofer, ed.), p. 415. Ann Arbor Sci. Publ., Ann Arbor, Michigan. Schabel, F. M., Jr., and Pittillo, R, F. (1961). Adoan. Appl. Microbial. 3, 223. Schein, P. S., and Loftus, S. (1968). Cancer Res. 28, 1501. Schein, P. S., Cooney, D. A., and Vernon, M. L. (1967). Cancer Res. 27, 2324. Schenck, J. R., and DeRose, A. F. (1952). Arch. Biochem. Biophys. 40, 263. Schlogl, K. (1958). Monutsh. Chem. 89, 377. Schrift, A. (1954). Amer. J. Bot. 41, 345. Schrift, A. (1961). Fed. Proc., Fed. Amer. SOC. Exp. Biol. 20, 695. Schroeder, W., and Hoeksema, H. (1959). J. A m r . Chem. SOC. 81, 1767. Shah, R., Neuss, N., Gorman, M., and Boeck, L. D. (1970). J . Antibiot. 23, 613.
ANTIMETABOLITES FROM MICROORGANISMS
61
Shapira, J., and Dittmer, K. (1961). J. Bacteriol. 82, 640. Shealy, Y. F., and Clayton, J. D. (1966). J. A m . Chem. SOC.88,3885. Shealy, Y. F., and Clayton, J. D. (1969). J. Amer. Chem. SOC. 91, 3075. Shigeura, H. T. (1963). Arch. Biochem. Biophys. 100, 472. Shigeura, H. T. (1967). In “Antibiotics” (D. Gottlieb and P. D. Shaw, eds.), Vol. 1, p. 451. Springer-Verlag, Berlin and New York. Shigeura, H. T., and Gordon, C. N. (1962). J . Biol. Chem. 237, 1937. Shive, W., and Macow, J. (1946). J. Biol. Chem. 162, 451. Shoulders, B. A., Gipson, R. M., Jandacek, R. J., Simonsen, S. H., and Shive, W. ( 1968). J . Amer. Chem. SOC. 90, 2992. Shull, G. M., and Sardinas, J. L. (1955). Antibiot. Chemother. (Washington, D.C.) 5, 398. Simon, A., (1969). Anal. Biochem. 31, 532. Sinden, S. L., and Durbin, R. D. (1968). Nature (London) 219,379. Skinner, C. G., McCord, T. J., Ravel, J. M., and Shive, W. (1955). J. Amer. Chem. SOC.78, 2412. Slechta, L. (1960). Biochem. Phurmuco2. 5, 98. Smith, E. L. ( 1965). “Vitamin Ba,” p. 94. Wiley, New York. Smith, R. L., and Dunn, F. W. (1970). J . Biol. Chem. 245, 2962. Smith, S. S., Bayliss, N. L., and McCord, T. J. (1963). Arch. Biochem. Biophys. 102, 313. Snell, E. E., and Guirard, B. M. ( 1943). Proc. Nut. Acad. Sci. US. 29, 66. Snow, M, L., Lauinger, C., and Ressler, C. (1968). J. Org. Chem. 33, 1774. Stammer, C. H. ( 1971). In “Chemistry and Biochemistry of Amino Acids, Peptides and Proteins” (B. Weinstein, ed.), Vol. I, p. 23. Dekker, New York. Stammer, C. H., Wilson, A. N., Holly, F. W., and Folkers, K. (1955). J. Amer. Chem. SOC. 77, 2346. Stapley, E. O., Mata, J. M., Miller, I. M., Demny, T. C., and Woodruff, H. B. (1964): Antimicrob. Ag. Chemother. p. 20. Stapley, E. O., Demny, T., Miller, A. K., and Woodruff, H. B. (1967). Antimicrob. Ag. Chemother. p. 595. Stapley, E. O., Miller, T. W., Mata, J. M., and Hendlin, D. (1968). Antimicrob. Ag. Chemother. p. 401. Stewart, W. W. ( 1971). Nature (London) 229, 174. Stieglitz, B., and Calvo, J. M. (1971). J . Bacteriol. 108, 95. Stim, T. B., Arnwine, B. C., and Foster, J. W. (1959). J . Bacteriol. 77, 566. Stock, C. C., Reilly, H. C., Buckley, S. M., Clarke, D. A., and Rhoads, C. P. (1954). Nature (London) 173, 71. Streightoff, F. J., Nelson, J. A., Cline, J. C., Gerzon, K., Hoehn, M., Williams, R. H., Gorman, M., and DeLong, D. C. (1969). Conf. Antimicrob. Ag. Chemother., gth, 1969 p. 8. Suhadolnik, R. J. ( 1970). “Nucleoside Antibiotics.” Wiley, New York. Suzuki, S., and Marumo, S. ( 1961). J . Antibiot. 14, 34. Suzuki, S., Isono, K., Nagatsu, J., Mizutani, T., Kawashima, Y., and Mizuno, T. (1965). 1. Antibiot. 18, 131. Takatsuki, A., and Tamura, G. (1971). J . Antibiot. 24, 232. Takatsuki, A., Arima, K., and Tamura, G. (1971). J . Antibiot. 24, 215. Takeshima, H., Kotani, M., Yagisawa, T., Yamagishi, M., Nomura, S., Omura, S., and Hata, T. ( 1969). 42nd Ann. Meet. Jap. Bacteriol. SOC. Takeuchi, S., Ogawa, Y., and Yonehara, H. (1969). Tetrahedron Lett. No. 32, p. 2737. Tamura, C. (1963). BUZZ. Chem. SOC. lap. 36, 1187.
62
DAVID L. PRUESS AND JAMES P. SCANNELL
Tanaka, F., Takeuchi, S., and Tanaka, N. (1961). J. Antibiot. 14, 161. Tanaka, F., Tanaka, N., Yonehara, H., and Umezawa, H. (1962a). I. Antibiot. 15, 191. Tanaka, F., Takeuchi, S., and Yonehara, H. (1962b). J. Antibiot. 15, 197. Tanaka, K., Tamaki, M., and Watanabe, S. (1969). Biochim. Biophys. Act4 195, 244. Tanaka, N., Miyairi, N., and Umezawa, H. (1960). J . Antibiot. 13, 265. Taylor, P. A., ‘Schnoes, H. K., and Durbin, R. D. (1972). Biochim. Biophys. Acta, 286, 107. Tejera, E., Backus, E. J., Dann, M., Ervin, C. D., Shakofski, A. J., Thomas, S . O., Bohonos, N., and Williams, J. H. ( 1952). Antibiot. Chemother. (Washington, D.C.) 2, 333. Terao, M. (1963). J. Antibiot. 14, 182. Terao, M., Karasawa, K., Tanaka, N., Yonehara, H., and Umezawa, H. (1960). 1. Antibiot. 13, 401. Tesser, G . I., and Nefkens, G. H. L. (1959). Rec. Trau. Chim. Pays-Bas. 78, 404. Tesser, G. I., Nivard, R. J. F., and Gruber, M. (1962). Rec. Truu. Chim. Pays-Bas. 81, 713. Toohey, J. I. ( 1965). Proc. Nat. Acad. Sci. U.S. 54, 934. Toohey, J. I. (1966). Fed. Proc., Fed. Amer. SOC. Exp. Biol. 25, 1628. Tuve, T., and Williams, H. H. ( 1961). J. Biol. Chem. 236, 597. Umezawa, H. (1973). Pure AppZ. Chem. 33, 129. Umezawa, H., Oikawa, K., Okami, Y., and Maeda, K. (1953). J. BacterioZ. 68, 118. Vavra, J. J., Deboer, C., Dietz, A., Hanka, L. J., and Sokolski, W. T. (1960). Antibiot. Annu. p. 230. Villa-Trevino, S., Schull, K. H., and Farber, E. (1963). J. Bid. Chem. 238, 1757. Wagner, G. ( 1971). P b a m z i e 26,377. Walker, J. E., and Abraham, E. P. (1970). Biochem. I . 118, 557. Wakon, R. B., and Rickes, E. L. (1962). 1. Bacterial. 84, 1148. Westley, J. W., Pruess, D. L., Volpe, L. A., Demny, T. C., and Stempel, A. (1971). 1. Antibiot. 24, 330. Whitney, J. G., and Funderburk, S. S. (1970). Abstr. Int. Congr. Microbiol. loth, 1970, p. 101. Williams, R. H., Lively, D. H., DeLong, D. C., Cline, J. C., Sweeney, M. J., Poore, G. A., and Larsen, S. H. ( 1968). 1. Antibiot. 21, 463. Woods, D. D. (1964). Proc. Int. Congr. Chemother., 3rd, 1963 Vol. I, p. 227. Woods, R. C., Ferone, R., and Hitchings, G. H. ( 1961). Biochem. Pbarmucol. 6, 113. Woolley, D. W. (1946). J. Biol. Chem. 166, 783. Woolley, D. W. (1952). “A Study of Antimetabolites.” Wiley, New York. Woolley, D. W. (1963). In “Metabolic Inhibitors” (R. M. Hochster and J. H. Quastel, eds.), Vol. 1, p. 445. Academic Press, New York. Woolley, D. W., Schaffner, G., and Braun, A. C. (1955). J. BioZ. Chem. 215, 485. Yamashita, T., Miyairi, N., Kunugita, K., Shimizu, K., and Sakai, H. (1970). J. Antibiot. 23, 537. Yiintsen, H. (1958). J. Antibiot. 11, 244. Yiintsen, H., Ohkuma, K., Ishii, Y., and Yonehara, H. (1956). J. Antibiot. 9, 195. Zahner, H., and Poralla, K. (1970). Proc. Znt. Congr. Chemother., 6th, 1969 Vol. 11, p. 1111. Ziihner, H., Hiitter, R., and Bachmann, T. ( 1960). Arch. MicrobioZ. 38,325.
lipid Composition as a Guide to the Classification of Bacteria
NORMAN SHAW Mimoblological Chemisty Research Laboratory, School of Chemistty, University of Newcastle upon Tyne, Newcastle upon Tyne, England
I. Introduction ..................................... 11. The Major Types of Lipids Found in Bacteria ......... A. Apolar Components ........................... B. Phospholipids ................................ C. Glycolipids ................................... D. Neutral Lipids ................................ E. Nonextractable Lipids ......................... 111. Analysis of Bacterial Lipids ........................ IV. Distribution of Lipids in Bacteria .................... A. Fatty Acids ................................... B. Phospholipids ................................. C. Glycolipids ................................... V. Correlation of Lipid Composition with Taxonomic Classification ..................................... A. Pseudomonadales .............................. B. Eubacteriales ................................. C. Actinomycetales .............................. D. Mycoplasmatales .............................. VI. Conclusions ...................................... References ........................................
I.
63 64 64 67 69 69 70 71 74
75 81 81 98 98
99 102 103 103 104
Introduction
The first attempt to correlate lipid composition with taxonomic classification was made by Abel et al. (1963), who showed that qualitative fatty acid analyses could be used to differentiate between various organisms. In the following year Kates (1964) reviewed the'information then available on all types of bacterial lipids, and he was able to extend these correlations to many more bacteria. In the ensuing years, owing to an increasing awareness of the importance of lipids in membrane processes and a tremendous improvement in lipid methodology, information on bacterial lipids has increased logarithmically and shows no sign of diminution. This information has been discussed extensively in two monographs ( Asselineau, 1966; O'Leary, 1967) and several reviews ( Op den Kamp et al., 1969b; Lennarz, 1970; Shaw, 1970). The purpose of this review is to reassess in the light of this intensive work the value of lipid composition as a guide to the classification of bacteria. The ideal chemotaxonomic method has three basic criteria. First, it should be applicable to as large a number of organisms as possible; second, the required information should be readily obtained; and third, 63
64
NORMAN SHAW
the parameters utilized should differ as widely as possible from one genus or family to the next. After reading this review, I hope you will share my view that the use of lipid composition as a chemotaxonomic method goes further toward satisfying these criteria than the other methods presently in use. Lipids are universally present in bacteria, they are easily and specifically extracted, and they are readily identified. Moreover, the great variety of lipid species present in bacteria satisfies in large measure the third criterion and is probably as near to an ideal solution as we are likely to reach. There are three parameters which nay be used in a taxonomic study of lipid composition-namely, phospholipids, glycolipids, and their respective apolar constituents. Each of these three classes has many different members and the presence or absence of any individual type may be significant. After a brief discussion of the types of lipids present in bacteria and their analysis, the distinctive taxonomic patterns which have clearly been established will be described. II.
The Major Types of Lipids Found i n Bacteria
Lipids are most simply defined as those natural products which may be isolated from biological materials by extraction with organic solvents and which are usually insoluble in water. This broad definition would include sterols, terpenoids, isoprenoids, waxes, and pigments, many of which are not present in bacteria. The lipids commonly found in bacteria are amphiphatic molecules, i.e., they consist of distinct polar and apolar regions. The apolar part is usually a diacylglycerol derivative-diglyceride-in which long-chain fatty acids are esterified to carbon atoms 1 and 2 of glycerol. The polar group linked to carbon atom 3 of glycerol may be a phosphate ester-phospholipid-or a carbohydrate derivative-glycolipid.
A. THE APOLARCOMPONENTS
1. Fatty Acids The fatty acids most frequently found in bacteria are between C,, and C,, in length although those between C , , and C,, are usually the most prevalent. They may be divided into four major groups: straightchain, branched-chain, unsaturated, and cyclopropane ( Fig. 1). Their common names and shorthand notation are shown in Table I. The straight-chain fatty acids are those found elsewhere in nature, C12, Cli, Cle, and CIS. However, the corresponding p-hydroxy derivatives, in particular p-hydroxymyristic acid (3-OH C , , ) , are not normally
CHEMOTAXONOMY OF BACTERIAL LIPIDS
CH,(CH,)n COOH
65
CH,(CH& CHCH,COOH
I
OH
p - Hy droxy
Saturated
CH,?H(CH,),
COOH
CHS is0
CH, ( CH,) CH= CH ( CH,) COOH
CH,CH,CH(CH,), COOH I CHS
anteiso
CH,( CH,) I CH‘C’
CH(CH,), COOH
H,
Unsaturated
Cyclopropane
FIG.1. Formulas of the major types of fatty acids.
found in higher organisms, but are common components of the bound lipids present in the walls of gram-negative bacteria ( Section 11,E). The branched-chain fatty acids are of two types: the is0 form in which the methyl group is located on the penultimate carbon atom and the anteiso in which the methyl group is located on the antepenultimate TABLE I THESYSTEMATIC NAMES,COMMON NAMES, AND SHORTHAND FORMULAS OF THE FATTYACIDSFOUNDI N BACTERIA Shorthand formula. Saturated:
Dodecanoic acid Tetradecanoic acid CIS Hexadecanoic acid C18 Octadecanoic acid C*O Eicosanoic acid cl G: I*’ cis-9-Hexadecenoic acid ClS:l*~ cis-9-Octadecenoic acid clS:l*ll cis-1 1-Octadecenoic acid is0 Cl€.br 13-Methyl tetradecanoic acid anteiso Clbbr 12-Methyl tetradecanoic acid anteiso C 17br 14Methylhexadecanoic acid C1,, (or CIgv) cis-11,12-Methylene octadecanoic acid c1*
Cl4
Unsaturated
Branched chain
Cyclopropane
Systematic name
Common name Lauric acid Myristic acid Palmitic acid Stearic acid Arachidic acid Palmitoleic acid Oleic acid Vaccenic acid
Lactobacillic acid
I n unsaturated acids, the number preceding the colon indicates the number of carbon atoms, and that following the number of double bonds. The second number indicates the position of the double bond, counting from the carboxyl end of the chain.
68
NORMAN SHAW
H,COCH=CH(CH,), CH, CH,(CH2),coo& I H2COP0,C~CH,NH,
FIG.2. Plasmalogen analog of phosphatidylethanolamine.
carbon atom. The unsaturated acids found in bacteria are monounsaturated; the double bond in these is most frequently found between carbon atoms 11 and 12. The polyunsaturated fatty acids present in higher organisms are completely absent in bacteria. Conversely, the cyclopropane fatty acids, rarely found in higher organisms, are frequently encountered in bacteria. The biosynthetic precursors of these fatty acids are the corresponding monounsaturated fatty acids; as a consequence the major example is cis-ll,12-methylenehexadecanoicacid ( lactobacillic acid).
2. Alk-1-enyl Ethers An increasing number of anaerobic bacteria, in particular Clostridium (Goldfine, 1964), have been shown to contain “plasmalogens,” which are lipids containing an alk-1-enyl ( a,p-unsaturated ) ether substituent usually on C-l of glycerol, together with a normal fatty acid in ester linkage at C-2 (Fig. 2 ) . The alk-I-enyl ether substituent is released as the corresponding aldehyde upon acid hydrolysis, and aldehydes corresponding to the major types of fatty acids have been identified.
3. Alkyl Ethers The lipids of extremely halophilic bacteria do not contain normal fatty acid components but have long-chain alcohols bound by an ether linkage (Kates et al., 1966). This type of linkage is extremely resistant to chemical hydrolysis and presents considerable difficulty for structural analysis. These di5culties may be responsible in part for the dearth of information on the distribution of this type of lipid. The principal alcohol so far described is dihydrophytyl alcohol (Fig. 3 ) .
4. More Complex Fatty Acids Mycobacteria and related organisms possess considerably more complex fatty acids containing up to 90 carbon atoms. It is interesting to note that these most complex lipids, whose structures are only now being established by the use of modern techniques, particularly nuclear magnetic resonance spectroscopy and mass spectrometry, were among the CH,CHCH,CH,(CH,CHCH,CH,),CH,CHCH,CH,OH I I I CH, CH, CH,
FIG.3. Dihydrophytyl alcohol.
CHEMOTAXONOMY OF BACTERIAL LIPIDS
67
first bacterial lipids to be isolated and studied in the pioneering work of Anderson and his colleagues. Mycolic acids are derivatives of longchain p-hydroxy fatty acids, which may be unsaturated or contain cyclopropane rings, containing an additional long-chain alkyl substituent on the carbon atom carrying the carboxylic acid (Fig. 4 ) . Related compounds have been isolated from some Corynebacterium spp. (GO-GO) and Nocardia (around C,,) and are of great taxonomic value (see Section V,C ) . OH I CH,(CHJn,CH= CH(CHJ,~CH=CHCH(CHJn~CHCHCOOH I
CH,
I
CZZ%,
FIG.4. A mycolic acid.
B. PHOSPHOLIPIDS The simplest phosphohpid is 1,2-di-O-acyl-sn-glycerol 3-phosphate, “phosphatidic acid,” which although an important intermediate in biosynthesis, rarely occurs itself in bacteria. The common phospholipids are based on phosphatidic acid containing an additional group, X, forming a phosphodiester bond, and are usually named “phosphatidyl-X (Fig. 5). Phosphutidylglycerol is probably the most widely occurring bacterial phospholipid although it was first isolated from plants. Bisphosphutidylglycerol usually co-occurs with phosphatidylglycerol, and a biosynthetic relationship between these two phospholipids has been established (Short and White, 1972). This lipid was originally isolated from beef heart, hence the trivial name cardiolipin. It is the most apolar of the phospholipids, a property resulting from the presence of four acyl residues in the molecule instead of the more normal two. Aminoacyl phosphatidylglycerol This recently discovered class of phospholipids ( Macfarlane, 1962b) is apparently unique to bacteria. An amino acid is esterified to a hydroxyl group of the glycerol moiety in phosphatidylglycerol. The range of amino acids found so far is limited, alanine and lysine being predominant. Phosphutidylethunolamine ( cephalin ) is a very common phospholipid and its N-methyl and N-dimethyl derivatives also occur. Phosphatidylcholine (lecithin), although widely distributed in higher organisms, is comparatively rare in bacteria. Phosphutidylinositol. This lipid is not a common constituent of bacteria, but derivatives containing mannose, phosphatidylinositol mannosides, are prevalent in mycobacteria and related organisms.
68
NORMAN S M W
c:
H, OCOfCHJnCH, CH,(CH,), COOCH I H,COPO,-X
Phosphatidyl- X
X =
Name
H
Phosphatidic acid
CH,CH,NH,
Phosphatidy lethanolamine
CH,CH&CHJ~
Phosphatidylcholine
CH,CH(OH)CH,OH
Phosphatidy lgly cerol
F
CH,CH(OH) H, 0 I RCH-C=O
Aminoacyl phosphatidylglycerol
I
NH, CH,CH(OH)CH20POsCH,CHCHzOCOR Bisphosphatidylglycerol I
(-J
OCOR
HoQ-Mmose
HO HO
0-
Phosphatidylinositol
Mannoee 0 ~
Phosphatidylinositol dimannoside
FIG.5. Structures of the major phospholipids.
Minor phospholipids. Phosphatidylserine is an intermediate in the synthesis of phosphatidylethanolamine but is rarely present itself. Another intermediate which rarely accumulates is phosphatidylglycerophosphate. Trace amounts of Zysophospholipids are also occasionally found. These are monoacyl derivatives of the major phospholipids; i.e., one of the acyl substituents has been lost. The sphingolipids, commonly found in animal tissues, were until recently thought to be absent from bacteria but they have now been found in Bacteroides melaninogenicus (Rizza et al., 1970). It is interesting to note that the polar groups of these lipids resemble those of normal bacterial phospholipids as distinct from the animal sphingolipids which are usually based upon phosphorylcholine. Another recent development has been the isolation and characterization of a new class of glycophospholipids which are glycerophosphoryl or phosphatidyl derivatives of diglycosyl diglycerides, the latter being common glycolipid components of gram-positive bacteria ( Section II,C ) .
CHEMOTAXONOMY OF BACTERIAL LIPIDS
69
( The term “glycophospholipid is used for those phospholipids which also contain carbohydrate constituents, thus the phosphatidylinositol mannosides mentioned above are also glycophospholipids.) Although they have been found in several bacteria (Shaw and Stead, 1972), it is doubtful that they will prove to be of taxonomic importance as they are always structurally related to the diglycosyl diglyceride which is present in the same organism, usually in larger concentrations.
C. GLYCOLIPJDS Glycolipids are derivatives of fatty acids and carbohydrates and do not contain phosphorus. Two major types occur in bacteria: diglycosyl diglycerides and acylated sugars. A comprehensive review on all aspects of bacterial glycolipids has recently been published ( Shaw, 1970). Diglycosyl diglycerides consist of a disaccharide moiety glycosidically bound to the hydroxyl group of a diglyceride. Five major types have so far been characterized: a-diglucosyl, p-diglucosyl, dimannosyl-, digalactosyl-, and galactosylglucosyl diglyceride ( Fig. 6). The related mono-, tri-, and tetraglycosyldiglycerides have also been found, but usually in much smaller quantities. Acylated sugars. These glycolipids do not contain glycerol, and the fatty acids are esterfied directly to the sugar. They vary in complexity from the simple acylated glucoses to the diacyl trehalose and diacyl inositol mannoside (Fig. 7).
D. NEUTRAL LIPIDS
Glycerides. Unlike higher organisms, glycerides do not occur in large amounts in bacteria. Those present are mono- and diglycerides; no conclusive evidence has been presented for the occurrence of triglycerides. Poly-P-hydroxybutyric acid. This polymeric lipid can constitute a large proportion of the dry cell weight of some bacteria and presumably functions as an energy reserve. It is of no taxonomic importance, but its presence in large amounts can complicate the purification and identification of the other lipids. Sterols and carotenoids. Bacteria either do not contain sterols or they are present in such small amounts that it is impossible to exclude contamination as the probable source. Although bacteria are capable of synthesizing isoprenoids and utilize such derivatives as intermediates in cell wall synthesis (Rothfield and Romeo, 1971), they apparently cannot perform the cyclization steps to form sterols. Carotenoids occur universally in photosynthetic bacteria and in some aerobic nonpigmented bacteria.
70
&-
NORMAN SHAW
YH,OH
oy,
HO
OH
CHOCOR I CH,OCOR
HO OH
CH,OH YH,OH
CHOCOR I CH,OCOR
PCH, CHOCOR I CH,OCOR
OH OH
(d)
CH,OH
CHOCOR I
HOG H & O /
CH,OCOR (e)
FIG.6. Structures of the five major types of diglycosyl diglycerides: ( a ) a-diglucosy1 diglyceride; ( b ) p-diglucosyl diglyceride; ( c ) galactosylglucosyl diglyceride; ( d ) digalactosyl diglyceride; ( e ) dimannosyl diglyceride.
E. NONEXTRACTABLE LIPIDS In many bacteria, acid or alkaline hydrolysis of the cells after exhaustive extraction with lipid solvents releases further quantities of fatty acids. The nature of the material from which these fatty acids emanate is in many instances unknown. In gram-negative bacteria, a lipid moiety called “lipid A is an important constituent of the lipopolysaccharide present in the cell walls. Lipid A is a complex molecule composed of glucosamine, phosphate and fatty acids of which there is a large proportion of p-hydroxymyristic acid, The detailed structure of this lipid is
71
CHEMOTAXONOMY OF BACTERIAL LIPIDS
$!H,OCOR
(-J
RCOO
CH,OCOR
0 I OH
I
I
RCOO
I
RCOOFH,
OH
CH,OCOR
(b)
FIG. 7. Some glycolipids of the acylated sugar type: ( a ) an acylated glucose; ( b ) diacyltrehalose ( “cord-factor” ) ; ( c ) diacylinositolmannoside.
under active investigation and preliminary results would suggest a striking similarity in the basic structure of lipid A from Salmonella, Escherichia, Pseudomonm, and Shigella ( Luderitz, 1970). Another lipid-polysaccharide polymer has recently been isolated from several gram-positive bacteria, This “lipoteichoic acid” consists of a teichoic acid and covalently bound lipid which may be a phosphatidyl diglycosyl diglyceride or a related compound (Toon et al., 1972). However, in both gram-positive and gram-negative organisms these lipid containing polymers are extremely difficult to isolate and purify and therefore from both a chemical and a practical standpoint do not appear to have taxonomic potential. Ill.
Analysis of Bacterial Lipids
The expansion of our knowledge of lipids has been effectively controlled by the availability of suitable practical techniques for their investigation. The present exponential growth was initiated by the advent of gas-liquid chromatography and thin-layer chromatography, and by a realization by biochemists and microbiologists that lipids, as major components of cell membranes, must play a fundamental part in cell
72
NORMAN S H A W
processes. A study of lipid composition using these chromatographic techniques which are now (or should be) routinely available in aI1 laboratories, is a comparatively undemanding exercise which compares favorably with other chemotaxonomic methods. Numerous books and review articles have been devoted exclusively to lipid technology (e.g., Marinetti, 1967); indeed one is forced to the conclusion that much more effort has been devoted to devising lipid techniques than actually using them to obtain results. The premise that the analysis of lipids is a “black art” best left to practising mystics is certainly a myth that should be immediately dispelled. All chromatographic techniques rely on the availability of authentic materials to enable adequate comparisons to be made and many pure lipids are now available from commercial suppliers although often at inflated prices. To overcome the latter, or when a particular lipid is not commercially available, two alternatives present themselves; either to request a sample from a colleague known to possess some, or to isolate the lipid from a known source. The former alternative is easier and usually successful, the latter can provide valuable practical experience. A complete analysis (Fig. 8 ) requires ( i ) isolation of the lipids, (ii) determination of fatty acid composition, and ( iii ) identification of individual lipid components. The total lipid present in bacteria usually represents at least 3-5% of the dry cell weight, although it can be much higher, so a gram or so of dry cells is sufficient. The lipids are extracted by stirring at room temperature with organic solvents, usually chloroform-methanol mixtures, and evaporation of the solvents leaves the crude lipid mixture. This can be analyzed directly, but it is preferable to remove any impurities present, the procedure using Sephadex (Wells and Dittmer, 1963) being extremely efficient and convenient. This step effectively removes nonlipid contaminants, e.g., amino acids, sugars which are usually present albeit in small quantities, but which can lead to erroneous identifications. Treatment of a sample of the total lipid with sodium methoxide liberates the fatty acids as their methyl esters which may then be analyzed by gas-liquid chromatography. If no further lipid analyses are to be carried out the fatty acid composition can be examined without prior removal of the lipids. Acids or alkaline hydrolysis of the cells followed by extraction with organic solvents, usually ether, effectively removes the liberated fatty acids which following esterification can be analyzed by gas-liquid chromatography, However, it is important to note that this latter procedure also removes the fatty acids present in the nonextractable lipids (see Section 11,E).The analysis of the individual lipid components is conveniently carried out by thin-layer chromatography coupled with the use of specific spray reagents. Phospholipids can be detected with the Zinzadze reagent (Dittmer and Lester, 1964),
73
CHEMOTAXONOMY OF BACTEXIAL LIPIDS
I Dry rells extraction with chloroform/ methanol
acid or alkaline hvdrolvsis followed by extraction with ether
Fatty acids identified by GLC
I
Crude lipid
i
removal of contaminants with Sephadex
alkaline 4
Pure lipid silicic acid chromatography
hydrolysis
Neutral ripids
-1
Glycolipids
Water-soluble gly cosides, etc., identified by paper chromatography
I-
Preliminary identification of major components by TLC
Phospholipids
alkaline hydrolysis
Fatty acids
5
Fatty acids
Water-soluble phosphate esters identified by paper chromatography
FIG.8. An analytical sequence for the separation a n d identification of bacterial lipids. GLC, gas-liquid chromatography; TLC, thin-layer chromatography.
and free amino groups with the ninhydrin reagent (Marinetti, 1962). Thus phosphatidylethanolamine would react with both these reagents. Glycolipids and other lipids containing vicinal hydroxyl groups (-CH*OH-CH.OH-) can be detected with the periodate-Schiff reagents ( Shaw, 1968b), which also give characteristic colors with some phospholipids. Many solvent systems have been described, but the system chloroform-methanol-water, 65 :25 :4, is particularly useful for bacterial lipids. Two-dimensional analysis gives a much better resolution and Fig. 9 illustrates a typical separation of a hypothetical mixture (Minnikin and Abdolrahimzadeh, 1971). The lipids may be separated into neutral, glycolipid, and phospholipid components by chromatography on a column of silicic acid (Vorbeck and Marinetti, 1965), and the components are further characterized, The water-soluble phosphate esters produced by deacylation of phospholipids may be identified by paper chromatography ( Dawson, 1960), as may the diglycosylglycerols similarly produced from diglycosyl diglycerides ( Brundish and Baddiley, 1968).Their sugar
74
NORMAN SHAW
FIG. 9. A separation of the major types of lipids found in bacteria by twodimensional thin-layer chromatography. BPG, bisphosphatidylglycerol, PG, phosphatidylglycerol; APG, aminoacyl phosphatidylglycerol; PE, phosphatidylethanolamine; PC, phosphatidylcholine; PI, phosphatidylinositol; DGDG, diglycosyl diglyceride. The arrows indicate the direction of development. Q , charac@ , Phospholipid; , phospholipid containing NH, group; teristic reaction with the periodate-Schiff reagents.
composition is easily established by acid hydrolysis and the anomeric configuration by hydrolysis with specific glycosidases. Separation into glycolipid and phospholipid components enables individual fatty acid analyses to be carried out, but the procedure is unnecessary in the present context. The identification of new lipids would certainly require a much more rigorous approach, but even the observation of an unknown lipid, irrespective of its identity, could be of great taxonomic significance. IV.
Distribution of lipids in Bacteria
Before considering the distribution of the various types of lipids a cautionary note is advisable concerning the comparison of data obtained from bacteria grown under unspecified conditions. The chemical composition of many bacterial components, including lipids, can be affected by a variety of external factors, e.g., temperature of growth, substrate
CHEMOTAXONOMY OF BACTERIAL LIPIDS
75
composition, pH of environment, time of harvesting, etc. Fortunately, from a taxonomic standpoint this is not usually a particularly serious situation with respect to lipid composition as taxonomic conclusions are derived mainly from qualitative rather than quantitative differences and it is usually the latter that are most affected by external factors. Many bacteria will incorporate into their membranes exogenous lipid, but fortunately the media routinely used for cultivation are free from the types of lipids usually found in bacteria. The other external factors usually affect quantitative composition, and it is extremely rare, except under extreme conditions, for one particular lipid species to disappear and to be replaced by another different lipid. However, it is obviously preferable when comparative studies are to be made to grow the bacteria under as near identical conditions as possible. The lipid composition of bacteria is summarized in Tables II-VI. The classification scheme adopted throughout is that used in the seventh edition of Bergey’s Manual (Breed et al., 1957). I have not attempted to cite every reference to bacterial lipids which has appeared in the literature, but I have chosen those which are either the most recent, comprehensive, and in the author’s opinion, most reliable. The tables have been divided into sections for phospholipids, glycolipids, and fatty acids. In order to keep them as clear as possible, I have not attempted to include quantitative determinations; only the positive identification of a particular lipid is recorded. Of the class Schizomycetes, information is available on the genera of the Orders Pseudomonadales, Hyphomicrobiales (Table 11), Eubacteriales (Tables I11 and IV), Actinomycetales (Table V), Spirochaetales, and Mycoplasmatales (Table VI). The most significant feature to emerge from the data presented is the clear distinction between the lipid composition of gram-negative and gram-positive bacteria. The majority of gram-negative organisms have a simpler lipid composition although they have lipid in their cell walls as well as their cytoplasmic membrane. The lipids of gram-positive bacteria are generally more complex and therefore offer more scope for taxonomic correlations.
A. FAIT ACIDS A consideration of the number of different fatty acids theoretically possible in any particular lipid assuming a chain length of between ten and twenty carbon atoms for all of the four major types, straightchain, branched-chain, unsaturated, and cyclopropane, will reveal that it is extremely high. White and Frerman (1967) were able to positively identify no less than 64 different fatty acids in the lipids of Staphylococcus aureus. Fortunately, two or three fatty acids usually represent
Tables 11-VI: The following abbreviations are used in these tables. PG, phosphatidylglycerol; BPG, bisphosphatidylglycerol; APG, aminoacylphosphatidylglycerol;PE, phosphatidylethanolamine; PC, phosphatidylcholine; PI, phosphatidylinositol; PIM, phosphatidylinositol mannosides; S, straight-chain fatty acids; B, branched-chain fatty acids; U, unsaturated fatty acids; C, cyclopropane fatty acids. TABLE I1 LIPIDSOF PSEUDOMONADALES AND HYPOMICROBIALES Phospholipids PG PSEUDOMONADALES Thiorhodaceae Chromatium strain D Athiorhodaceae Rhodopseudomonas spheroides R . capsulata R . gelatinosa R. palustrw Rhodospirillum rubrum R . capsulatus Chlorobacteriaceae Chlorobium sp. Chloropseudomonaa ethylieum Nitrobacteraceae Nitrosocystis oceanus Nitrosomonaa europaea
+ +
BPG APG
+
+
+ + + + + + + +
PE
+ +
PC
Fatty acids
PI
GlymOther lipid
S
B
U
+" +
+
+ + + + + +
+ +
+ + +
+ + +
1-
+" + +
+ +
+ +
Tr
References
Steiner et al., 1970a
fC
+
C Other
Miscellaneous
+
+*
fb
Woodet al., 1965 Gorchein, 1968 Steiner et al., 1970b Wood et al., 1965 Wood et al., 1965 Wood et al., 1965 Wood et al., 1965 Hirayama, 1968 Hirayama, 1968 Cruden and Stanier, 1970 Constantopoulis and Bloch, 1967 Hagen et al., 1966 Hagen et al., 1966
z
$j
E
P
Methanomonadaceae Hydrogenomonas sp. Thioacteriaceae Thiobacillus neapolitanus T . thioparus T . intermedius T . novellus
T . thiooxidans Pseudomonadaceae Pseudomonas acidovorans P. aureofaciens P . aeruginosa
+ + + + + + + + + + + + + + +
+ + + + +
+d
+
+ + + + + + + +
+ +
P . alcaligenes P. chloroaphis P . denitri$cans P . diminzlta
+ + + + +
+ +
P . fluorescens
+ +
+
Thiele, 1971
+'
+
+g
+h
+ + + +
+ + + +
+
+
+b
+" +"
+"
+b
Barridge and Shively, 1968 Barridge and Shively, 1968 Barridge and Shively, 1968 Barridge and Shively, 1968 Shively and Benson, 1967 Levin, 1971 Wayne Moss et al., 1972 Wilkinson, 1970 Hancock and Meadow, 1969 Wayne Moss et al., 1972 Wayne Moss et al., 1972 Wilkinson, 1970 Wilkinson, 1970 Wilkinson 1968a, 1969 Wilkinson and Bell, 1971 Cullen et al., 1971 Welsh et al., 1968 (continued)
2
TABLE I1 (Continued) Phospholipids PG
BPG APG
PSEUDOMONADALES Pseudomonadaceae (Continued) P . frugi P . kingii P . maltophilia
+ +
P . mucidolas P . multworans P . ovalis P . pavonacea P . putida P . rubescens P . stutzeri
P . synoynea P . synxantha
+ + + +
PE
PC
PI
Other
Glycolipid
S
+a
+ + +
+ + + +" + +'
+ + +
+ + + +" +
+ + +
+ + +
+ +
+ + +
.+ +
+ + + +
+ +
MiScellaC Other neous
Fatty acids
Tr
+'
+ +a
B
U
+
+ +
+ +
+ +
+ +
+ +
Wilkinson, 1970 Ssmuels et al., 1973 Wilkinson, 196th Wayne Moss et al., 1972 Wilkinson, 1970 Samuels et al., 1973 Wilkinson, 1970
+" +b
+'
References
+b
+*
Phizackerley et al., 1966 Wilkinson et al., 1973 Wilkinson, 1970 Wayne Moss et al., 1972 Wilkinson, 1968a,b, 1972 Wilkinson et al., 1973 Wikinson, 1972 Wayne Moss et al., 1972 Wilkinson et d.,1973 Wilkinson, 1972 Wilkinson, 1970
t
P 5 z
E
8
P . taetrolens P . testosteroni Halobacterium cutirubrum H . hulobium
H . salinarium
Halobacterium sp (moderately halotolerant) Siderocapsaceae Ferrobacillus ferroozidans Spirillaceae Vibrio costicolus V .fetus
+ +
+
I-
+
+"
+
+'
+'
+'
+
+'
+&
+'
+ f
+
+' +
+
+
+
+'
+'
+&
+'
Wilkinson, 1970 Wayne Moss et al., 1972 Katea et al., 1966, 1967 Hancock and Kates, 1972 Kates et al., 1966, 1967 Hancock and Kates, 1972 Marshall and Brown, 1968 Kates et al., 1966, 1967 Hancock and Kates, 1972 Peleg and Tietz, 1971
BK 2 0
3
5
8 m b
3L! Tr
Short et al., 1969
+d
P !i!
+
+
+
+ +
+
+ +" + f
V . cholerae But yrwibrio jibrisolvens
+ +
+
+
?
+
+ + + +
Kates et d.,1966 Tornabene and Ogg, 1971 Brian and Gardner, 1968 Kunsman, 1970 (continued)
8
3
00
0
TABLE I1 (Continued) Phospholipids PG HYPOMICROBIALES Hypomicrobiaceae Hypomicrobium vulgare Rhoabmicrobium vanniellii
BPG APG
PE
Fatty acids
PI
PC
GlycoOther lipid
S
U
C
Other
References
z
+
+
+
+
+ +
n
8
+" +
+
Glucosyl diglyceride. Ornithine lipid. c Galactosyl diglyceride unknown containing galactose and rhamnose. d N-Methylphosphatidylethanolamine. Hydroxy fatty acids. J Glycophospholipid. 0 Glycolipid containing uronic acid.
Ir
b
i
+
+
Goldfine and Hagen, 1968 Park and Berger, 1967
Acylated sugar. Phospholipid containing glucosamine. j Dialkyl ether analog of phosphatidylglycerophosphate. Glycolipid sulfate. 2 Dialkyl ethers. Digalactosyl diglyceride. Dimethylphosphatidylethanolamine.
a
6
B
MiScellaneous
E
CHEMOTAXONOMY OF BACTERIAL LIPIDS
81
a major proportion of the total. A summary of the distribution of the major types of fatty acids is shown in Table VII. While there are major differences at the level of Order, significant differences can also often be observed within a particular genus. Here a comparison between the trace from a gas-liquid chromatographic separation of fatty acids and an infrared spectrum is not inappropiate. With the latter it is usual to identify only the major absorptions, but the “fingerprint” region of minor but unidentified absorptions is also important when one spectrum is compared to another. Such a situation is applicable to gas-liquid chromatographic traces of fatty acids from related species. The relative amounts of minor, unidentified, fatty acids can enable organisms to be subdivided within a genus. At this level, however, it is obviously important that growth conditions be as uniform as possible. The isolation of enzymes which specifically hydrolyze the fatty acids esterified at either carbon atoms 1 or 2 of a diglyceride has enabled significant results to be obtained concerning the distribution of specific fatty acids at these two sites. However, a discussion of these results is outside the scope of this review.
B. PHOSPHOLIPIDS The distribution of the various phospholipids is summarized in Table VIII. There is little qualitative difference between many gram-negative organisms of the Orders Pseudomonadales and Eubacteriales, the major component being phosphatidylethanolamine, and this is certainly the least satisfactory area from a taxonomic standpoint. Phosphatidylethanolamine does not usually occur in gram-positive bacteria with the notable exception of the Bacillaceae. Phosphatidylinositol does not appear until the Corynebacteriaceae except for a few reports of its occurrence in two micrococci. In the Actinomycetales phosphatidylinositol mannosides are the major phospholipids. Ikawa ( 1967) has discussed possible phylogenetic relationships which emerge from a study of phospholipid composition. C. GLYCOLIPIDS The presence of glycolipids, particularly in gram-positive bacteria, has been a comparatively recent discovery, but one of great taxonomic significance. .Of the two types of glycolipids, insufficient information is available on the structure and distribution of acylated sugars to enable general taxonomic conclusions to be drawn with certain exceptions, e.g., the diacyl inositol mannoside in propionic acid bacteria. The distribution of diglycosyl diglycerides is summarized in Table IX. This type of gly-
TABLE I11 LIPIDS OF EWACTERIALES (GRAMNEQATIVE) Phospholipids PG Azotobacteraceae Awtobacter agilis A . vinelandii Rhizobiaceae Agrobacterium tumefaciens Chromobacterium violaceurn Rhiwbium japonicum Achromobacteraceae Ackomobacter sp. Flwobacterium thermophilus Enterobacteriaceae Escherichia coli B
E. coli K12 Serratia marcescens Proteus vulgaris
BPG APG
PE
PC
+ +
+ T r
+
+
+
+ + + + +
+ + + + +
Fatty acids
PI
GlycoOther lipid
+"
+
+ + + + + +
+ + +
B
U
C Other
+ + +
+"
cellaneous
References
Randle et al., 1969 Kaneshiro and Man, 1962 Jurtshuk and Schlech, 1969 Randle et al., 1969 Randle et al., 1969 Bunn and Elkam, 1971
+*
+ +
S
Mis-
+" +"
+ + +
+d
+
+ + +
Jauch et aZ., 1970 Oshima and Yamakawa, 1972 Kanfer and Kennedy, 1963 Welsh et al., 1968 Brennan et al., 1970a Ames, 1968 Kates et al., 1964 Randle et al., 1969
*z
! i 8
Proteus mirablis Proteus P18 Salmonella typ himurium
S. paratyphi Brucellaceae Brucella abortus 3. melitensis Hemop hilus parainjluenzae Bacteroidaceae Bacteroides melaninogenicus Neisseriaceae Neisseria gonorrheae
+ + + + + +e
+ +
+ + +
Trc
+ +
+"
+ + +
+ + + + + +
+
+ + + + +'
Tr
Sud and Feingold, 1970 Nesbitt and Lennare, 1965 Ames, 1968 Macfarlane, 1962a Olsen and Ballou, 1971 Modak et al., 1970
+g
+
+
+
+ +
+ +
+ +
+
Tr
+
N . meningitidis Brevibacteriaceae Brevibacterium jlavum B . thiogenitalis N-Methyl- and N-dimethylphosphatidylethanolamine. Tetraglycosyl diglyceride. Phosphatidylserine. Acylated glucose.
+
+
d
Thiele et al., 1968 Prome et al., 1969 White, 1968
I Risea et al., 1970
+
+
+
+
+
+
8
*
U
Wayne Moss et al., 1970 N . Shaw, unpublished Wayne Moss et al., 1970 Otsuka and Shiio, 1968 Okaeaki et al., 1969
A triacyl derivative of phosphatidylglycerol also present. Hydroxy fatty acids. g Ornithine lipid. 50-70 % phosphosphingolipids. e
3
I r
f
R
TABLE I V LIPIDS OF EUBACTERIALES (GRAMPOSITIVE) Phospholipids PG
BPG APG
PE
PC
Fatty acids
PI
GlycoOther lipid
S
B
U
C Other
Miscellaneous
References ~
Micrococcaceae Micp.ocoecus caseol yticus M . cerijicans M . conglomeritus M . denitrificans M . 1ysodeikticus
M . roseus M . tetragenus M . varians Staphylococcus aureus
+ + +
+ + + + + + +
+
+ + + +
+ + + +
m
+ + + + +
+ +
+" +
+b
+
+" +" +"
+d
+ + + + + + + +
~~
Whiteside et al., 1971 Makula and Finnerty, 1970 Whiteside et al., 1971 Wilkinson el al., 1972 Lennarz and Talemo, 1966 Whiteside et al., 1971 Macf arlane, 1961,a,b Whiteside et aZ.,1971 Whiteside et al., 1971 Whiteside et al., 1971 Gould and Lennarz, 1970 Brundish and Baddiley, 1968 Short and White, 1970 Macfarlane, 1962s. Joyce et d.,1970 Houtsmuller and van Deenen, 1965 White and Frerman. 1967
*
P8
Sarcina Java
+
+
+
+ + + + +" + +
S. lutea
+ + +
+
+" + +
S. aureus ( L form)
+
+
+
+d
S. lactis
S . maxima
s. V e T t T k U l i Sporosareina ureae Lactobacillaceae Pneumoeoccus type1 Pneumococcus type XIV Streptococcus faecalis
S. lactis
S . hemolyticus
+d
+ + + +
+ +
+
+ +
+" +"
+ + + +
+f
+f
f
+a
+
+
+a
+
+
+
+c
+"
+h,i
+A
+h
+
+ +
Ward and Perkins, 1968 Brundish et al., 1967b Huston et al., 1965 Kates et al., 1966 Whiteside et al., 1971 Hunter and Thirkell, 1971 Kates et al., 1966 Whiteside et al., 1971 Whiteside et al., 1971 Whiteside et al., 1971 Whiteside et al., 1971 Brundish et al., 1965, 1967a Kaufmann el al., 1965 Fischer and Seyferth, 1968 Dos Santos Mota et al., 1970 Ambron and Pieringer, 1971 Pieringer, 1968 Welsh et al., 1968 Fischer and Seyferth, 1968 Fischer, 1970 Ishizuka and Yamakawrt, 1968 (continued)
a
5
2o
3
I 8 m c
3
2
6
P
+4
03
(x,
TABLE I V (Continued)
m
Phospholipids PG
S . pyogenes
+
BPG APG
PE
PC
Fatty acids
PI
GlycoOther lipid
+
+h
Pediococcus acidilacti P . cerevisiae P . halophilus
P . homari P . urinae-equi
P . pentosaceus Leuconostoc mesenteroides Lactobacillus acidophilus
L . arabinosum L . buchneri L. bulgaris L . casei
S
B
U
C Other
+ + + + + + +
+ + + + + + + + + Tr
+
+ +
+" +
+
+
+ + + + + + + + - I -
f'
+' +' +
+-I-
Miscellaneous
References Cohen and Panos 1966 Uchida and Mogi, 1972 Uchida and Mogi, 1972 Uchida and Mogi, 1972 Uchida and Mogi, 1972 Uchida and Mogi, 1972 Uchida and Mogi, 1972 Shaw and Stead, 1972 Exterkate et al., 1971 Shaw, 1070 Uchida and Mogi, 1972 Exterkate et al., 1971 Shaw, 1970 Exterkate et al., 1971 Exterkate et al., 1971 Shaw et al., 1968b Uchida and Mogi, 1972
z
0 in
E
' ! 8
3
+ + +
+ +
3
3 3 3
+ + +
+ ++ + + + + + + + +
3
+ +
+
." + +
+
CHEMOTAXONOMY OF BACTERIAL LIPIDS
+ &
+ + + +
+ + +
2
b W
2 'zl eid
+ + +
..
+ + +
87
TABLE IV (Continued) Phospholipids PG
BPG APG
PE
PC
PI
B
+" + +
C . coelicolor C . diphtheriae
+ + +
++
+l
C . equi
+
i-
+'
+i.n
+"
+ +"
c. ovis
+
f
C . palvum C . xerosis
+
+ +'
Listeria
+ +
Microbacterium lacticum M . thermosphaetum
U
+ + +
C . hofmanii
monocytogenes
MiScellaC Other neous
Fatty acids GlycoOther lipid
+ + + +
+'
+'
+
+' + +@
+' +hi
+ +
+ +
+ +
References Whiteside et aZ., 1971 Senn et al., 1967 Brennan et al., 1970b Gomes et al., 1966 Brennan and Lehane, 1971 Brennan and Lehane, 1971 We1by-Gieusse et aZ., 1970 Brennan and Lehane, 1971 Etemadi, 1963 Brennan, 1968 Brennan and Lehane, 1969,1971 Carrroll et al., 1968 Raines et aZ., 1968 Shaw and Stead, 1972, and unpublished Shaw, 1968a Shaw and Stead, 1970
+ +
+
+"
+d
+ +
C . jimi
+
+
+
+'
+d
+ +
A rthrobacter crystallopoites A . globiformis
+ +
+ +
+ +
+" +"
+ +
+ +
+ +
+ +
+"
+
Cellulomonas biazotea
-4. pascens
A . simplex Bacillaceae Bacillus alvei B . anthracis B . cereus
B . circulans B . licheniformia B . macerans B . megdherium
+
+
+
+
+ + + +
+d
+c
+r
+ + + + + + + + +
+f
Shaw and Stead, 1972, and unpublished Shaw and Stead, 1972, and unpublished Shaw and Stead, 1971 Shaw and Stead, 1971 Walker and Bastl, 1967 Walker and Fagerson, 1965 Shaw and Stead, 1971 Yano et al., 1970b
" A
*1
m
c
Kaneda, 1967 Kaneda, 1968 Lang and Lundgren, 1970 Saito and Mukoyama, 1970 Kaneda, 1968 Kaneda, 1967 Kaneda, 1967 Kaneda, 1967 Op den Kamp et al., 1965 (continued)
3it! r
3
$g
TABLE IV (Continued Phospholipids PG
B. natto B. polymyza B. pumilis B. stearothermophilus B . subtilis
B. thurangiensis Clostridium botulinum C . butyricum
BPG APG
+ +
+
+
+
+
+
+
+
PE
PC
Fatty acids
PI
GlywOther lipid
+ + +
+
+
+
+d
+g
S
B
U
C Other
+ + + +
+ + + + + +" + + +
Miscellaneous
References MacDougall and Phizackerley, 1969 Phizackerley et al., 1972 Kaneda, 1967 Utakami and Umetanik, 1968 Matches et al., 1964 Kaneda, 1967 Kaneda, 1967 00 and Lee, 1972 Op den Kamp et al., 1969a Bishop et al., 1967 Brundish and Baddiley, 1968 Kaneda, 1967 Kaneda, 1968 Kimble et al., 1969 Baumann et al., 1965 Goldfine and Panos, 1971 Matsumoto et al., 1971
3
P
Z
C . bifermentans
C. histolyticum
C . perfringens C . sporogenes C . welchii
+
+
+
Glycolipid of unknown structure. b Dimannosyl diglyceride. 8 Glycophospholipid. d pDiglucosy1 diglyceride. 0 Unidentified phospholipid as major component. f Hydroxy fatty acids. 0 Galactosylglucosyl diglyceride. a
1
a-Diglucosyl diglyceride. Acylated glucose.
+”
+ + + + +
+ +
Wayne Moss and Lewis, 1967 Wayne Moss and Lewis, 1967 Wayne Moss and Lewis, 1967 Wayne Moss and Lewis, 1967 Macfarlane, 1962b
Glycolipid containing galactofuranose. k Diacylinositol mannoside. 1 Phosphatidylinositol mannosides. * Diacyltrehalose. * Corynemycolic acids. Mixture of digalactosyl and dimannosyl diglycerides. P Glucosaminyl diglyceride. c “Plasmalogen” phospholipids. i
0
Bg
i 0
3
5
$ W
ii
F r
TABLE V LIPIDSOF ACTINOMYCETALES Phospholipids
Gly-
Fatty acids
co-
PG
BPG APG
PE
PC
PI
PIM Other lipid
My cobacteriaceae Mycobacterium aurum M . aviurn M . brevicale
S
B
U
+b
M . bovis M . butyricum M . chitae
+
+
+
+ + +
M. diernhofera M . flavescens M . fortuitum
+ +
+b
MiscellaC Other neous
References
+"
Lechevalier et al.,
+"
Miquel et al., 1963 Lechevalier et al.,
+"
Lechevalier et al.,
1971
1971 1971
+" +"
Okuyama et al., 1967 Lechevalier et al.,
+"
Lechevalier et al.,
+" +"
197 1 1971
Lechevalier et al., 1971
Vilkas and Rojas, 1964
Lechevalier et a1 ., M . gallinarum
M . gastri
M . intracellulare
+" +" +"
1971
Lechevalier et al., 1971
Lechevalier et al., 1971
Lechevalier et al., 1971
3
E 8
M . kansasii M . marinum M . nmum M . parafinicum M . pellegrino M . phlei
M . rhodochrous
+ + +
+ + +
+ +
+
b
+
+
+
+"
+
+"
M . smegmatis
M . terrae M . thermoresistible
M . tuberculosis
M . vaccae
+" +" +" +" +" +"
+
+
+
+'+++
+" +" +" t"
Lechevalier et al., 1971 Lechevalier et al., 1971 Lechevalier et al., 1971 Lechevalier ei al., 1971 Laneelle et al., 1965 Lee and Ballou, 1965 Brennan and Ballou, 1967 Azuma et al., 1962 Lechevalier et al., 1971 Laneelle et al., 1965 Lechevalier et al., 1971 Brennan et al., 1970a Azuma et al., 1962 Lechevalier et al., 1971 Lechevalier et al., 1971 Lechevalier et al., 1971 Lee and Ballou, 1965 Brennan et al., 1970a Lechevalier et al., 1971 Lechevalier et al., 1971 (continued)
[ g
2 X
0
3
5
$
ti
1 r
!I P
co
w
W
rp
TABLE V (Continued) Phospholipids PG
BPG APG
PE
PC
PI
GlycoPIM Other lipid
Actinomycetaceae Nocardia aateriodes N . braailiensis
Fatty acids
S €3
+"
+b
+
+
+
U
MiscellaC Other neous
+O
N . carneus
+O
N . cwiae
+O
N . coeliaca
+
+ + +
+ +" + ' + +
N . corallina
+b
N . erythropolis
+b
N . eppingerii N . farcinica
+b
N . kirovani N . leishmanii
+ +
+
+ +
+O
+" +"
+ +
+c
+a
References
Ioneda et al., 1970 Lechevalier et al., 1971 Laneelle et al., 1965 Lechevalier et al., 1971 Lechevalier et al., 1971 Lechevalier et al., 1971 Maurice el al., 1971 Yano et al., 1969 Khuller and Brennan, 1972b Yano et al., 1971 Batt et al., 1971 Yano et al., 1971 Maurice et al., 1971 Yano et al., 1971 Lechevdier et al., 1971 Vacheron et al., 1972 Yano et al., 1970a
3
E
5
N . pol ychromogenes
+
+
+
+
+h
+*
N. rhodochrozis N. rubra N. Sumatra
S . coelicolor S. jlavovirens S. gelaticus
S. sioyaensis S. viridochromogenes Mycolic acids. Diacyltrehalose. Nocardic acids. Acylated glucose. 6 Phosphatidylserine.
a
+e
+"
+b
Streptomycet aceae Streptomyces LA7017 S . aureofaciens
S . griseus
+
+
+
+
+
+ +
+ +
+
+'
+ + + + +-I-
+
+g
+#
$0
+ Glycolipids containing glucose. Hydroxy fatty acids. * Diglucosyl diglyceride. Glycosyl diglyceride containing uronic acid.
f
Yano et al., 1968 Khuller and Brennan, 1972b Ioneda et al., 1970 Yano et al., 1971 Maurice et al., 1971 Bergelson et al., 1970 Laneelle et al., 1968 Ballio et al., 1965 Ballio et al., 1965 Ballio et al., 196.5 Laneelle et al., 1968 Ballio et al., 1963 Kutaoka and Nojima, 1967 Laneelle et al., 1968 Ballio et al., 1965 Kimura et al., 1967 Ballio et al., 1966
g g
g
3
I 5
[ 5
3 4
VI
TABLE VI LIPIDSOF SPIROCHAETALES AND MYCOPLASMATALES Phospholipids PG SPIROCHAETALES Treponemataceae Treponema pallidum
T . zuelzerae MYCOPLASMATALES A choleplasma laidlawii
Mycoplasma m ycoides M . hominis
M. avian sp. strain J
M. T strain 0
+
BPG APG
PE
+
+
PC
Fatty acids
PI
GlycoOther lipid
+"
+ + +
+ + + + + +
Choline plasmalogen.
* Galactosyl diglyceride. Glucosyl diglyceride. Glycophospholipid. ~~-Diglucosyl diglyceride.
+
fd
S
B
U
+ +< +
+ +
+" +
+
+b
C Other
+' +o
+
+'
+
+
+
+
+h
Galactofuranosyl diglyceride. Phosphatidylglycerophosphate. h Acyl glucose. i Phosphatidic acid. p
Miscellaneous
References
Livermore and Johnson, 1970 Livermore and Johnson, 1970 Shaw et al., 1968a, 1972 Smith and Henrikson, 1965 Plackett, 1967 Smith and Mayberry, 1968 Smith and Mayberry, 1968 Romano et al., 1972
2
8$
i! 8
CHEMOTAXONOMY OF BACTERIAL LIPIDS
DISTRIBUTION OF
97
TABLE YII MAJOR TYPJ~S OF FATTY ACIDS
THE
Universal, but minor components in many species Widespread, particularly in gram-negative bacteria; absent or very minor components in most gram-positive bacteria except Lactobacillaceae Usually cooccur with unsaturated f a t t y acids in gram-negative Cyclopropane bacteria; also found in some members of the Lactobacillaceae Branched chain Absent or very minor components in gram-negative bacteria; widely found in gram-positive bacteria except Lactobacillaceae Alk-1-enyl ethers Clostridium and some other anaerobes Alkyl ethers Extreme halophiles Higher fatty acids Corynebacterium and Actinomycetales Straight chain Unsaturated
TABLE VIII DISTRIBUTION OF THE MAJORPHOSPHOLIPIDS PhosphatidylglycerQl Bisphosphatidylgl ycerol
Phosphatidylethanolamine Phosphatidylinositol Phosphatidylinositol mannosides
Present in all bacteria except Actinomycetales Present in most bacteria together with phosphatidylgly cerol Major component of all gram-negative bacteria; also present in Bacillaceae Propionibacterium, Corynebacterium, Arthrobacter, Nocardia Corynebacterium and Actinomycetales; may be present in Propionibacterium
TABLE IX DISTRIBUTION OF DIGLYCOSYL DIGLYCERIDES 8-Diglucosyl diglyceride a-Diglucosyl diglyceride Galactosylglucosyl diglyceride Dimannosyl diglyceride Digalactosyl diglyceride
Staphylococci, bacilli Streptococci, Acholeplasma laidlawii Lactobacilli, pneumococci, Listeria monocytogenes Micrococcus lysodeikticus, Corynebacteraum aquaticum, Microbacterium sp., Arthrobacter A rthrobacter
colipid is found in most gram-positive bacteria of the Order Eubacteriales and is genus specific. Thus all lactobacilli investigated contain the galactosylglucosyl diglyceride, and all streptococci contain the a-diglucosyl diglyceride. The same glycolipid may occur in another genus, e.g., the p-diglucosyl diglyceride is found in both staphylococci and bacilli, but species of the same genus have the same glycolipid.
98 V.
NORMAN SHAW
Correlation of Lipid Composition with Taxonomic Classification
Sufficient information is available on genera of the Orders Pseudomonadales, Eubacteriales, Actinomycetales, and Mycoplasmatales to enable meaningful comparisons to be made. The taxonomic correlations which emerge from a consideration of the lipid composition of the genera and families of these Orders will now be assessed. The relevant information is presented in the tables together with the references so the latter will not be cited again unnecessarily in the following discussion. A. PSEUDOMONADALES The genera of this Order which have received most attention are the photosynthetic bacteria, the sulfur bacteria, the pseudomonads, and the obligate halophilic bacteria. The lipids of Halobacterium are extremely characteristic and although organisms of this genus are gram-negative, they do not possess a typical cell wall. There are two significant features of the lipids of halophilic bacteria. First, the majority are negatively charged either by the presence of an additional phosphate group or a sulfate group; second, their lipids do not possess ester-linked fatty acids but have dihydrophytyl alcohol linked by an ether linkage to the glycerol. Both these deviations from the norm are undoubtedly modifications developed to contend with their unusual environment. A dialkyl phosphatidylglycerophosphate is the major phospholipid, with smaller amounts of dialkyl phosphatidylglycerol and a sulfated derivative thereof. A glycosyl diglyceride is also present as a sulfated derivative. Such a composition, ignoring the two unique modifications, is more typical of a gram-positive organism; no dialkyl derivative of phosphatidylethanolamine has been observed. The phospholipid composition of the remaining members of the Pseudomonadales is fairly typical of gram-negative bacteria; phosphatidylethanolamine ( or its N-methylated derivative) is the major lipid. Phosphatidylcholine has been found in all Rhodopseudomonas species but not Rhodospirillum. The photosynthetic bacteria also contain glycosy1 diglycerides, the most prevalent being the galactosyl diglyceride normally found in the chloroplasts of eukaryotic cells. This has a structure different from that of the galactosyl diglycerides found in grampositive bacteria. Thiobacilli have appreciable quantities of the N-methylated phosphatidylethanolamine, and Thiobacillus thiooxidans have an unusually high proportion of a CIS cyclopropane fatty acid. Considerable controversy has raged over the nature of the extracellular “wetting agent” which enables these organisms to utilize the sulfur. This agent was originally
CHEMOTAXONOMY OF BACTERIAL LIPIDS
99
thought to be phosphatidylinositol, but this lipid has not been identified as a cellular lipid component. At this juncture it is pertinent to note that the investigation of extracellular lipids produced by prokaryotic organisms is virtually an unexplored area. The Pseudomonas genus is an extremely large and heterogeneous group of organisms, and this is reflected in their lipid composition. Much of the information in this area has been obtained by Wilkinson and his colleagues during a systematic investigation of the cell walls of those Pseudononus species sensitive to EDTA. Unfortunately, the lipid compositions reported are also those of the cell walls and therefore may not be representative of the total lipids and also makes comparisons with other reports difficult. P. diminuta, P. maltophilia, and P . rubescens all have unusual lipid compositions, and it is therefore interesting to note that their taxonomic position has already been questioned ( Wilkinson, 1967). All three organisms contain unusual glycosyl diglycerides with glucose and glucuronic acid as the constituent sugars. P. diminuta is notable for the absence of phosphatidylethanoldmine although it must be stressed that this is from the cell wall, not necessarily the cytoplasmic membrane. Wayne Moss et al. (1972) have carried out a survey of the fatty acids, including those of the Iipopolysaccharides, of ten representative species of Pseudomonas and have noted significant differences particularly in the type of hydroxy fatty acid present. This is a good example of the value of fatty acid “spectra” in grouping members of a genus. Although much more work is necessary, it is becoming apparent that lipid analysis will be able to contribute significantly to the classification of this important group.
B. EUBACTERIALES The Order Eubacteriales is another very large and diverse group of bacteria which may be conveniently divided into two on the basis of the gram stain. Where information is available, bacteria belonging to gram-negative families, e.g., Azotobacteraceae, Rhizobiaceae, Enterobacteriaceae and Neisseriaceae all have qualitatively very similar lipid compositions and are not readily distinguishable one from another. Most of these organisms have a relatively simple lipid composition the major component being phosphatidylethanolamine which can account for up to 90% of the total lipid. Phosphatidylcholine has been detected in Azotobacter agilis, Agrobacterium tumefaciens, Rhizobium japonicum and is the major lipid in BrmceEla abortus. Glycolipids are usually absent in this group of gram-negative organisms. Bacteroides meluninogenim has a very unusual lipid pattern composed mainly of phosphosphingolipids. Whether this is typical of this genus remains to be established.
100
NORMAN SHAW
The lipids of many genera of the gram-positive families have been investigated, and several genus-specific features have emerged. Undoubtedly the most significant of these is the presence of diglycosyl diglycerides. Although glycolipids are known to be present in many micrococci, only the dimannosyl diglyceride in M . lysodeikticus has been characterized, and information on other members of this genus would be of interest, particularly because staphylococci contain a diglucosyl diglyceride. Which glycolipid would those organisms which fall midway between these two overlapping genera possess? Perhaps both? The phospholipid composition of some micrococci show minor variations, and two species have been shown to contain phosphatidylinositol, which is common to higher bacteria. Here is an area obviously in need of further investigation. The lipid composition of Micrococcus dentrificans, e.g., the presence of phosphatidylethanolamine and phosphatidylcholine each possessing unsaturated fatty acids is quite atypical and supports the suggestion that this organism is the same as Thiobacillus novellus (in Breed et al., 1957, p. 463). The lipid composition of Spmosarcina urae also supports its reclassification in the genus Bacillus (Whiteside et al., 1971). The Lactobacillaceae are differentiated from the other families of gram-positive bacteria by their fatty acid composition, which is similar to that of many gram-negative organisms in having large quantities of unsaturated and cyclopropane fatty acids. The two most common genera, Streptococcus and Lactobacillus, have different glycolipids; all streptococci have the a-diglucosyl diglyceride, whereas the lactobacilli have the galactosylglucosyl diglyceride. It has been suggested that Lactobacillus bifidus should constitute a separate genus Bifidobacterium, and the lipids of the latter are certainly very different from those of lactobacilli. Bifidobacterium bifidum has a glycolipid containing galactofuranose and an unusual polyglycerophosphatide of ill-defined structure. The genus Propionibacterium possesses a unique glycolipid, diacylinositol mannoside, which has not yet been found in any other organism and is the only glycolipid known which contains inositol. It is structurally related to the phosphatidylinositol mannoside present in many corynebacteria and mycobacteria, but the presence of these phospholipids in Propionibacterium has yet to be conclusively demonstrated. With the exception of Erysipelothrix, considerable information is available on genera of the Cornynebacteriaceae, and they may be readily distinguished. The lipids of Listeria monocytogenes have attracted considerable attention, as it was originally thought that the “monocyte-producing agent” was a lipid, a view no longer held. This organism contains a galactosylglucosyl diglyceride identical to that found in Lactobacillus and the transfer of this genus into the Lactobacillaceae has been sug-
CHEMOTAXONOMY OF BACTERIAL LIPIDS
101
gested. Microbacterium lacticum contains a dimannosyl diglyceride which also probably occurs in small amounts in M . thermosphactum, the classification of which has been questioned by some authors who consider it more related to the Lactobacillaceae. Despite the presence of phosphatidylethanolamine, its lipid composition is more akin to the Corynebacteriaceae; branched-chain fatty acids predominate and unsaturated acids are absent. Dimannosyl diglycerides have not been found in any Lactobacillaceae. Two strains of the gram variable CeZZu2omona.s species C . jimi and C. biazotea have been examined and have similar compositions reminiscent of the bacilli; phosphatidylethanolamine and p-diglucosyl diglyceride are both present. Arthrobacter is characterized by the presence of phosphatidylinositol and two diglycosyl diglycerides, digalactosyl and dimannosyl diglyceride. The co-occurrence of two unrelated diglycosyl diglycerides is a phenomenon as yet unique to Arthrobacter. The corynebacteria have received considerable attention probably because of the presence of the “diphtheria bacillus” in this genus. C. diphtheriae i s closely related to the mycobacteria in that both have very complex cell walls of similar constitution containing free fatty acids of considerable complexity. Little information is available concerning the distribution of these “corynemycolic acids” in other corynebacteria. They have been detected in C. hofmanii but are absent from many other corynebacteria. C. diphtheriae also contains diacyltrehalose, “cord-factor,” commonly found in mycobacteria but so far not reported in any other member of this genus. Another distinguishing feature of C. diphtheriw is the presence of appreciable quantities of unsaturated fatty acids esterified to the phospholipids whereas other corynebacteria have predominantly branched-chain fatty acids. Although acylated glucoses are prevalent, glycolipids of the diglycosyl diglyceride type have been found only in C. aquaticum. This organism is also unusual in containing phosphatidylethanolamine. Phosphatidylinositol mannosides have been found in many corynebacteria. The anaerobic C . acnes has also been classified as Propionibacterium acnes. Recent opinion, however, favors the former classification and the lipid composition is in agreement with this view. c. acnes does not possess the diacylinositol mannoside found in Propionibacterium, and moreover the ratio of is0 C,, to anteiso C,, fatty acids is very much higher in C. acnes than in Propionibacterium species. However no evidence could be found for the presence of phosphatidylinositol mannosides, which are prevalent in most corynebacteria but are not found in any other genus of the ,Corynebacteriaceae. Much of the above confirms the already acknowledged unsatisfactory state of the taxonomy of the corynebacteria, and as yet no clear picture is emerging except
102
NORMAN SHAW
to note that C. diphtheriae is reasonably distinct from other members of the genus. The lipids of the spore-forming Bacillaceae are extremely characteristic. Members of the genus Bacillus are characterized by the presence of a p-diglucosyl diglyceride and phosphatidylethanolamine. The amount of the latter present is usually less than that found in gram-negative bacteria. A unique glucosaminyl diglyceride has been found in one strain of B. megatherium together with a glucosamine-containing phospholipid. The fatty acid “spectra” of many representative bacilli show minor differences. Less information is available on Clostridium species, but this genus also contains phosphatidylethanolamine. Glycolipids have been observed, but are not well characterized. High concentrations of plasmalogens are a characteristic feature of Clostridium.
C . ACI~NOMYCETALES The lipids of the Order Actinomycetales are the most complex found in bacteria and have been the subject of intensive studies. Phospholipids, glycolipids, complex fatty acids, sulfolipids, lipopolysaccharides, mycosides, and waxes make up the lipid content of these organisms (Lederer, 1967; Goren, 1972). The most important class of lipids, however, from a taxonomic point of view are the high molecular weight fatty acids known collectively as “mycolic acids.” They are found as the free acids in the cell wall or esterified to wall polymers and as the apolar constituents of glycolipids. Those present in mycobacteria, mycolic acids, are the most complex, with carbon numbers around 80; those present in nocardia, nocardic acids, are smaller, with carbon numbers around 50, and are thus intermediate between the my colic acids and the corynemycolic acids found in C. diphtheriae. Streptomyces do not contain these large fatty acids, but apparently they have a-hydroxy acids of normal length. Nocardia and rapidly growing mycobacteria are extremely difficult to differentiate by the usual morphological and physiological tests. Moreover their GC ratio and wall composition are very similar. The identification of mycolic or nocardic acids is therefore of great importance, and Lechevalier et al. (1971) have used this method to classify many mycobacteria and nocardia. Thus they were able to show that M . rhodochrous contained nocardic acids and therefore should be reclassified as N . rhodochrous. A rapid method based upon solubilities for differentiating mycolic and nocardic acids has been described (Kanetsuda and Bartoli, 1972), and it is not necessary to carry out a full chemical structural elucidation. The latter is an extremely complex process which requires all the modern techniques available to the organic chemist. However such studies have shown that, within the genus Myco-
CHEMOTAXONOMY O F BACTERIAL LIPIDS
103
bacterium, species specificity is shown in mycolic acid structure. Thus M. tuberculosis, M . avium, M . smegmutis and M . phlei all have different mycolic acids (Lederer, 1971). However, these differences cannot be routinely used for classification until simpler methods are available for their characterization. The Mycobacterium, Nocardia, and Streptomyces all contain the complex phosphatidylinositol mannosides and phosphatidylethanolamine. These phospholipids, however, do not contain mycolic acids as their apolar constituents but have the normal straight-chain and unsaturated fatty acids. One branched-chain fatty acid, 10-methyl octadecanoic acid ( tuberculostearic acid) is a characteristic component of these lipids. Diacyl trehalose, cord-factor, has been found in Mycobacterium and Nocardia, but not yet in Streptomyces. D. MYCOPLASMATALES The mycoplasma are gram-negative owing to the absence of a normal cell wall but, like the halobacteria, their lipid composition is more akin to that of gram-positive bacteria. These organisms have been very popular with microbial biochemists interested in membrane phenomena, as they show a marked ability to incorporate exogenous lipid into their membranes thereby enabling studies of the influence of fatty acid composition on membrane permeability to be made. Many mycoplasma will not grow on a completely synthetic, lipid free, medium so it is impossible to determine their true lipid composition. The most detailed studies have been carried out on Acholephma laidlawii whose lipids closely resemble those of streptococci. Appreciable quantities of the a-diglucosyl diglyceride are present and the structurally related glycophospholipid both of which are also found in streptococici. Phosphatidylglycerol and its amino acid ester derivatives have also been isolated. The major glycolipid of an avian strain of Mycoplasma is a triacyl glucose. VI.
Conclusions
There are clear, well defined patterns emerging from studies on lipid composition as a guide to the classification of bacteria. Although many anomalies have already been observed, it is significant that in nearly all cases the taxonomy of the organism in question has previously been disputed using other criteria. Assuming no prevous knowledge of bacterial classification, except perhaps the gram stain, the classification of bacteria solely on lipid composition would in effect produce a scheme which is basically very similar to the one presently accepted. There are obviously very large groups of organisms for which information
104
NORMAN SHAW
about their lipid composition is virtually nonexistent. It is the hope of the author that this review will stimulate those microbiologists presently studying these organisms to undertake such studies, and that this method will become accepted as a valuable guide to bacterial taxonomy.
REFERENCES Abel, K., deschmertzing, H., and Peterson, J. L. (1963). 1. Bacteriol. 85, 1039. Ambron, R. T., and Pieringer, R. A. (1971). J.-Bid.Chem. 246,4216. Ames, G. F. ( 1968). J . Bacteriol. 95, 833. Asselineau, J. ( 1966 ) . “The Bacterial Lipids.” Holden-Day, San Francisco, California. Azuma, I., Nayasuga, T., and Yamamura, Y. (1962). J. Biochem. (Tokyo) 52, 92. Ballio, A., Barcellona, S., and Boniforth, L. (1965). Biochem. J. 94, 11C. Barridge, J. K., and Shively, J. M. (1968). J . Bacteriol. 95, 2182. Batt, R. V., Hodges, R., and Robertson, J. G. (1971). Biochim. Biophys. Acta 239, 368. Baumann, N. A., Hagen, P.-O., and Golfine, H. (1965). J . B i d . Chem. 240, 1559. Bergelson, L. D., Batrakov, S. G., and Pilipenko, T. V. (1970). Chem. Phys. Lipids 4, 181. Bishop, D. G., Rutberg, L., and Samuelsson, B. ( 1967). EUT.J. Biochem. 2, 448. Breed, R. S., Murray, E. G. D., and Smith, N. R. (1957). “Bergey’s Manual of Determinative Bacteriology,” 7th ed. Williams & Wilkins, Baltimore, Maryland. Brennan, P. J. (1968). Biochem. J . 109, 158. Brennan, P. J., and Ballou, C. E. ( 1967). J. Biol. Chem. 242, 3046. Brennan, P. J., and Ballou, C. E. (1968). Biochem. Biophys. Res. Commun. 30. 69. Brennan, P. J., and Lehane, D. P. (1969). Biochim. Biophys. A d a 176,675. Brennan, P. J., and Lehane, D. P. (1971). Lipids 6, 401. Brennan, P. J., Flynn, M. P., and Griffin, P, F. S. ( 1970a). FEBS Lett. 8,322 Brennan, P. J., Lehane, D. P., and Thomas, D. W. (1970b). Eur. J. Biochem 13, 117. Brian, B. L., and Gardner, E. W. (1968). J. Bacterial. 96, 2181. Brundish, D. E., and Baddiley, J. ( 1968). Carbwhyd. Res. 8,308. Brundish, D. E., Shaw, N., and Baddiley, J. (1965). Biochem. J. 97, 158. Brundish, D. E., Shaw, N., and Baddiley, J. (1967a). Biochem. J. 104,205. Brundish, D. E., Shaw, N., and Baddiley, J. (196710). Biochem. J . 105,885. Bunn, C. R., and Elkam, G. H. ( 1971). Can. J. Microbiol. 17,291. Carroll, K. K., Cutts, J. H., and Murray, E. G. D. (1968). Can. J. Biochem. 46, 899. Cohen, M. and Panos, C. (1966). Biochemistry 5,2385. Constantopoulos, G., and Bloch, K. (1967). J. Bacteriol. 93, 1788. Cruden, D. L. and Stanier, R. Y. (1970). Arch. MikrobioZ. 72, 115. Cullen, J., Phillips, M. L., and Shipley, G. G. (1971). Biochem. J . 125, 733. Dawson, R. M. C. (1960). Biochem. J. 75, 45. Dittmer, J. C. and Lester, R. L. (1964). J. Lipid Res. 5, 126. Dos Santos Mota, J. M., Op den Kamp, J. A. F., Verheij, H. M., and van Deenen, L. L. M. (1970). J . Bacterial. 104, 611. Etemadi, A. H. (1963). Bull. Soc. Chim. Biol. 45, 1423.
CHEMOTAXONOMY OF BACTERIAL LIPIDS
105
Exterkate, F. A., Otten, B. J., Wassenberg, H. W., and Veerkamp, J. H. (1971). J. Bacteriol. 106, 824. Fischer, W. (1970). Biochem. Biophys. Res. Commun. 41, 731. Fischer, W., and Seyferth, W. (1968). Hopper-Seyler's Z. Physiol. Chem. 349, 1662. Goldfine, H. (1964). J. Biol. Chem. 239,2130. Goldfine, H., and Hagen, P-0. (1968). J. Baderiol. 95, 367. Goldfine, H., and Panos, C. (1971). J. Lipid Res. 12, 214. Gomes, N. F., Ioneda, T., and Pudles, J. ( 1966). Nature (London) 211, 81. Gorchein, A. (1968). Biochim. Biophys. Acta 152, 358. Goren, M. B. ( 1972). Bacteriol. Rev. 36, 33. Gould, R. M., and Lennarz, W. J. (1970). J. Bacteriol. 104, 1135. Hagen, P-O., Goldfine, H., and Williams, P. J. le B. (1966). Science 151, 1543. Hancock, A. J., and Kates, M. (1972). Chem. Phys. Lipids 8, 87. Hancock, I. C., and Meadows, P. M. (1969). Biochim. Biophys. Acta 187, 366. Hirayama, 0. ( 1968). Agr. Biol. Chem. 32, 34. Houtsmuller, U. M. T., and van Deenen, L. L. M. (1985). Biochirn. Biophys. Acta 106, 564. Hunter, M. I. S., and Thirkell, D. ( 1971). J. Gen. Microbiol. 65, 115. Huston, C. K., Albro, P. w., and Grindley, G. B. ( 1965). J. Bacteriol. 89,768. Ikawa, M. (1967). Bactem'ol. Rm. 31,54. Ioneda, I., Lederer, E., and Rozanis, J. ( 1970). Chem. Phys. Lipids 4, 375. Ishizuka, I. and Yamakawa, T. (1968). J. Biochem. (Tokyo) 64,13. Jauch, R., Schiele, U., and Lynen, F. (1960). Arch. Mikrobiol. 72, 186. Joyce, G. H., Hammond, R. K., and White, D. C. (1970). J. Bacteriol. 104, 323. Jurtshuk, P. and Schlech, B. A. (1969). J. Bacteriol. 97, 1507. Kaneda, T. ( 1967). J. Bacteriol. 93, 894. Kaneda, T. ( 1968). J. Bucteriol. 95, 2210. Kaneshoiro, T., and Marr, A. G. (1962). J. Lipid Res. 3, 184. Kanetsuna, F., and Bartoli, A. (1972). J. Gen. Microbiol. 70, 209. Kanfer, J., and Kennedy, E. P. (1963).3. Biol. Chem. 238,2919. Kates, M. (1964). Aduan. Lipid Res. 2, 17. Kates, M., Adams, G. A., and Martin, S. M. (1964). Can. J . Biochem. 42, 461. Kates, M., Wassef, M. K., Kushner, D. J,, and Gibbons, N. E. (1966). Biochemistry 5, 4092. Kates, M., Palameta, B., Perry, M. P., and Adams, G. A. (1967). Biochim. Biophys, Acta 137, 213. Kaufmann, B., Kundig, F. D., Distler, J., and Roseman, S. (1965). Biochem. Biophys. Res. Commun. 18, 312. Khuller, G. K., and Brennan, P. J. (1972a). Biochem. J. 127,369. Khuller, G. K., and Brennan, P. J. (1972b). J. Gen. Microbiol. 73, 409. Kimble, C. E., McCollough, M. L., Paterno, V. A., and Anderson, A. W. ( 1969). Appl. Microbiol. 18, 883. Kimura, A., Kawanami, J., and Otsuka, H. ( 1967). J. Biochem. (Tokyo) 62,384. Kunsman, J. E. (1970). J. Bacteriol. 103, 104. Kutaoka, T., and Nojima, S. (1967). Biochim. Biophys. Acta 144, 681. Laneelle, M. A., and Asselineau, J. (1968). C. R. Acud. Sci., Ser. D 266, 1901. Laneelle, M. A., Asselineau, J., and Castelnuovo, G. (1965). Ann. Inst. Pasteur, Paris 108, 69. Laneelle, M. A., Asselineau, J., and Castelnuovo, G. (1968). Ann. Inst. Pusteur, Paris 114, 305. Lang, D. R., and Lundgren, D. G. (1970). J. Bucteriol. 101,483. ~
106
NORMAN SHAW
Lechevalier, M. P., Horan, A. C., and Lechevalier, H. (1971). J . Bacteriol. 105, 313. Lederer, E. (1967). Chem. Phys. Lipids 1, 294. Lederer, E. (1971). Pure Appl. Chem. 25, 135. Lee, Y. C., and Ballou, C. E. (1965). Biochemistry 4, 1395. Lennarz, W. J. (1970). In “Lipid Metabolism” (S. J. Wakil, ed.), pp. 154-184. Academic Press, New York. Lennarz, W. J., and Talemo, B. (1966). J. Biol. Chem. 241,2707. Levin, R. A. ( 1971). J . Bacteriol. 108, 992. Livermore, B. P., and Johnson, R. C. (1970). Biochim. Biophys. Acta 210, 315. Luderitz, 0. (1970). Angew. Chem., Int. Ed. Engl. 9,649. MacDougall, J. C., and Phizackerley, P. J. R. (1969). Biochem. J. 114, 381. Macfarlane, M. G. (1961a). Biochem. J. 79, 4P. Macfarlane, M. G. (1961b). Biochem. J. 80, 45P. Macfarlane, M. G. (1962a). Biochem. 1. 82, 40P. Macfarlane, M. G. ( 196213). Nature (London) 196, 136. Makula, R. A,, and Finnerty, W. R. (1970). J . Bucteriol. 103, 348. Marinetti, G. V. (1962). J. Lipid Res. 3, 1. Marinetti, G. V. ( 1967). “Lipid Chromatographic Analysis,” Dekker, New York. Marshall, C. L., and Brown, A. D. (1968). Biochem. J . 110,441. Matches, J. R., Walker, H. W., and Ayres, J. C., (1964). 1. Bacteriol. 87, 16. Matsumoto, M., Tamiya, K., and Koizumi, K. (1971). J. Biochem. (Tokyo) 69, 617. Maurice, M. T., Vacheron, M. J., and Michel, G. ( 1971). Chem. Phys. Lipids 7, 9. Minnikin, D. E., and Abdolrahimzadeh, H. (1971). J . Chromutogr. 63, 452. Miquel, A.-M., Ginsburg, H., and Asselineau, J. (1963). Bull. Soc. Ghim. B i d . 45, 715. Modak, M. J., Nair, S., and Venkataraman, A. (1970). J . Gen. Microbiol. 60, 151. Moss, C. W., Dowell, V. R. Lewis, V. J., and Schekter, M. A. (1967). J. Bacteriol. 94, 1300. Nesbitt, J. A,, and Lennarz, W. J. (1965). J . Bacteriol. 89, 1020. Okazaki, H., Sugino, H., Kanzaki, T., and Fukuda, H. (1969). Agr. Biol. Chem. 33, 764. Okuyama, H., Kankura, T., and Nojima, S. (1967). J . Biochem. (Tokyo) 81, 732. O’Leary, W. M. (1967). “The Chemistry and Metabolism of Microbial Lipids,” World Publ. Co., Cleveland, Ohio. Olsen, R. W., and Ballou, C. E. ( 1971). J. Biol. Chem. 246, 3305. 00,K. C., and Lee, Y. C. ( 1972). J. Biochem. (Tokyo) 71, 1081. Op den Kamp, J. A. F., Houtsmuller, U. M. T., and Van Deenen, L. L. M. ( 1965). Biochim. Biophys. Actu 106, 438. Op den Kamp, J. A. F., Redai, I., and van Deenen, L. L. M. (1969a). J . Bacteriol. 99, 298. Op den Kamp, J. A. F., van Deenen, L. L. M., and Tomasi, V. ( 1969b). In “Structural and Functional Aspects of Lipoproteins in Living Systems” (E. Tria and A. M. Scanu, eds.), p. 227. Academic Press, New York. Oshima, M., and Yamakawa, T. (1972). Biochem. Biophys. Res. Commun. 49, 185. Otsuka, S. I., and Shiio, I. (1968). J . Gen. Appl. Microbiol. 14, 135. Park, C. E., and Berger, L. R. (1967). J . Bacteziol. 93, 221. Peleg, E., and Tietz, A. ( 1971). FEBS Lett. 15, 309. Phizackerley, P. J. R., MacDougall, J. C., and Francis, M. J. 0. (1966). Biochem. J., 99, 21c.
CHEMOTAXONOMY OF BACTERIAL LIPIDS
107
Phizackerley, P. J. R., MacDougall, J. C., and Moore, R. A. (1972). Biochem. J. 126, 499. Pieringer, R. A. (1968). J. Biol. Chem. 243, 4894. Plackett, P. ( 1967). Biochemistry 6, 2746. Prome, C., Lacave, C., and Laneelle, M. A. (1969). C . R. A c d Sci., Ser. c 269, 1664. Raines, L. J., Wayne Moss, C., Farshtchi, D., and Pittman, B. (1968). J. Bacteriol. 96, 2175. Randle, C . L., Albro, P. W., and Dittmer, J. C. (1969). Biochim. Biophys. Acts 187, 214. Rizza, V., Tucker, A. N., and White, D. C. (1970). J. Bacterial. 101, 84. Romano, N., Smith, P. F., and Mayberry, W. R. ( 1972). J. Bacteriol. 109, 565. Rothfield, L., and Romeo, D. (1971). Bacteriol. Reu. 35, 14. Saito, K., and Mukoyama, K. ( 1970). J. Biochem. (Tokyo) 69,83. Samuels, S. B., Moss, C. W., and Weaver, R. E. (1973). J. Gen. Microbiol. 74, 275. Senn, M., Iondea, T., Pudles, J., and Lederer, E. (1967). Eur. J. Biochem. 1, 33. Shaw, N. (1968a). Biochim. Biophys. Acta 152,427. Q 435. Shaw, N., (196813). Biochim. Biophys. A C ~164, Shaw, N., (1970). Bacterial. Reu. 34, 365. Shaw, N., and Dinglinger, F. (1968). Biochem. J. 112, '769. Shaw, N, and Stead, D. (1970). J . Appl. Bacterial. 33, 470. Shaw, N., and Stead, D. (1971). J. BQcteTiOl.107, 130. Shaw, N., and Stead, A. (1972). F E B S Lett. 21, 249. Shaw, N., Smith, P. F., and Koostra, W. L. (1968a). Biochem. J. 107,329. Shaw, N., Heatherington, K., and Baddiley, J. (1968b). Biochem. J. 107, 491. Shaw, N., Smith, P. F., and Verheij, H. M. (1972). Biochem. J. 129, 167. Shively, J. M., and Benson, A. A. ( 1967). J. Bncteriol. 94, 1679. Short, S. A., and White, D. C. (1970). J. Bacteriol. 104, 126. Short, S. A., and White, D. C. (1972). J. Bacterial. 109, 820. Short, S. A., White, D. C., and Aleem, M. I. H. ( 1969). J. Bacteriol. 99, 142. Smith, P. F., and Henrikson, C. V. (1965). J. Lipid Res. 6, 106. Smith, P. F., and Mayberry, W. R. (1968). Biochemistry 7, 2706. Steiner, S., Burnham, J. C., Conti, S. F. and Lester, R. L. (1970a). J. Bacteriol. 103, 500. Steiner, S., sojka, G. A., Conti, S. F., Gest, H., and Lester, R. L. (1970b). Biochim. Biophys. A C ~203, Q 571. Sud, I. J., and Feingold, D. (1970). 3. Bacteriol. 104, 289. Thiele, 0. W., (1971). Experientia 27, 1268. Thiele, 0. W., Busse, D., and Hofmann, K. ( 1968). EUT.J. Biochem. 5,513. Toon, P., Brown, P. E., and Baddiley, J. (1972). Biochem. J. 127, 399. Tornabene, T. G., and Ogg, J. E. (1971). Biochim. Biophys. Acts 239, 133. Uchida, K., and Mogi, K. ( 1972). J. Gen. Appl. Microbiol. 18, 109. Utakami, C., and Umetani, K. (1988). Biochim. Biophys. Act0 164, 64. Vacheron, M. J., Guinand, M., Michel, G., and Ghuysen, J.-M. (1972). EUf. J. Biochem. 29, 156. Veerkam@ J. H. (1970). Biochim. Biophys. Acta 210, 267. Vilkas, E., and Rojas, A. (1964). Bull. Soc. Chim. B i d . 46, 689. Vorbeck, M. L., and Marinetti, G. V. ( 1965). J. Lipid Res. 6, 3. Walker, R. W., and Bastl, C. P. (1967). Carbohyd. Res. 4, 49. Walker, R. W., and Fagerson, P. (1965). Can. J. Microbiol. 11, 229. Ward, J. B., and Perkins, H. R. ( 1968). Biochem. J. 106, 391. Wayne Moss, C., and Lewis, V. J. (1967). Appl. Microbiol. 15, 390.
108
NORMAN SHAW
Wayne Moss, C., Kellog, D. S., Farshy, D. C., Lambert, M. A., and Thayer, J. D. ( 1970). J. Bacteriol. 104, 63. Wayne Moss, C., Samuels, S. B., and Weaver, J R . E. (1972). Appl. Microbiol. 24, 596. Welby-Gieusse, M., Laneelle, M. A., and Asselineau, J. (1970). EUT. J. Biochem. 13, 164. Wells, M. A., and Dittmer, J. C. (1963). Biochemistry 2, 1259. Welsh, K., Shaw, N., and Baddiley, J. (1968). Biochem. J. 107, 313. White, D. C. (1968).J. Bucteriol. 96, 1159. White, D. C., and Frerman, F. E. ( 1967). J. Bacteriol. 94, 1854. Whiteside, T. L., de Siervo, A., and Salton, M. J. R. (1971). J. Bacteriol. 105, 957. Wilkinson, B. J., Morman, M. R., and White, D. C. (1972). J. Bacteriol. 112, 1288. Wilkinson, S. G. (1967).J. Gen. Microbiol. 47, 67. Wilkinson, S . G. (1968a). Biochim. Biophys. Acta 152, 227. Wilkinson, S. G. (196813). Biochim. Biophys. Actu 164, 148. Wilkinson, S. G. (1969). Biochim. Biophys. Acta 187, 492. Wilkinson, S. G. (1970). J. Bacteriol. 104, 1035. Wilkinson, S. G. (1972). Biochim. Biophys. Acta 230, 1. Wilkinson, S. G., and Bell, M. E. ( 1971). Biochim. Biophys. Acta 248, 293. Wilkinson, S. G., Galbraith, L., and Lightfoot, G. A. (1973). Eur. J. Biochem. 33, 158. Wood, B. J, B., Nichols, B. W., and James, A. T. (1965). Biochim. Biophys. Acta 106, 261. Yano, I., Furakawa, Y., and Kusunose, M. ( 1968). J. Biochem. (Tokyo) 63, 133. Yano, I., Furakawa, Y., and Kusunose, M. (1969). J. Bucteriol. 98, 124. Yano, I., Furakawa, Y., and Kusunose, M. (1970a). Biochim. Biophys. Acta 202, 189. Yano, I., Furakawa, Y., and Kusunose, M. (1970b). Biochim. Biophys. Acta 210, 105. Yano, I., Furakawa, Y., and Kusunose, M. (1971). J. Gen. Appl. Microbiol. 17, 329.
Fungal Sterols and the Mode of Action of the Polyene Antibiotics
J. M. T. HAMILTON-MILLER Department of Medical Microbiology, Uniuersity of London, Royal Free Hospital, London, Great Britain
.
I. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 11. Sterols in the Microbial Kingdom . . . . . . . . . . . . . . . . . . A. Bacteria .................................... B. Yeasts and Fungi . ... . .. .. .. .. .. .. .. .. .. .. .. . 111. Factors Affecting the Sterol Content of Fungal Cells . . A. Aerobiosis . .. .. ... ....... . . .. .. .. .. .. . . .. . . . B. Growth and Morphological Phase . . . . . . . . . . . . . . C. Medium Composition . . . . . . . . . . . . . . . . . . . . . . . . D. Temperature . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . IV. Physiological Role of Sterols . . . . . . . . . . . . . . . . . . . , . . V. Sterols and the Mode of Action of Polyenes . . . . . . . . . . A. Studies in Solution . . . . . . , . . . . . . . . . . . . . . . . . . . B. Differential Calorimetry . . . . . . . . . . . . . . . . . . . . . . C. Experiments with Monolayers . . . . . . . . . . . . . . . , . D. Experiments with Bilayers . . . . . . . . . , . . . . . . . . . . E. Liposomes .................................. F. Studies with Disrupted. Natural Membranes . . . . . . G. Experiments with Whole Cells and Functional Subcellular Fractions . . . . . . . . . . . . . . . . . . . . . . . . . . . . H. Discussion .................................. VI. Resistance to the Polyene Antibiotics . . . . . . . . . . . . . . . . VII. The Role of Sterols in Resistance to the Polyenes . . . . . VIII. Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . References . . . . . . . . . . . . . . . . . . . . . , . . . . . . . . . . . . . . . .
1.
109 110 110 110 112 112 112 113 113 114 115 116 117 118 119 120 122 123 125 126 128 130 131
Introduction
When I started work on mycological topics in 1970, I was given the brief to investigate the mode of action of polyene antibiotics and resistance to them among pathogenic yeasts. After a few weeks in the library, I came to two conclusions: first, that the mode of action was already known; and second, that resistance did not occur (at least in nature). These same conclusions could very well be reached by anyone else who studied the question for a short time only, and they could be excused for turning to some apparently more fruitful field. However, on more mature reflection, it became apparent that my first conclusion was untrue, and my second (apparently true) of potentially staggering import. Further reading and subsequent and concurrent experimental work showed me that a full study of the mode of action of the polyene antibiotics leads to a biophysical world entirely removed from conventional medical mycology. Experiments designed to probe the mode of action 109
110
J. M. T. HAMILTON-MILLER
of polyenes have revealed, often for the first time, vital information on basic membrane function and structure, and have thus paved the way for fundamental discoveries in this most crucial field. In much the same way, studies on antibiotics that inhibit protein synthesis have vastly increased knowledge on protein synthesis in general. It is gratifying for workers in mycological disciplines, who are often regarded as the Cinderellas of Microbiology, that such experiments are the result of their early and continuing interest in these antibiotics. Problems of drug resistance have been a continual worry to the medical bacteriologist since antimicrobial therapy started in earnest in the 1930's with the introduction of the sulfonamides. Mycologists have been spared this problem, and an explanation of why this might be so is of the greatest interest and importance. A short analysis of this problem is presented toward the end of the present review. Various aspects of sterols in relation to polyene activity are considered here; first, the distribution, nature, and function of sterols is discussed; then their role in the mode of action of the polyenes; and finally the part they have to play in resistance mechanisms in yeasts.
II. Sterols in the Microbial Kingdom
A. BA-IA Sterols are notably absent from bacteria ( Asselineau and Lederer, 1960) with the exception of the nitrogen-fixing Azotobacter chroococcum which has a sterol content of 10 mg/100 gm. Schubert et al. (1964, 1968) were able to isolate minute amounts of cholesterol, campesterol ( a homolog of cholesterol), p-sitosterol, and stigmasterol from Escherichia coli, but the total sterol yield was only 400 pg/lOO gm. Sterols are important in the classification of Mycoplasmataceae, the two genera Mycoplasma and Acholeplasma being distinguished by the ability of the latter to grow in the absence of added cholesterol. However, A. laiduwii is capable of incorporating exogenous sterol, a phenomenon which has helped to adduce important evidence as to the mode of action of the polyene antibiotics (see Section V ) (Feingold, 1965; Weber and Kinsky, 1965).
B. YEASTSAND FUNGI The existence of sterols in the fungal kingdom has been known for many years. The most widely distributed sterol, ergosterol, was so named
FUNGAL STEROLS AND POLYENE ANTIBIOTICS
111
after the mold ergot, from which it was first isolated more than 90 years ago (Tanret, 1879); before the end of the 19th century, ergosterol had also been found in Penicillium and Mucor. As ergosterol is a commercially important natural product, being a precursor of vitamin D, much attention has been paid to finding the best source of this compound. Dulaney et al. (1954) investigated 558 yeast cultures, and found that Sacchuromyces carlsbergensis, S. cerevisiae, and S . ovif ormis contained at least 2% by weight of sterols; brewer’s yeast and ale yeasts were the most consistent in this respect. Appleton e,t al. (1955) screened more than 50 strains from a total of more than 30 genera of molds in all except Neuroand yeasts and found a low sterol content (
112
J . M.
Ill.
T. WMILTON-MILLER
Factors Affecting the Sterol Content of Fungal Cells
A. AEROBIOSIS It is now clearly established that sterol metabolism is dependent upon oxygen availability. The reason for this seems to be that the conversion of squalene to sterols requires oxygen; both the oxidative cyclization of squalene to lanosterol and the conversion of the latter to cholesterol require molecular oxygen. Thus, squalene can be shown to accumulate in yeast cells grown anaerobically, and is converted to sterol when aerobiosis is resumed. Sacchuromyces cerevisiae requires a suitable sterol in order to grow anaerobically; a very wide range of sterols can substitute for the naturally occurring ergosterol. Requirements for such sterols are that the molecule must be planar, have a long C-17 alkyl side chain and a hydroxyl group (Proudlock et al., 19SS). By no means all yeasts, however, are incapable of growing anaerobically; Schixosaccharomyces jnponicus grows very well anaerobically unsupplemented, but anaerobic cells are virtually devoid of ergosterol ( Bulder, 1971). A similar situation obtains for Mucor genevensis, in which squalene accumulates anaerobically (Gordon et al., 1971).
B. GROWTH AND MORPHOLOGICAL PHASE There are several instances of reports of alterations in sterol content, both qualitative and quantitative, occurring during the growth cycle of various yeasts and fungi. In M . genevensis, Gordon et al. (1971) found that ergosterol comprised about 80%of the total sterol content during the exponential phase of growth, and that the stigmasterol content rose to 40% in the stationary phase. Capek and Simek (1972) found that the sterol content (mainly ergosterol) of the dermatophytes Microsporum gypseum and Tdchophyton mentagrophytes increased as the cultures aged. Bianchi (1967) reported a higher proportion of the lipid fraction from juvenile ( logarithmic phase) than from mature yeast cells of Candida albicans was composed of sterol and sterol esters; four sterols were separated by thin-layer chromatography, but only cholesterol was tentatively identified. Between them, these two fractions always outweighed the other lipid components of the cell wall (triglycerides, free fatty acids, and phospholipids). The same author has also compared the sterol contents of C. albicans cells in the yeast form with those of the filamentous phase; although the total sterol content was greater when the organism was in the mycelial form, the proportions of the various lipid fractions were markedly different. Anaerobiosis, which markedly decreases the ergosterol content of M. geneuensis cells (see
FUNGAL STEROLS AND POLYENE ANTIBIOTICS
113
previous section), is one of the factors which predisposes toward the yeastlike development of this species (Gordon eat al., 1971). However, it is the opinion of these workers that this decrease in sterol, and the concomitant alteration in fatty acid content, is an effect rather than the cause of the morphological change. C. MEDIUM COMPOSITION Inasmuch as a certain amount of dimorphism may be induced by alteration of medium [e.g., use of a liquid medium to obtain the filamentous form of C. albicans: (Bianchi, 1967; Hamilton-Miller, 1972a)], the physical composition of medium may be said to affect the sterol content of yeast cells, but more attention in this respect has been paid to the affects of different sources of carbon and nitrogen. Thus, various authors have claimed the following carbon sources to be the most favorable for the production of sterols by yeast: maltose, glucose, sucrose, and pyruvate; similarly, many nitrogen sources have also been investigated, NH,’ being favored by some, peptone by others (see El-Refai and ElKady, 1968a,b). Concentrations of nutriments may also be crucial. The situation is complicated not only by the multiplicity of sources of nitrogen and carbon available-giving the possibility of virtually limitless permutations and combinations to be tested-and the differing strains and cultural conditions, but also by the fact that ergosteroI is a valuable commercial product and hence what has often been sought, understandably, is maximum yields of sterol per volume of culture rather than maximum yield per gram dry weight of cells. It is thus clear that the true importance of the nature and concentration of nutriments and the production of sterols by yeast and fungi is very difficult to assess. Dulaney (1957) has shown how the ergosterol content of S. cerevisiae may be raised to as much as lo%, w/w; this was done by growing the organisms to maximum cell yield, harvesting and resuspending in fresh medium for a “refermentation” phase during which ergosterol enrichment occurs.
D. TEMPERATURE The true effect of alterations in temperature on the cellular processes in microorganisms is very difficult to assess except by the use of continuous culture. In batch culture, changing the incubation temperature is accompanied by an alteration in growth rate, so that any overall effects may be the result of either the altered growth rate, the altered temperature, or a combination of the two. It should be noted that the above
114
J . M . T. HAMILTON-MILLER
argument also applies, although perhaps not to such an extent, to alterations in nutriments. Hence, from the strictly scientific point of view, one should reject virtually all the studies made on the effects of altering the incubation temperature on sterol production, while bearing in mind that, from an applied point of view (obtaining the maximum overall yields of sterol), such studies are of obvious importance. The problem of dissociating changes in growth rate from alterations in temperature is solved by the use of continuous culture, using a fermenter-a piece of apparatus regrettably much more familiar to scientists in industry than to those in universities. By this technique, the growth rate (dilution rate) of the culture can be adjusted independently of the temperature, so that a constant growth rate can be achieved over a range of temperatures and, conversely, growth rates can be varied at any one desired temperature. An excellent illustration of the application of this technique to the current problem is the work of Hunter and Rose (1972). They found that, although in batch culture lowering the growth temperature had little or no effect on the content of sterols and sterol esters, lowering the growth rate at fixed temperature caused an increase in the amount of sterol esters, whereas decreasing the incubation temperature while maintaining the same growth rate brought about a decrease in total and esterified sterols. Parks and Starr (1963) found that growing S. cerevisiae at 42°C caused a sharp reduction in sterol content. IV.
Physiological Role of Sterols
Sterols seem to have only one major function in the majority of fungi, a structural role in maintaining membrane integrity and permeability. Studies at the molecular level have shown that sterols have a marked condensing effect upon experimental membranes composed of phospholipid, reducing their permeability to polyo1 compounds, such as glucose, glycerol, and erythritol, and to water (see Demel et al., 1972b). Incorporation of cholesterol into the membrane of cells which usually lack sterols was found to decrease the leakiness of the cells ( Child et al., 1969). In one group of fungi, however, the oomycetes, sterols do have an additional role. Members of this group, typified by the genera Pythium and Phytophthora, do not contain sterols under normal cultural conditions (Schlosser et al., 1969); vegetative growth can occur in the absence of sterols, but they are required for sexual reproduction and the formation of normal sporangia and zoospores. Hendrix (1964) found that ergosterol, stigmasterol, phytosterol, and cholesterol allowed the formation of oospores, and that the latter two compounds also increased growth rates. Divalent cations (Lenney and Klemmer, 1966) are additionally
FUNGAL STEROLS AND POLYENE ANTIBIOTICS
115
required for sexual maturation. As they contain no sterols, oomycetes are resistant to the antifungal action of polyenes, but Defago et al. (1969) reported that polyenes in high concentrations ( 0 . 5 1 mg/ml) induced oogenesis in Pythium, and that this effect was reversed by cholesterol. Sterols can be incorporated into the cell membranes of Pythium, and the resulting cells are sensitive to polyenes (Schlosser and Gottlieb, 1966). The general necessity for sterol biosynthesis to fungal growth is shown by the fact that, when S. cerevisiae is grown anaerobically to a state of total ergosterol depletion, no intracellular membranous organelles can be seen (Morpurgo et al., 1964). It is of interest, too, that certain drugs known to inhibit sterol biosynthesis in animals also possess some antifungal activity (Elliott, 1969; Hamilton-Miller, 1973b). It is interesting to speculate whether the fact that oomycetes lack sterol confers any ecological advantage on them over other fungal types. It could be argued that the oomycetes will be at a disadvantage due to a slower growth rate and their inability to reproduce sexually in the absence of sterols, but that they will enjoy a telling advantage in the presence of Streptomyces spp., which produce polyene antibiotics. While there is no doubt that organisms capable of producing polyenes are widespread in the soil (see Hamilton-Miller, 1973a), the question of whether antibiotics are actually produced under natural conditions is still far from resolved (see Hill, 1972).
V.
Sterols and the Mode of Action of Polyenes
It is now firmly established that the presence of sterols is a prerequisite for sensitivity to polyene antibiotics. The evidence for this has been reviewed frequently, most recently by the present author (HamiltonMiller, 1973a), and it would not serve any useful purpose in the present context to repeat it. At the multicellular level, the action of polyenes on a wide variety of organisms has been studied: mycoplasmas, yeasts and filamentous fungi, chloroplasts, protozoa, flatworms, flies and moths, amphibian tissues (muscle fibers, skin, and bladder), chick intestine, and various mammalian tissues. It is at the fractionated-cell and molecular levels, however, that the greatest strides have been made recently toward an understanding not only of the intimate details of the nature of the interaction of polyene and sterol, but also of membrane function as a whole. It is the results of this type of experiment that will be reviewed here. These studies, most of which emanate from the Utrecht Laboratory of L. L M. van Deenen, are chiefly biophysical in nature, and interpretation of the findings made may offer some difficulty to the reader who
116
J . M. T. HAMILTON-MILLER
is more usually occupied with medical or microbiological matters. It will therefore be appreciated that the following summary is much condensed and simplified. Various systems, at different levels of organization, have been used in the studies, and the order of review (in ascending order of complexity), although not chronologically correct, appears apt. It is noticeable that the majority of these studies involve filipin, which has been conclusively shown to be much the most active of the common polyene antibiotics as far as membrane activity is concerned in in vitro experiments. Much of the work was done before it was reported (Bergy and Eble, 1968) that filipin was a highly heterogeneous mixture composed of several compounds with similar molecular structures but distinct properties. The main component of the complex, filipin 111, comprises about 53%of the total. Some of the latter work was done using filipin 111, but some workers have continued to use the complex. Thus, all results with “filipin” may hot be strictly comparable. Some pertinent differences between the biological properties of the various filipin fractions are discussed by Sessa and Weissmann ( 1968b).
A. STUDIESIN SOLUTION The earliest work carried out on the problem of sterol-polyene interaction was based on the observation of changes in absorption spectra that occurred when sterols were added to aqueous preparations of polyenes. Thus, Lampen et al. (1960) and Gottlieb et al. (1961) deduced that cholesterol and ergosterol combined with nystatin, antimycoin, and filipin, greatest spectral changes occurring with filipin. Norman et al. ( 1972a,b) have recently repeated these experiments, and found that filipin, lucensomycin ( Etruscomycin ) , amphotericin B, nystatin, and pimaricin interact with cholesterol, the magnitude of the interaction being in the order given. The precise chemical nature of the sterol greatly affected the degree of action, an optimum effect being obtained with compounds containing a cholestane ring and a A-22 double bond. Thus, it appears that the interaction is hydrophobic. Sterol esters were found to be of low activity in this respect. Polyenes are known to form suspensions of micelles rather than true solutions in aqueous solvents; e.g., Lampen et al. (1959) and Norman et al. (1972b) found that Em for filipin was consequently lower in water than in methanol, and the Beer-Lambert law is not obeyed. Thus, experimental results based on spectrophotometric measurements are open to the criticism that changes in spectra may be due merely to the fact that polyenes are less soluble in dilute aqueous solutions of sterols than in pure water, However, change in micellar size may be argued to be
FUNGAL STEROLS AND POLYENE ANTIBIOTICS
117
a direct effect, and, if specific for a certain sterol, is clearly of potential physiological significance; similarly, where qualitative changes occur the only explanation is interaction. These hypothetical difficulties may be overcome, however, by measuring a parameter which is (unlike extinction coefficient) not concentration dependent. Such a parameter is partial quantum efficiency, measured spectrofluorimetrically. As a criterion for fluorescence appears to be an uncharged molecule, original experiments were carried out using the nonionized pentaenes filipin and Iagosin (Norman et aE., 1972a; Schroeder et al., 1971; Bittman and Fischkoff, 1972). The combination of sterols with these compounds was found in general to decrease fluorescence and partial quantum efficiency, thereby offering direct evidence for the interaction of such compounds as cholesterol, p-stigmasterol, ergosterol, and P-cholestenol with the antibiotics. The intrinsic fluorescence of amphoteric polyenes, such as nystatin, amphotericin B, pimaricin and its homolog lucensomycin, is extremely low. However, it was found that fluorescence increased ( in some cases substantially) when the antibiotics combine with cholesterol and other P-OH sterols (Crifo et al., 1971; Strom et al., 1973a,b; Schroeder et al., 1972; Norman et al., 1972a), thus again providing evidence in favor of the sterol-polyene interaction hypothesis. By means of another fluorimetric parameter, fluorescence polarization, Bittman and Fischkoff (1972) and Strom et al. (1973a), were able to show that when polyene antibiotics combine with the sterols the rigidity of the polyene molecule increases. Schroeder et al. (1972) reported that the stoichiometry of the filipin/cholesterol interaction was 1:1; they also found that filipin may, after recrystallization from organic solvents, exist in forms that react with sterols only after some considerable period of time in aqueous solution.
B. DIFFERENTIAL CALORIMETRY Norman et al. (1973a,b) have investigated the effects of the incorporation of cholesterol into, and the subsequent addition of polyene antibiotics to, dispersions of lecithin. The lecithins used in these cases, l-oleoyI-2-stearoyI-sn-glycero-3-phosphorylcholine and 1,2-dielaidoyl-snglycero-3-phosphorylcholine, each display a phase change at about 13OC which is characterized by a sharp absorption of heat as the lecithin changes from a crystalline to a liquid crystalline structure. The heat is required to melt the hydrocarbon chains. When sterols are incorporated into the lecithin dispersion, the phase change becomes less endothermic (de Kruyff et al., 1972); it is interesting that cholesteroI had a much greater effect on the energy content of this phase transition than did epicholesterol or sterols lacking a 3-OH group or a 17 side chain.
118
J . M.
T. HAMILTON-MILLER
Demel et al. (1972b) further showed that such sterols-which have also been shown to be those that interact the best with the polyenes-also have the greatest effect on the permeability of liposomes (see next paragraph). This system clearly offers scope for the investigation of the interaction of polyenes with sterols, as the combination of the two will result in a greater or lesser negation of the effect of the sterol on the heat content of the phase transition of lecithin. By differential scanning calorimetry, Norman et al. (1972a,b) have shown that filipin, lucensomycin, pimaricin, nystatin, and amphotericin B all interact with cholesterol, and that the antibiotics by themselves had no effect on the phase transition of lecithin. Under the conditions used (viz. highly concentrated solutions ), the stoichiometry of the interaction varied from 1.2 to 7.9 molecules of cholesterol complexed per polyene molecule (Norman et al., 1972a).
C. EXPERIMENTS WITH MONOLAYERS The interaction of polyenes and sterols can also be quantitated by measuring changes in surface pressure occurring when polyenes ( which behave as soluble compounds under the experimental conditions obtaining) are injected beneath monolayers of lipids or lipid mixtures at varying initial surface pressures. These changes are brought about because interactions alter the spatial orientation of the lipid molecules with respect to the air-water interface; Demel et al. (1967) discovered that cholesterol had a condensing effect on monolayers of certain lecithins. Demel et al. (1965), using this technique, found that nystatin was less active than filipin, which reacted more strongly with cholesterol than with ergosterol, and virtually not at all with phospholipids. Monolayers prepared from material extracted from bacterial protoplast membranes were not affected by filipin, in contrast to similar monolayers made from erythrocyte membranes. In an extension of this study, Demel et al. (1968a) found that lucensomycin, amphotericin B, and pimaricin behaved like filipin and nystatin; they also showed that the activity of filipin was decreased if the phospholipid: cholesterol ratio of the monolayer was increased. Filipin at high concentrations interfered with monolayers of lecithin alone, but this interaction, also reported by Sessa and Weissman (1967) using a different system (see below), was not considered to be of physiological significance. The facts that ( i ) monolayers of cholesteryl acetate were virtually unaffected by filipin, (ii) filipin at low concentrations reacted with monoand (iii) 5 M urea, layers of cetyl alcohol (CH,.(CH2),,.CH,0H), which is known to disrupt hydrogen bonds, diminishes the effect of filipin on cholesterol monolayers, suggested that, in this heterogeneous system as
FUNGAL STEROLS AND POLYENE ANTIBIOTICS
119
opposed to in solution (see above), hydrophilic bonding may be important in the interaction of sterols with polyenes (see Demel et al., 1972a).
D. EXPERIMENTS WITH BILAYERS Van Zutphen et al. (1966) were the first to exploit the fact that stable bilayer lipid films possess certain dimensional, mechanical, electrical, and permeability properties, which are characteristic of the membranes of living cells, in order to investigate the sterol-polyene interaction. Such bilayer films had been developed a few years previously; they are formed from solutions of lipids across a small hole in a membrane, contained in a small cell. The cell is then filled with an appropriate solution, such as 0.1 M NaCl, and the passage of ions across the film can be studied by introducing the marker on one side of the membrane, and measuring its concentration subsequently on the other side. In their early work, van Zutphen et al. (1966) in fact merely studied the macroscopic stability of bilayer films in the presence of filipin; they found that lecithin films were stable for more than 1 hour in the presence of c. 4 x M filipin and nystatin, while bilayers comprised of equal parts of cholesterol and lecithin disrupted after 5 and 25 minutes, respectively, when these polyenes were added. Films made of 10 parts of lecithin to 1 of cholesterol were more stable. The concentration of polyene used in these experiments was about 10 times that required to prevent the growth of Candida albicans (see Hamilton-Miller, 1973a), and some 5000 times greater than that which had an effect on lipid monolayers (see preceding section) ; this discrepancy is doubtless due to the rather crude criterion of activity. In a later, more extended study, van Zutphen et al. (1971) investigated the effects of filipin, nystatin, lucensomycin, pimaricin, and amphotericin B on bilayers of various compositions. In addition to showing the disrupting effects of the antibiotics, which roughly paralleled their physiological activities in terms of hemolytic abilities (Kinsky, 1963), it was found that the electrical dc resistance of lecithinlcholesterol black films could also be markedly decreased ( u p to 1000-fold) by polyene treatment. Bilayers exposed to filipin (components 11, 111, or the complex) became selectively permeable to Ca'+ ions, while those treated with nystatin or amphotericin B became, under appropriate conditions, anion selective, although being of increased permeability to cations as well. High concentrations of filipin (0.1 mM) or nystatin ( 10 mM) also slightly lowered the resistance of, and disrupted, bilayers composed of lecithin alone. Lippe (1968) found that the permeability of mixed bilayers to an uncharged molecule, thiourea, was increased, while the film remained completely stable, 10fold and 4-fold by 1 p M and 0.2 p M amphotericin B, respectively [cf.
120
J . M. T. HAMILTON-MILLER
antiyeast activity of amphotericin B c. 0.5 pM ( Hamilton-Miller, 1973a)1. Andreoli and Monahan (1968) and Andreoli et al. (1969) used bilayers made from sheep erythrocyte lipids, and their observations on the action of nystatin and amphotericin B on such films are in general agreement with those made by van Zutphen et al. (1966, 1971)-thus, electrical resistance was decreased one millionfold, permeability to C1- and CH,.COO- was increased greatly and to Na+, K+, and Li+ to a lesser extent. On the basis of their findings, they calculated that amphotericin B causes the formation in this type of membrane of pores of equivalent radii 0.7 to 1 nm. The results of Finkelstein and Cass (1968) are also generally in line with those listed above; they made the further observations that, in nystatin-treated bilayers, membrane conductance decreased extraordinarily with increasing temperature, the process having a Ql0 of about 1000, and also that the conductance was proportional t o the tenth power of the nystatin concentration. Both the latter authors and Andreoli et al. (1968, 1969), however, were unable to detect changes in ion permeability or electrical properties after filipin treatment, although bilayers were readily lysed by this compound. Cass et al. (1970) and Holz and Finkelstein (1970) investigated the changes in permeability to ions, water, and nonelectrolytes in lipid membranes induced by amphotericin B and nystatin, and concluded that the behavior of such systems was consistent with the formation of nonstatic pores, of diameter about 0.8 nm, which coalesce and reform continuously. The permeability to water and small hydrophilic solutes of polyene-treated bilayers approximated closely to that of normal erythrocytes.
E. LIPOSOMES
If 'lecithin is allowed to swell in water, or if solutions (in solvents such as decane or chloroform) of lecithin, dicetylphosphate, and, if desired, sterols are mixed, allowed to evaporate and then suspended in an aqueous menstruum, the result is the formation of spherical structures consisting of several bimolecular layers of mixed lipids separated by aqueous compartments, varying in diameter (according to the method of homogenization) from 0.5 to 50 pm (Sessa and Weissmann, 1968a). Such bodies, now generally called liposomes, are very useful as model membranes, and have been widely utilized for the study of the interaction of polyenes and sterols. Liposomes are, by nature, much less permeable to cations than to anions, and are liable to osmotic swelling, as water is freely diffusible through the membranes. The permeability of lecithin liposomes is reduced by the incorporation of cholesterol, but this sterol effect is markedly dependent upon the chemical nature of
FUNGAL STEROLS AND POLYENE ANTIBIOTICS
121
the lecithin (Demel et al., 1968b; de Gier et al., 1968). Cholesterol seems to make the phospholipid molecules pack more tightly, thereby increasing the stability of the membrane. It is, presumably, this packing effect with which polyenes interfere in order to have their effect on permeability. One of the most convenient methods of applying liposomes involves the trapping of a marker such as glucose, Cr042-,or H,PO,-, removal of external marker by dialysis or gel filtration, and measurement of its transfer from the disperse to the continuous phase after treatment of the suspension with a polyene. A disadvantage inherent in the use of liposomes is that high concentrations of antibiotics ( > 10 p M ) are necessary, a fact which gave rise to some early confusion when Weissmann and Sessa (1967) reported that filipin was active against liposomes composed of lecithin only-a cognate phenomenon to that found with bilayers. Reaction also occurred with liposomes made from sphingomyelin, cardiolipin, and phosphatidylcholine, and was not due to the nature of the charge on the liposome (Sessa and Weissmann, 1967). This paradox was resolved when it was found that filipin 11, which comprises 252 of the filipin complex, was responsible for this phenomenon (Sessa and Weissman, 1968b). The results obtained with this techinque using liposomes of lecithin and lecithin /cholesterol in general provide evidence which supports the sterol-polyene interaction theory; thus, using a sensitive assay for glucose, Kinsky et al. (1968) showed that the filipinmediated release of this substance was much more rapid from cholesterol/lecithin liposomes than from lecithin liposomes. Neither they nor Weissmann and Sessa (1967), however, were able to show interaction between either pimaricin or lucensomycin and cholesterol-containing liposomes. Recent experiments by HsuChen and Feingold (1973) indicate the importance of the nature of phospholipid; they found that cholesterol incorporation into egg lecithin liposomes enhanced the sensitivity of the liposome to amphotericin B (as found above), but that the sensitivity of dipalmitoyl lecithin liposomes was in fact decreased by the incorporation of cholesterol. This phenomenon is explained by postulating that the membrane must be in an ordered state for a polyene to cause permeability changes therein, and that cholesterol, while making liposomes of egg lecithin more ordered, decreases the order of dipalmitoyl lecithin liposomes. Liposomes containing sterols have been shown both to bind and to alter the ultraviolet absorption spectra of polyene antibiotics. Norman et al. (1972a) demonstrated this for filipin, lucensomycin, and amphotericin B, but the phenomenon was not apparent using nystatin or pimaricin. The same workers showed that the presence in the sterol of a 3P-OH group is an absolute requirement for interaction with polyenes, in conand 3 keto trast to the situation in solution (see above), where 3 ~ 0 H
122
J . M. T. HAMILTON-MIL,LEXI
sterols, as well as sterol esters, do react, although less well than 3 p O H compounds. Similarly, liposomes of appropriate composition alter the fluorescence properties of polyenes: Drabikowski et al. (1973) and Strom et al. (1973a) reported that the fluorescence intensities of solutions of filipin and lucensomycin, respectively, were enhanced in the presence of liposomes made from cholesterol and lecithin. The finding in respect to filipin is of interest in view of the quenching of fluorescence by “soluble” cholesterol ( see above). Liposomes can also be made from material extracted from naturally occurring membranes. De Kruyff et al. (1972) and McElhaney et al. ( 1973) have indicated that such liposomes have permeability properties very similar to those of the cells from which they were derived-in these cases, A. laidlawii. This model, in the hands of Demel et al. (19721,) and de Kruyff et aE. (1972, 1973), shows quite clearly that the structural requirements for sterols to give optimal reductions in permeability to noneIectrolytes ( e.g., erythritol and glycerol) as well as electrolytes (e.g., Rb’), in both whole cells of A. laidlawii and derived liposomes, are identical with those for maximum interaction with the polyenes. This is indeed an intriguing finding, which indicates why polyenes can have such a devastating effect on cellular permeability, combining most avidly with the very steroIs whose presence most affect permeability.
F. STUDIESWITH DISRUPTED NATURAL MEMBRANES Most of these studies have been carried out using erythrocyte ghosts, which are very easy to prepare in bulk, and are known to contain about 50 mole I% of their total lipid as cholesterol and are thus equivalent to liposomes composed of equal parts of cholesterol and lecithin, or membrane preparations from A. laidlawii. The convenience of the latter is that it may be preconditioned to contain a particular sterol, or none. Crifo et al. (1971) and Strom et ul. (1973b) found that the fluorescence of lucensomycin was enhanced by erythrocyte ghosts; treatment of the ghosts with formaldehyde or extraction with methanoI/chloroform did not remove this effect. The enhancement occurred much more rapidly than when free cholesterol was used. Norman et al. (1972a,b) reported that erythrocyte ghosts alter the absorption spectra of filipin, lucensomycin, and amphotericin B, as did membranes from A. laidluwii enriched with cholesterol; membranes lacking cholesterol, or enriched with the 3a isomer epicholesterol, did not bring about spectral changes. Electron microscope examination of red cells lysed with filipin and negatively stained revealed the presence of pits about 12 nm in diameter (Kinsky et al., 1966). This sort of evidence is fully consistent with the
FUNGAL STEROLS AND POLYENE ANTIBIOTICS
123
theory (Kinsky et al., 1967b) that filipin acts by inducing a lamellar to micellar phase change in membranes. These electron micrographic studies have also been able to show conclusively that the action of saponins, which are hemolytic agents whose activity is blocked by sterols, is entirely different to that of polyenes. A later study (Verkleij et al., 1973), using a freeze-etch technique as opposed to negative staining, showed that the pits were not in fact pores which penetrated the membrane, but were rather areas of aggregated material, presumably composed of filipin-cholesterol complexes. Lesions of an identical type were seen in A. laidlawii membranes and liposomes damaged by filipin. No parallel phenomenon was observed in membranes which had been in contact with amphotericin B, but the postulated size of “pores” produced under these conditions-0.5-1 nm in diameter (Andreoli et al., 1969)-would not be visible after freeze-etching. Membranes from A. Zaidawii, if they contained cholesterol, caused changes in the absorption spectrum of filipin, lucensomycin, and amphotericin B and also bound the antibiotics (Norman et al., 1972a,b). Similar findings were made for filipin interacting with membranes obtained from disrupted rabbit sarcoplasmic reticulum ( Drabikowski et al., 1973); such binding was associated with an increase in the .fluorescence of filipin.
G. EXPERIMENTS WITH WHOLE CELLSAND FUNCTIONAL SUBCELLULAR FRACTIONS 1 . Erythrocytes
Kinsky et al. (1962) were the first to show that polyenes caused hemolysis; filipin was the most active compound, followed by amphotericin B and nystatin. In further experiments, Kinsky (1962, 1963) showed that several polyenes lysed erythrocytes and caused permeability changes to N . crassa protoplasts, but did not affect bacterial protoplasts; the polyenic compound vitamin A (retino1)-which, it should be noted, is not a macrolide-lysed red cells and bacterial protoplasts, but not fungal protoplasts. Kinsky et al. (1967a) correlated the hemolytic and chemical properties of various filipin derivatives, the perhydro compound (obtained by catalytic hydrogenation), the irradiated derivative and the saponified adduct (the lactone ring having been broken by aqueous NaOH ) . All these derivatives had drastically decreased hemolytic and antifungal activities, and were later shown (e.g., Demel et al., 1968a) also to have diminished power to combine with sterols. A further degradation product of filipin (structurally much less altered than the compounds mentioned above), the tetraenic epoxide ( Rickards et al., 1970), is also devoid of sterol-combining power (Schroeder et al., 1972). Sessa
124
J.
M. T. HAMILTON-MILLER
and Weissman (1968b) found that the hemolytic and sterol-combining activities of the four components of filipin ran in parallel. An important point, stressed by Kinsky et al. (1967a), is that it is the ratio of antibiotic to sterol, rather than the absolute concentration of antibiotic, which determines the rate and extent of hemolysis. 2. Mitochondria The function of mitochondria, isolated from a sensitive organism, N . crassa, was not affected by polyenes, although the antibiotics were bound (Kinsky et al., 1965). This lack of sensitivity was attributed to the high phospholipid to sterol ratio in the mitochondria1 membrane (c. 40: 1)) compared to microsomes ( 7 : 1 ) , the latter fraction accounting for the bulk of antibiotics binding in this species. These phospholipid: sterol ratios are virtually identical to those reported in mammalian tissues (Parsons and Yano, 1967), and should be compared with the figures for parenchymatous cell membranes (c. 1.3:1 Dod and Gray, 1968), and erythrocyte membranes ( 1:1) . Weissman et al. (1966) reported that polyenes disrupted lysosomes, but did not affect mitochondria, from rabbit cells. 3. Tissues from Cold-Blooded Animals
Lippe and Giordana (1967) reported a differential effect on amphotericin B on the large and small intestine of Testudo; the mucosal bur not the serosal side of the large intestine became more permeable to thiourea after exposure to the antibiotic. A similar type of effect was noted using toad bladder; Lichtenstein and Leaf (1965) observed that amphotericin B acted on the mucosal side of the bladder only, mimicking to some extent the action of antidiuretic hormone. Leung and Eisenberg (1973) have reported an effect of nystatin on frog skeletal muscle, the result of which is an increase in membrane conductance.
4. Insect Larvae The experiments of Sweeley et al. (1970) and Schroeder and Bieber (1971/1972) have shown that filipin kills the larvae of the house fly and interferes with cholesterol metabolism in the Iarvae of the wax moth. The administration of cholesterol can reverse some of these deleterious effects. The disturbance of phospholipid metabolism reported may not be a direct effect of polyene, but a consequence of the altered cholesterol metabolism.
5 . Microorganisms Experiments elucidating the role of sterols in the mode of action of the polyenes will be described very briefly, as they have been covered
FUNGAL STEROLS AND POLYENE ANTIBIOTICS
125
in detail elsewhere. That exogenously added sterols can protect sensitive organisms from the action of polyenes has been demonstrated by Lampen et al. (1960) and Gottlieb et al. (1960) for S. cerevisiw, and by Zygmunt and Tavormina (1966) for C . albicans. Resistant organisms that do not contain sterols become sensitive when they have incorporated sterols into their membranes: this was shown for A. Zaidlawii by Feingold (1965) and Weber and Kinsky (1965), for Schizosaccharomyces iaponiCW by Bulder (1971), and for Pythium spp. by Schlosser and Gottlieb (1966) and by Child et al. ( 1969).
H. DISCUSSION All the diverse and ingenious systems which have been used to probe the mode of action of the polyene antibiotics have given consistent results and have satisfied their users that their behavior resembles that of living cells. Filipin, the antibiotic which shows the greatest membrane-disrupting activity, in terms of lysis of erythrocytes, protoplasts, and black films, and alteration in pressure relationships in monolayers and permeability changes, is also the compound which reacts most strongly with sterols, and whose antiyeast activity is reversed most easily by sterols (Zygmunt and Tavormina, 1966). The general order agreed upon by the various groups using the different techniques is roughly filipin >> amphotericin B ( >lucensomycin, pimaricin ) >nystatin; lucensomycin and pimaricin are in parentheses because by no means all the studies included them. While this order correlates to some extent with the relative toxicities of the antibiotics (thus, filipin is too toxic for human use; nystatin is used topically whereas amphotericin B can be used parenterally), it does not tally at all with the order of antiyeast activity, which is amphotericin B >> nystatin > filipin = pimaricin (HamiltonMiller, 1973a). One is inevitably led to the conclusion that the results of the experiments described above throw more light quantitatively upon the toxicity of the polyenes than upon their precise mode of antimicrobial activity. It is still not clear which of the many sequelae of membrane damage is ultimately responsible for yeast cell death (Lampen, 19f39). The atomic architecture of the sterols with which polyenes preferentially complex has been worked out very clearly. The differences between requirements in solution (where the interaction was primarily by hydrophobic forces) and on the surface of membranous structures (where it is hydrophilic forces that seem to predominate) are of particular interest, While something is known of the stoichiometry of the interaction, there is Iittle information about the precise chemical and physical nature of the sterol-polyene complex. Gale (1973) has recently put forward
126
J. M. T. HAMILTON-MILLER
a tentative scheme for the reaction of polyenes and membranes in V ~ V O . From a physiological point of view, and with the medical microbiologist in mind, perhaps the most significant findings in this respect are that cholesterol and ergosterol are good “receptors” for polyenes, and that cholesteryl esters are much less effective. Again, there is not total agreement when the “polyene avidity” league table for sterols is compared with the ability of sterols to inhibit the antiyeast activity of polyenes. Thus, Gottlieb et al. (1960) and Zygmunt and Tavormina (1966) found that cholesterol acetate effectively reversed the action of filipin on C . albicans, and that stigmasterol, the most active compound in in vitro tests in models, was not as good an antipolyene agent as was ergosterol. It is of passing interest to note that the actions of two other antibiotics, mycobacillin ( a polypeptide) and pyrrolnitrin ( a halogenated pyrrole), are to some extent nullified by the presence of certain lipids, including phospholipids and sterols ( Haldar and Bose, 1973). Another point which bears strongly upon the physiological activity of the polyenes and which is brought out by the experiments described above is that it is not only the qualitative and quantitative nature of the sterol in a membrane that is important, but also the stero1:phospholipid ratio, and the chemical nature of that phospholipid. Further, the multiplicity of polyene to sterol molecules also affects the final issue. With all these variables in mind, it can be seen that mechanisms of selective toxicity will be at best difficult and at worst impossible to work out precisely. Overall, however, the quality and the quantity of the research done on the mode of the action of the polyenes is most impressive, if only as an exercise in applied biophysics, and has given rise to two, at least, potentially valuable spin-offs, namely, the nystatin-modified erythrocyte (Cass and Dalmark, 1973) and the muscle fiber with high conductance (Leung and Eisenberg, 1973), both of which may prove to be of extreme value to the physiologists. VI.
Resistance to the Polyene Antibiotics
A search of the literature has revealed only two examples of the occurrence of apparent polyene resistance: Bodenhoff (1968) reported on two cases in which drug-resistant C. albicans appeared in vivo after the prolonged use of polyenes, and Hejzlar and Vymola (1970) describe an apparent increase in the incidence of low-level nystatin resistance in clinically isolated yeasts. Thus, from a clinical point of view, the problem of polyene resistance is nonexistent. There are no other antibiotics in common therapeutic use about which a similar statement could be made. Before experimental work is reviewed in this section, it seems worth while to speculate briefly on this remarkable fact.
FUNGAL STEROLS AND POLYENE ANTIBIOTICS
127
First, the extent of its veracity must be probed. It must be accepted that, at least in the United Kingdom, most medical mycology is carried out in laboratories geared to microbiological investigations in general, the bulk of which involves bacteria and viruses. The presence in such routine laboratories of a trained mycologist is not regarded as necessary. Bearing in mind that the speciation of yeasts is certainly not as easily carried out as is bacterial identification, there is a distinct chance that strains of potentially pathogenic yeasts may be misidentified (or, most commonly, not identified at all), and therefore not reported upon. Further, sensitivity testing to the polyenes is not always routinely carried out, as it is generally assumed that sensitivity is universal. Perhaps the advent of new antimycotics, such as clotrimazole and 5-fluorocytosine, to which there is a range of sensitivities ( Hamilton-Miller, 1972c), may lead to a reappraisal of the whole question of the sensitivity testing of clinically isolated yeasts. The problem of misidentification, however, is by no means so easy to rectify. As pointed out previously by the reviewer ( Hamilton-Miller, 1972a), if resistant variants have even slightly unusual properties ( and the limited evidence available suggests that this might indeed be so), they may very well be misidentified even by experienced mycologists. However, whatever doubts one may cast on the lack of resistance to polyenes, for practical purposes it must be assumed that the happy situation exists whereby the vast majority, at least, of pathogenic yeasts and fungi have retained their sensitivity throughout 15 years or more of polyene usage. Why, then, has resistance not arisen so far? It is known that many (but probably not all) Candida strains are capable, genetically, of giving rise to mutants with markedly lower sensitivity to the polyenes, especially to amphotericin B. Multistep resistant mutants, made in the usual laboratory fashion of serial subculture in the presence of increasing concentrations of antibiotics, have been characterized from several Candida species. Also, single-step mutants of C. albicans have been isolated either with or without the necessity of mutagenesis (see Hamilton-Miller 1973a for reference to the above), but the multistep pathway seems much more common. The only reports of polyene-resistant dermatophytes have so far come from one group (Capek and Simek, 1972), and under in vitro conditions only. Perhaps dermatophyte infections are more often treated with Whitfields ointment or with griseofulvin than with nystatin, but nevertheless there must have been considerable opportunities for the emergence of resistant mutants, which the pathogens do not seem to have grasped. The lack of resistance is even more surprising when one considers the enormous topical use of antifungal antibiotics, topical use of an antibacterial compound often sounding its death knell. Official figures (Annual Report for 1970, 1971) show that 2.9
128
J . M. T. HAMILTON-MILLER
million prescriptions, worth ;E900,000, were written in 1970 in the United Kingdom for “antibacterial and fungicidal agents” prepared for use on the skin and mucocutaneous junctions: a substantial proportion of those prescriptions must have been for preparations containing nystatin. Any attempted explanation for the lack of acquisition of resistance to the polyenes must take into account two predominant factors-first, the opportunistic nature of the pathogen, and second, the physical properties of the antibiotics. While a true study of the nature of polyene resistance is, by its very nature, impossible, such observations as have been made on strains made resistant in vitro tend to support the view that resistance ( a t least the multistep variety) is associated with diminished virulence ( see Athar and Winner, 1971, and references therein). A further lowering of an already low virulence may not allow the organism to continue its parasitic existence, even in the compromised host, so that any resistant celIs that appear under selection during antibiotic treatment may succumb to lost bodily defense mechanisms. As to the second point: the only clear qualitative difference between the polyenes, to which resistance does not occur, and all other antibiotics, to which resistance does occur, is that the polyenes are virtually insoluble in water. This fact may have very important repercussions; as is well known, multistep resistance is encouraged by the use of too small doses of antibiotics, and prevented by the use of massive dosages. Even in very dilute aqueous solution, it seems probable that polyene antibiotics exist in micelles, i.e., packets or quanta of molecules. Thus, a subinhibitory concentration of a polyene antibiotic may well be one in which there are fewer quanta than there are organisms, and one can visualize the situation that any cell that comes in contact with a quantum will perish. In this way, an all-or-none phenomenon will exist, despite superficial appearances to the contrary, as cells will either die or not be exposed at all to the antibiotic, thus effectively preventing the selection of mutants. It is interesting in this respect that Lampen et al. (1959) found that yeast cells absorb far more nystatin than is necessary to kill them. If this hypothesis is correct, namely, that the lack of resistance to polyenes is a consequence of their lack of solubility in water, then the introduction of soluble derivatives of amphotericin B (see Keim et al., 1973) is to be deplored. Time alone will tell.
VII.
The Role of Sterols in Resistance to the Polyenes
Polyene resistance has been demonstrated not only in Candida spp. and dermatophyte strains, as discussed in the preceding section, but has also been found in other organisms of mycological interest, namely Sacchromyces cerevisiae and Neurospora mmsa. In the former species,
FUNGAL STEROLS AND POLYENE .ANTIBIOTICS
129
nystatin-resistant mutants were selected, without prior mutagenesis, by Ahmed and Woods (1967) and Patel and Johnston (1968), while Molzahn and Woods (1973) used ethyl methanesulfonate to obtain their mutants. Grindle ( 1973) isolated polyene-resistant N . crmsu variants after treatment with nitrous acid or ultraviolet light. Patel and Johnston (1971) suggested that the low-level (3.5-fold) resistance occurring in tetraploid S. cerevisiae was due to the difference in surface area to volume ( A I V ) ratio in these cells as compared to haploids, rather than to a biochemical mechanism. Unfortunately, this interesting suggestion was not supported by any hard evidence. In an attempt to resolve this question, the present reviewer ( Hamilton-Miller, 1973c) calculated that AIV ratios for tetraploid yeast cells were 2.7 times larger than for haploid cells, so this “physiological” theory of nystatinresistance is indeed a possibility for polyploid strains of S . cere’euisiae, but cannot be proved in the absence of sterol analyses. In all other cases of reported polyene resistance, where sterol assays have been carried out, changes, qualitative, quantitative, or both, in sterol patterns have been observed. Thus, Woods (1971) and Molzahn and Woods (1972) found a new sterol in nys-1 and pol-1 mutants, and reduction in the content ol ergosterol and its dehydro analog, with replacement by a second new sterol in nys-3 mutants. The pol-2 mutants (Molzahn and Woods, 1972) appeared to lack sterol altogether. Mutants studied by Bard (1972) lacked ergosterol and his nyr-15 strain resembled the nys-3 mutant mentioned above. Most of the N . crussu mutants examined by Grindle (1973) lacked ergosterol: types I and I1 were devoid of sterols; type I11 had greatly reduced levels of ergosterol; and types IV, V, and VI lacked ergosterol and contained other sterols instead. In C . albicuns mutants, Hamilton-Miller ( M 2 b ) found that sterol patterns in strains YL and YS resembled those in the nys-1 mutants of Woods (1971), but that all 4 mutant strains studied contained more ergosterol than the wild-type. The multistep mutants of various Cundidu species studied by Athar and Winner (1971) seemed to be ergosterol-deficient,but lack new sterols (Athar, 1969). It is apparent from the above that alterations in sterol patterns play a crucial role in resistance to the polyenes. Lampen et ul. (1959) showed that the binding of polyene was a prerequisite for the killing of cells, and that a low-level resistant strain of C. albicans absorb